<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="https://www.dolcera.com/wiki/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>https://www.dolcera.com/wiki/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Amika.sethi</id>
		<title>DolceraWiki - User contributions [en]</title>
		<link rel="self" type="application/atom+xml" href="https://www.dolcera.com/wiki/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Amika.sethi"/>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Special:Contributions/Amika.sethi"/>
		<updated>2026-05-01T09:27:25Z</updated>
		<subtitle>User contributions</subtitle>
		<generator>MediaWiki 1.24wmf12</generator>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Gastrointestinal_Endoscopy_-Landscape_Report&amp;diff=9790</id>
		<title>Gastrointestinal Endoscopy -Landscape Report</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Gastrointestinal_Endoscopy_-Landscape_Report&amp;diff=9790"/>
				<updated>2011-09-29T11:30:11Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Overview==&lt;br /&gt;
===Introduction===&lt;br /&gt;
[[Image:Gastrointestinal Tract.png|thumb|right|500px|'''Gastrointestinal Tract''']]&lt;br /&gt;
'''Gastrointestinal Endoscopy''' deals with the endoscopic examination, therapy or surgery of the gastrointestinal tract. Gastrointestinal Tract generally refers to the digestive structures stretching from the mouth to anus, but does not include the accessory glandular organs such as liver, billary tract, panceras. The gastrointestinal tract is categorized into various sections, these include:&lt;br /&gt;
*'''Intestines''': The section of the alimentary canal from the stomach to the anal canal, includes the large intestine and small intestine.&lt;br /&gt;
*'''Lower Gastrointestinal Tract''': The segment of gastrointestinal tract that includes the small intestine below the duodenum, and the large intestine.&lt;br /&gt;
*'''Mouth''': The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper.&lt;br /&gt;
*'''Pharynx''': A funnel-shaped fibromuscular tube that conducts food to the esophagus, and air to the larynx and lungs. It is divided into the nasopharynx; oropharynx; and hypopharynx (laryngopharynx).&lt;br /&gt;
*'''Upper Gastrointestinal Tract''': The segment of gastrointestinal tract that includes the esophagus, stomach and the duodenum.&lt;br /&gt;
(Source: [http://www.ncbi.nlm.nih.gov/mesh/68041981 MeSH Database])&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Procedures===&lt;br /&gt;
Currently, the most commonly used imaging methods for detection of gastrointestinal disorders, including disorders of the small intestine, are&lt;br /&gt;
endoscopy and radiological imaging.&amp;lt;br&amp;gt;&lt;br /&gt;
A traditional endoscope is a device consisting of a flexible tube and an optical system. There are several types of endoscopic procedures used to&lt;br /&gt;
identify disorders in the gastrointestinal tract. The basic endoscopic procedures available include:&lt;br /&gt;
[[Image:upper endoscopy.jpg|thumb|right|300px|[http://www.thaimedicalnews.com/what-is-endoscopy-gastrointestinal-digestion-disorder-exam/2008/04/22/ Upper Endoscopy]]]&lt;br /&gt;
* '''Upper Endoscopy''': In upper endoscopy, the physician inserts an endoscope, which is an approximately 3.5 foot long tube, through the patient’s mouth. In esophagogastroduodenoscopy, or EGD, the gastroscope passes down the esophagus and into the stomach and duodenum for visual examination. In esophagoscopy, only the esophagus is viewed.&lt;br /&gt;
* '''Colonoscopy''': In colonoscopy, the physician inserts a colonoscope, which is an approximately 5.5 foot long endoscope, into the patient’s colon through the anus. Colonoscopy is the primary method for detecting disorders of the colon and is the standard screening tool for early detection of colon cancer.&lt;br /&gt;
* '''Push Enteroscopy''': Push enteroscopy involves the insertion of an approximately six-foot long push enteroscope into the mouth. Due to the length and curvature of the small intestine, push enteroscopy enables the physician to view only the first one-third of the small intestine. The procedure is time consuming and difficult to perform for the physician and significantly more difficult to bear for the patient compared to traditional endoscopy.&lt;br /&gt;
* '''Double Balloon Endoscopy''': The technique involves the use of a balloon at the end of a special enteroscope camera and an overtube, which is a tube that fits over the endoscope, and which is also fitted with a balloon. The procedure is usually done under general anesthesia, but may be done with the use of conscious sedation.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==GI Imaging==&lt;br /&gt;
Gastrointestinal endoscopy is undergoing major improvements, which are driven by new available technologies and substantial refinements of optical features. Detection, characterization and confirmation are essential steps required for proper endoscopic diagnosis. Optical and nonoptical methods can help to improve each step; these improvements are likely to increase the detection rate of neoplasias and reduce unnecessary endoscopic treatments. Furthermore, functional and molecular imaging are emerging as new diagnostic tools that could provide an opportunity for personalized medicine, in which endoscopy will define disease outcome or predict the response to targeted therapy.&lt;br /&gt;
[[Image:Key steps to endoscopic diagnosiss.png|thumb|center|1030px|[http://www.nature.com/nrgastro/journal/vaop/ncurrent/full/nrgastro.2011.152.html Key steps to endoscopic diagnosis]]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Several new technologies are now available for each step, some of them include:&lt;br /&gt;
* '''Narrow-Band Imaging(NBI)''' by Olympus America, uses filter to illuminate mucosa at specific wavelength&lt;br /&gt;
*'''Fujinon Intelligent Color Enhancement(FICE)''' by Fujinon, uses Spectral endoscopic image processing technology which has been developed to estimate spectral information from RGB image data obtained through a routine endoscopy and to better characterize mucosal tissue structures &lt;br /&gt;
*'''I-Scan''' by Pentax Medical, a next generation technology, is a dynamic, multimodal tool revealing the hidden colors, topography, vascularity, and structure of disease. i-SCAN explores the possibility of the first electronic version of chromoendoscopy (e-Chrome™) through the use of complimentary color filters and enhancements&lt;br /&gt;
*'''Third Eye Retroscope®''' by Avantis Medical Systems, an additional small-caliber endoscope that can be passed over the working channel of standard colonoscopes with the possibility of retro view—leads to a substantially increased detection of neoplastic changes&lt;br /&gt;
*'''Endoflag''' by Endopix, is a single filter, single-pass implementation that processes standard or high-definition video sequences after acquisition&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:GI Imaging.png|thumb|center|1030px|'''Classification of GI Imaging''']]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Product Portfolio Heat Map==&lt;br /&gt;
{|align=&amp;quot;center&amp;quot;&lt;br /&gt;
|&amp;lt;gflash&amp;gt;950 750 http://dolcera.com/upload/files/product_Heat_Map.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
==Market Size==&lt;br /&gt;
[[image:GI Endoscopy Market Size.png|center|900px|thumb|Source: Kalorama Information Report]]&lt;br /&gt;
&lt;br /&gt;
===Major Players===&lt;br /&gt;
====Detailed Company Profile====&lt;br /&gt;
[[Olympus Corporation]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
====Snapshot Profiles====&lt;br /&gt;
* [[Boston Scientific Snapshot| Boston Scientific]]&lt;br /&gt;
* [[Conmed Snapshot| Conmed]]&lt;br /&gt;
* [[Covidien Snapshot| Covidien]]&lt;br /&gt;
* [[Ethicon Endo Snapshot| Ethicon Endo ]]&lt;br /&gt;
* [[Fujinon Snapshot| Fujinon]]&lt;br /&gt;
* [[Given Imaging Snapshot| Given Imaging]]&lt;br /&gt;
* [[Karl Storz Snapshot| Karl Storz]]&lt;br /&gt;
* [[Hoya Snapshot| Hoya Corporation]]&lt;br /&gt;
* [[Stryker Snapshot| Stryker]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Source: [[media:kalorama.pdf|Kalorama]], Company website, Company SEC filings &lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==M&amp;amp;A Activity==&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''S.No.'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Date'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Details'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|1&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Oct-10&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.cookmedical.com/newsDetail.do?id=6614 Cook Medical Receives Two Contract Awards with HealthTrust Purchasing Group for Enteral Feeding and GI Endoscopic Supplies]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |2&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|Apr-10&lt;br /&gt;
|[http://www.prnewswire.com/news-releases/water-street-healthcare-partners-signs-definitive-agreement-to-sell-sierra-scientific-instruments-to-given-imaging-88791282.html Given Imaging Ltd acquires Sierra Scientific Instruments from Water St Healthcare Partners]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|3&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Apr-10&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.fujifilmusa.com/press/news/display_news?newsID=880031 Fujifilm signs a comprehensive Joint R&amp;amp;D aagreement with Fox Chase cancer center]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |4&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|Mar-09&lt;br /&gt;
| [http://www.karlstorz.com/cps/rde/xchg/SID-9641E54E-84C58126/karlstorz/hs.xsl/8250.htm KARL STORZ Acquires Global Care Quest]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|5&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Jan-09&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|[http://diagnosticimaging.medicaldevices-business-review.com/news/given_imaging_announces_expansion_of_distribution_agreement_with_fujifilm_090120 Given Imaging Inks Distribution Agreement with FUJIFILM]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |6&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Dec-08&lt;br /&gt;
| [http://www.dotmed.com/news/story/7624/ Given Imaging Ltd. Acquires Medtronic Bravo(R) pH Monitoring Business]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|7&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Nov-08&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.smiths.com/press_release_details.aspx?releaseID=356 Smiths Group Acquires Zhejiang Zheda Medical Instrument]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |8&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Nov-08&lt;br /&gt;
| [http://www.viatronix.com/pdfs/PR112408.pdf Visage Imaging Inks Marketing Agreement with Viatronix]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|9&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Jul-08&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.fujifilm.com/news/n080730.html FUJIFILM Merges Fujinon&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s Endoscope Business into Medical System Business Division]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |10&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Jun-08&lt;br /&gt;
| [http://www.itnonline.com/article/icad-acr-image-metrix-team-initiate-colon-cad-clinical-study ICAD and ACR Image Form Partnership to Initiate Colon-CAD Clinical Study]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|11&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Mar-08&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_31/ai_n24963346/ Karl Storz Inks Deal with EndoGastric for Marketing EsophyX and StomaphyX]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |12&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Mar-08&lt;br /&gt;
| [http://www.investinisrael.gov.il/NR/exeres/01104877-8720-4F39-8441-BD24EC58D8B9.htm Given Imaging Bags a 5-Year FSS Contract]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|13&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Nov-07&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://business.timesonline.co.uk/tol/business/industry_sectors/technology/article2903365.ece Olympus Takes Over Gyrus Group]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |14&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Aug-07&lt;br /&gt;
|[http://en.wikipedia.org/wiki/Pentax#Merger_with_Hoya PENTAX and HOYA Merge]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|15&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Apr-07&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|[http://www.news-medical.net/news/2007/06/26/26855.aspx Boston Scientific to acquire Remon Medical Technologies]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Procedure Volumes==&lt;br /&gt;
The three main areas where GI Endoscopy has considerable applications are Colon/Rectum cancer, Obesity (gastric bypass/gastric banding) and Digestive system disorders.&lt;br /&gt;
===Colon/Rectum cancer===&lt;br /&gt;
[[Image:Colon cancer.png|thumb|right|300px|[http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001308/figure/A000262.B19222/?report=objectonly Stages of Cancer]]]&lt;br /&gt;
Tumors or cancer of the colon or the rectum or both. Colorectal cancer starts in the large intestine (colon) or the rectum (end of the colon). Risk factors for colorectal cancer include chronic ulcerative colitis; familial polyposis coli; exposure to asbestos; and irradiation of the cervix uteri. ([http://www.ncbi.nlm.nih.gov/mesh?term=colorectal%20cancer MeSH]) Colorectal cancer is the third most commonly diagnosed cancer in the world, but it is more common in developed countries.&amp;lt;br&amp;gt;&lt;br /&gt;
Stages of colon cancer are:&lt;br /&gt;
*''Stage 0'': Very early cancer on the innermost layer of the intestine&lt;br /&gt;
*''Stage I'': Cancer is in the inner layers of the colon&lt;br /&gt;
*''Stage II'': Cancer has spread through the muscle wall of the colon&lt;br /&gt;
*''Stage III'': Cancer has spread to the lymph nodes&lt;br /&gt;
*''Stage IV'': Cancer has spread to other organs&lt;br /&gt;
(For more information on colon cancer [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001308/ click here])&lt;br /&gt;
====Volumes, Prevalence and Incidence====&lt;br /&gt;
*Overall, the '''lifetime risk''' of developing colorectal cancer is about '''1 in 20''' (5.1%). This risk is slightly lower in women than in men.&lt;br /&gt;
* Cases estimated in the US in '''2011''' are:&lt;br /&gt;
**''' 101,700''' cases of colon cancer &lt;br /&gt;
**'''39,510''' cases of rectal cancer &lt;br /&gt;
* Overall, colorectal cancer is the second-leading cause of cancer death in Canada.&lt;br /&gt;
** In '''2011''', an estimated '''22,200''' Canadians (12,500 men - 9,700 women) will be diagnosed with colorectal cancer and '''8,900''' (5,000 men - 3,900 women) will die from it.&lt;br /&gt;
** '''One in 14 men''' is expected to develop colorectal cancer during his lifetime and '''one in 27''' will die from it. &lt;br /&gt;
**'''One in 15 women''' is expected to develop colorectal cancer during her lifetime and '''one in 31''' will die from it.&lt;br /&gt;
** On average, '''426''' Canadians will be diagnosed with colorectal cancer every week and '''171''' will die from the disease every week.&lt;br /&gt;
(Source: [http://www.colorectal-cancer.ca/en/just-the-facts/colorectal/ Colorectal cancer association of Canada] &amp;amp; [http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-key-statistics American cancer society])&lt;br /&gt;
====Survival Rates====&lt;br /&gt;
[[Image:survival rates.png|center|thumb|800px|[http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-survival-rates Source:SEERdatabase]]]&lt;br /&gt;
====Incidence rates====&lt;br /&gt;
The estimated incidence rate of colorectal cancer in 2007 is expressed geography wise below:&lt;br /&gt;
&lt;br /&gt;
{|align = &amp;quot;center&amp;quot; border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;45%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Area'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Incidence per 100,000 people'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|North America&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|17-33.5&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Europe&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|17-33.6&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Asia&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|17-33.7&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|South America&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|17-33.4&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Africa&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|3.2-17&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
Source: Kalorama Information Report&lt;br /&gt;
&lt;br /&gt;
===Obesity (Gastric bypass/Gastric banding)===&lt;br /&gt;
A status with '''body weight''' that is grossly above the acceptable or desirable weight, usually due to accumulation of excess fats in the body. The standards may vary with age, sex, genetic or cultural background. In the Body mass index, a '''BMI greater than 30.0 kg/m2''' is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (morbid obesity).[[Image:gastric band.png|thumb|right|300px|[http://weightlosssurgery.ae/gastric-banding-surgery.php Laparoscopic Gastric Banding]]]&lt;br /&gt;
The two most common weight-loss surgeries are:&lt;br /&gt;
*[http://www.nlm.nih.gov/medlineplus/ency/article/007388.htm Laparoscopic Gastric Banding](also referred as lap band): The surgeon places a band around the upper part of your stomach, creating a small pouch to hold food. The band helps you limit how much food you eat by making you feel full after eating small amounts.&lt;br /&gt;
*[http://www.nlm.nih.gov/medlineplus/ency/article/007199.htm Gastric Bypass]: This surgery helps you lose weight by changing how your stomach and small intestine handle the food you eat. After the surgery, you will not be able to eat as much as before, and your body will not absorb all the calories and other nutrients from the food you eat.&lt;br /&gt;
====Volumes, Prevalence and Incidence====&lt;br /&gt;
* In '''United States''' obesity is estimated to cause an excess '''111,909 to 365,000 deaths per year'''&lt;br /&gt;
* '''One million''' (7.7%) of deaths in the '''European Union''' are attributed to excess weight.&lt;br /&gt;
* On an average, obesity reduces life expectancy by '''six to seven years''':&lt;br /&gt;
** A BMI of 30–35 reduces life expectancy by two to four years&lt;br /&gt;
** While morbid obesity (BMI &amp;gt; 40) reduces life expectancy by 10 years&lt;br /&gt;
* Large-scale American and European studies have found that mortality risk is lowest at a BMI of 20–25 kg/m2, with risk increasing along with changes in either direction. ([http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2960318-4/fulltext Source: thelancet] &amp;amp; [http://jama.ama-assn.org/content/282/16/1530.full jama-ama-assn])&lt;br /&gt;
*'''Obesity prevalence rate in USA'''&lt;br /&gt;
[[Image:prevalence.png|thumb|center|900px|[http://www.cdc.gov/obesity/data/trends.html Percent of Obese (BMI &amp;gt; 30) in U.S. Adults]]]&lt;br /&gt;
&lt;br /&gt;
===Digestive system disorders===&lt;br /&gt;
Diseases in any part of the gastrointestinal tract or the accessory organs (liver; biliary tract; pancreas). The digestive system disorders are categorized as: &lt;br /&gt;
*Biliary Tract Diseases&lt;br /&gt;
*Digestive System Abnormalities&lt;br /&gt;
*Digestive System Fistula&lt;br /&gt;
*Digestive System Neoplasms&lt;br /&gt;
*Gastrointestinal Diseases&lt;br /&gt;
*Liver Diseases&lt;br /&gt;
*Pancreatic Diseases&lt;br /&gt;
*Peritoneal Diseases&lt;br /&gt;
([http://www.ncbi.nlm.nih.gov/mesh?term=Digestive%20system%20disorders Source: MeSH])&lt;br /&gt;
====Volumes, Prevalence and Incidence====&lt;br /&gt;
*Hospital visits in USA (Digestive disorders as the primary reason)&lt;br /&gt;
[[image:digpri.png|thumb|center|600px|[http://www.cdc.gov/nchs/data/ad/ad374.pdf Source:CDC health statistics report]]]&lt;br /&gt;
*Disease wise breakup (Digestive disorders as the primary reason)&lt;br /&gt;
[[image:digbreakup.png|center|700px|thumb|[http://www.cdc.gov/nchs/data/series/sr_13/sr13_169.pdf Source: CDCsurvey]]]&lt;br /&gt;
*USA and Europe Procedure Volumes&lt;br /&gt;
[[Image:provol.png|center|700px|thumb|Source: Kalorama Information; WHO; US Census Bureau; Centers for Disease Control and Prevention]]&lt;br /&gt;
NOTE: All values for USA and Europe are in 000's. Data includes both in-patient and out-patient surgical procedures in all populations&lt;br /&gt;
==Reimbursements==&lt;br /&gt;
===Upper GI/ Colonoscopy===&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;90%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''CPT Code'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Procedure'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''2008 National Average Medicare Payment Facility'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43250&lt;br /&gt;
|Upper GI endoscopy including esophagus, stomach and either duodenum and/or jejunum as appropriate; with removal of tumors, polyps, or other lesions by hot biopsy forceps or bipolar cautery&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$172.91&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43251&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Upper GI endoscopy including esophagus, stomach and either duodenum and/or jejunum as appropriate; with removal of tumors, polyps, or other lesions by snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$199.58&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43255&lt;br /&gt;
|Upper GI endoscopy including esophagus, stomach and either the duodenum and/or jejunum as appropriate; diagnostic, with control of bleeding any method&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$258.99&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43256&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Upper GI endoscopy including esophagus, stomach and either the duodenum and/or jejunum as appropriate; with transendoscopic stent placement (includes predilation)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$233.09&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43258&lt;br /&gt;
|Upper GI endoscopy including esophagus, stomach and either the duodenum and/or jejunum as appropriate; with ablation of tumors, polyps, or other lesions not amendable by hot biopsy forceps, bipolar cautery or snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$244.14&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|45383&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$307.36&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|45384&lt;br /&gt;
|Colonoscopy, flexible, proximal to splenic flexure; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps or bipolar cautery&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$248.33&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|45385&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Colonoscopy, flexible, proximal to splenic flexure; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$281.84&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|91110&lt;br /&gt;
|Gastrointestinal tract imaging, intraluminal (e.g., capsule endoscopy), esophagus through ileum, with physician interpretation and report (Visualization of the colon is not reported separately)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$944.18&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
===Bariatric Surgery===&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;90%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''APC'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''APC Description (Hospital Outpatient Dept)'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Medicare Payment'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|130&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Level I Laparoscopy (CPT 43659)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$2,190.81&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|135&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Level III Skin Repair (CPT 43887)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$288.30&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|137&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Level V Skin Repair (CPT 43886, 43888)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,287.06&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|141&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Level I Upper GI Procedure (CPT 43999)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$541.59&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;90%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''CPT Code'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Procedure'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''2008 National Average Medicare Payment Facility'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43886&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric reconstructive procedure, open; revision of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$836.59&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43888&lt;br /&gt;
|Removal and replacement of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$836.59&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43644&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux-en-Y gastroenterostomy (Roux limb 150 cm or less)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,507.10&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43645&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,615.27&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43659&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Unlisted laparoscopy procedure, stomach (Removal and replacement of both adjustable gastric band and subcutaneous port component)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Carrier Priced&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43770&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric band (gastric band and subcutaneous port components)(use modifier - 52 for individual component placement)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$970.08&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43771&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Laparoscopy, surgical, gastric restrictive procedure; Revision of adjustable gastric band component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,107.95&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43772&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure; Removal of adjustable gastric band component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$833.72&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43773&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Laparoscopy, surgical, gastric restrictive procedure; Removal and placement of adjustable gastric band component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,107.95&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43774&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure: Removal of adjustable gastric band and subcutaneous port components&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$838.29&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43842&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical banded gastroplasty&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,071.01&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43843&lt;br /&gt;
|Gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical banded gastroplasty&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,097.67&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43845&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy (50 to 100 cm common channel) to limit absorption (billopancreatic diversion with duodenal switch)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,716.20&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43846&lt;br /&gt;
|Gastric restrictive procedure, with gastric bypass, for morbid obesity; with short limb (150 cm or less) Roux-en-Y gastroenterostomy&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,416.07&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43847&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric restrictive procedure, with small intestine reconstruction to limit absorption&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,553.19&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43848&lt;br /&gt;
|Revision of gastric restrictive procedure for morbid obesity (separate procedure), other than adjustable gastric band&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,680.40&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43886&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric reconstructive procedure, open; revision of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$287.18&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43887&lt;br /&gt;
|Removal of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$272.32&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43888&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Removal and replacement of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$387.34&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43999&lt;br /&gt;
|Unlisted procedure, stomach&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Carrier Priced&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|S2083&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Carrier Priced&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Technology Advancements==&lt;br /&gt;
{|align = &amp;quot;center&amp;quot; border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;60%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Areas'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Companies Involved'''&lt;br /&gt;
|-&lt;br /&gt;
|rowspan = &amp;quot;6&amp;quot;|'''Enhanced Imaging Modalities'''&lt;br /&gt;
|Olympus Medical System Corp.&lt;br /&gt;
|-&lt;br /&gt;
|Pentax Crop. (Hoya Corporation)&lt;br /&gt;
|-&lt;br /&gt;
|Fujinon&lt;br /&gt;
|-&lt;br /&gt;
|Mauna Kea Technologies&lt;br /&gt;
|-&lt;br /&gt;
|KARL STORZ&lt;br /&gt;
|-&lt;br /&gt;
|SpectraScience Inc.&lt;br /&gt;
|-&lt;br /&gt;
|'''Robotic-Assisted Endomicroscope'''&lt;br /&gt;
|EndoControl Inc.&lt;br /&gt;
|-&lt;br /&gt;
|'''Wireless Biosensors and Polymers for GI bleeding (Hemostasis)'''&lt;br /&gt;
|Pluromed Inc.&lt;br /&gt;
|-&lt;br /&gt;
|'''Electronic Nose &amp;quot;Smells&amp;quot; Disease'''&lt;br /&gt;
|Cyrano Science Inc.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:chromoendoscopy.png|thumb|center|800px|'''Enhanced Imaging Modalities''': High-definition and virtual chromoendoscopy; (a) White-light imaging during endoscopy; a lesion beside a diverticular is hardly visible (arrow). (b) Closer inspection and image enhancement reveals tubular surface structures (arrows); (c) Virtual chromoendoscopy leads to pseudocolorization and improved visualization of the flat adenoma (arrows); (d) Chromoendoscopy using methylene blue unmasks the full extent of the lesion (arrows).]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9789</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9789"/>
				<updated>2011-09-29T11:29:43Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: /* Technology */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Intellectual Property (IP) Services|Intellectual Property(IP) Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Business &amp;amp; Information Research Services|Business and Information Research Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Dolcera Technology Platforms|Dolcera Technology Platform]]&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Intellectual Property (IP) Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey;width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey; width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Alopecia - Hair Loss]] | ([http://www.youtube.com/watch?v=jAIoyKuKQ6o Video])&lt;br /&gt;
* [[Inflammation and cardiovascular drugs]] | ([http://www.youtube.com/watch?v=FVUFcz2dpIM Video])&lt;br /&gt;
* [[RNAi Database sample wiki]] | ([http://www.youtube.com/watch?v=nsZLUSPn3cg Video])&lt;br /&gt;
* [[Choline Bitartarate]]&lt;br /&gt;
* [[Non-wovens]]&lt;br /&gt;
* [[Pressure sensitive adhesives]] | ([http://www.youtube.com/watch?v=plP3TzjYsiQ Video])&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Smart Drug Delivery Systems]] | ([http://www.youtube.com/watch?v=vARe9eBFsq4 Video])&lt;br /&gt;
* [[Silicone Hydrogel contact lens]]&lt;br /&gt;
* [[SC Johnson]]&lt;br /&gt;
* [[Pinene: An off flavor in mango juice]] | ([http://www.youtube.com/watch?v=P4fI1rjPjSg Video])&lt;br /&gt;
* [[Bio-PET]]&lt;br /&gt;
* [[Interferon For Treatment of Melanoma]]&lt;br /&gt;
* [[Antibody against TNF]]&lt;br /&gt;
* [[Pressure sensitive adhesives in packaging]] &lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Hybrid Electric Vehicle Battery System]]&lt;br /&gt;
* [[Supply Chain RFID Applications]]&lt;br /&gt;
* [[Insurance sector]]&lt;br /&gt;
* [[CDMA Basics]]&lt;br /&gt;
* [[Quality of Service on CDMA platforms]]&lt;br /&gt;
* [[OLED - Organic Light Emitting Diode]]&lt;br /&gt;
* [[Carbon Nanotubes (CNT)]] | ([http://www.youtube.com/watch?v=HvZqBy8XvIE Video])&lt;br /&gt;
* [[Metallic and Ceramic construction materials]]&lt;br /&gt;
* [[Transactional memory]]&lt;br /&gt;
* [[Invalidation Search on a patent in the semiconductors space|Invalidation Search]]&lt;br /&gt;
* [[Golf Club Head Landscape]]&lt;br /&gt;
* [[Variable Valve Timing - Sample]]&lt;br /&gt;
* [[Wind Energy]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;STN Search Reports&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Markush Search Report]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard - live] &lt;br /&gt;
** ([[Alopecia Areata Dashboard Screenshots|Screenshots only]]) &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=587 RNAi Dashboard]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=27 Automotive dashboard - live]&lt;br /&gt;
** [[Automotive Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 WiMAX dashboard - live] &lt;br /&gt;
** [[WiMAX Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid_model.swf RFID dashboard]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;IP Valuation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*[[Holographic Image Display]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://dolcera.com/client/d8r3/hairloss_map.htm Alopecia/Hair loss IPMap]&lt;br /&gt;
* [[Markush Structure Search Sample]]&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Study: In re Bilski Impact&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[In re Bilski Impact assessed from US PAIR Information]]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Prior Art Search Process]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/satellite_antenna/ipmap.html Satellite Antenna IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid/ipmap.html RFID IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/multimodal_apps/ipmap.html Multimodal Applications IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/Invalidation_US4825448.htm Invalidation Claim Chart Sample]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Clinical Trial Database===&lt;br /&gt;
*[[Clinical Trial Database]]&lt;br /&gt;
&lt;br /&gt;
== Business &amp;amp; Information Research Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Veterinary Vaccines Market Report]]&lt;br /&gt;
* [[Olympus Corporation- Company Profile]]&lt;br /&gt;
* [[Rx to OTC Switch-Market Analysis]]&lt;br /&gt;
* [[Ureteral Stent - Market Analysis]], Company Profile:[[Boston Scientific - Company Profile |Boston Scientific ]]&lt;br /&gt;
* [[Cardiac Pacemakers]]&lt;br /&gt;
* [[Botox - from Medical Procedure to Household Word]]&lt;br /&gt;
* [[Diabetes products and services]]&lt;br /&gt;
* [[Drug Metabolism]]&lt;br /&gt;
* [[Toxicology]]&lt;br /&gt;
* [[Osteoporosis]]&lt;br /&gt;
* [[Oral Diabetes Drugs]]&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Premium Coffee Consumers Market Segmentation|Premium Coffee - Market Positioning]]&lt;br /&gt;
* [[Dolcera's Poster on Industrial Biotechnology|Industrial biotechnology]]&lt;br /&gt;
* [[OTC products for acne treatment]]&lt;br /&gt;
* [[Digestive Remedies Market in India and China]]&lt;br /&gt;
* [[OTC vs. Prescription Drugs]]&lt;br /&gt;
* [[Vaccines Market in Western Countries]], Company Profile:[http://dolcera.com/wiki/index.php?title=GlaxoSmithKline_profile GlaxoSmithKline]&lt;br /&gt;
* [[Gastrointestinal Endoscopy -Landscape Report]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[4G wireless technology developments]]&lt;br /&gt;
* [[LTE]]&lt;br /&gt;
* [[Femtocells]]&lt;br /&gt;
* [[HDTV in the US]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics Innovation Explorer]&lt;br /&gt;
* [[Web video]]&lt;br /&gt;
* [[OLED Mobile Phones Market Research and Analysis Report]] | ([http://www.viddler.com/explore/dolcera/videos/6/ Video])&lt;br /&gt;
* [[Samsung Company Profile]]&lt;br /&gt;
* [[Virtualization]]&lt;br /&gt;
* [[Cloud Computing]]&lt;br /&gt;
* [[Estimation of liquid carrying vehicles in USA]]&lt;br /&gt;
* [[A market study on Hybrid vehicles and the concept of V2G]]&lt;br /&gt;
* [[Patent Valuation]]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Finance===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Others and CPG===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Innovative personal finance products]]&lt;br /&gt;
* [[Life Insurance Industry in US]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
*[[Deodorants Market Analysis: Acquisition of Sanex by Colgate]]&lt;br /&gt;
*[[Partner in sales planning]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Dolcera Technology Platforms ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
==== Dashboard 1.1 ====&lt;br /&gt;
* [http://www.dolcera.com/auth/dashboarddemo/dashboard.php?workfilegroup_id=154 Demo Dashboard (Alopecia)]  &lt;br /&gt;
** [[Access details]]&lt;br /&gt;
* [[Sample list of patent numbers]]&lt;br /&gt;
* [http://www.dolcera.com/auth/index.php Dashboard login page]&lt;br /&gt;
&lt;br /&gt;
==== [[Workflow for creating a Dashboard]] ====&lt;br /&gt;
&lt;br /&gt;
==== IP and Products dashboard ====&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard] &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 4G wireless product and patent dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Patent-pathway mapping ====&lt;br /&gt;
* [[Inflammation and cardiovascular drugs#Interactive signaling pathways and patents|Patent-pathway mapping]]&lt;br /&gt;
==== Sequence dashboard ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Design analysis ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dental/main.html Dental Implant Design Analysis]&lt;br /&gt;
&lt;br /&gt;
==== Innovation explorer ====&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics innovation explorer]&lt;br /&gt;
==== KPort ====&lt;br /&gt;
* [http://dolcera.com/website/demos/kport/main.html Collaboration Portal]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Buy Dolcera Reports ==&lt;br /&gt;
* [[Landscape report for HEMT]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dolcera Offerings summary &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Dolcera Offerings|Dolcera offerings summary]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;[[Technology Support]] &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like any of these sample reports?&amp;lt;/span&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;p align=&amp;quot;center&amp;quot;&amp;gt; '''These are sample reports with brief analysis''' &amp;lt;br&amp;gt;&lt;br /&gt;
'''Dolcera can provide a comprehensive report customized to your needs'''&amp;lt;/p&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; align=&amp;quot;center&amp;quot; &amp;quot;&lt;br /&gt;
|style=&amp;quot;background:lightgrey&amp;quot; align = &amp;quot;center&amp;quot;  colspan = &amp;quot;3&amp;quot;|'''[mailto:info@dolcera.com &amp;lt;span style=&amp;quot;color:#0047AB&amp;quot;&amp;gt;Buy the customized report from Dolcera&amp;lt;/span&amp;gt;]''' &lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services Patent Analytics Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/business-research-services Market Research Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools/patent-dashboard Purchase Patent Dashboard]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Landscape Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/research-processes Dolcera Processes]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/industries Industry Focus]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Search Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/alerts-and-updates Patent Alerting Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools Dolcera Tools]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Contact Dolcera&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Samir Raiyani&lt;br /&gt;
|-&lt;br /&gt;
| '''Email''': [mailto:info@dolcera.com info@dolcera.com]&lt;br /&gt;
|-&lt;br /&gt;
| '''Phone''': +1-650-269-7952, +91-40-2355-3493&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Gastrointestinal_Endoscopy_-_Landscape_Report&amp;diff=9787</id>
		<title>Gastrointestinal Endoscopy - Landscape Report</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Gastrointestinal_Endoscopy_-_Landscape_Report&amp;diff=9787"/>
				<updated>2011-09-29T11:27:29Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: Gastrointestinal Endoscopy - Market and Volume analysis moved to Gastrointestinal Endoscopy - Landscape Report: Minor internal decision&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Overview==&lt;br /&gt;
===Introduction===&lt;br /&gt;
[[Image:Gastrointestinal Tract.png|thumb|right|500px|'''Gastrointestinal Tract''']]&lt;br /&gt;
'''Gastrointestinal Endoscopy''' deals with the endoscopic examination, therapy or surgery of the gastrointestinal tract. Gastrointestinal Tract generally refers to the digestive structures stretching from the mouth to anus, but does not include the accessory glandular organs such as liver, billary tract, panceras. The gastrointestinal tract is categorized into various sections, these include:&lt;br /&gt;
*'''Intestines''': The section of the alimentary canal from the stomach to the anal canal, includes the large intestine and small intestine.&lt;br /&gt;
*'''Lower Gastrointestinal Tract''': The segment of gastrointestinal tract that includes the small intestine below the duodenum, and the large intestine.&lt;br /&gt;
*'''Mouth''': The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper.&lt;br /&gt;
*'''Pharynx''': A funnel-shaped fibromuscular tube that conducts food to the esophagus, and air to the larynx and lungs. It is divided into the nasopharynx; oropharynx; and hypopharynx (laryngopharynx).&lt;br /&gt;
*'''Upper Gastrointestinal Tract''': The segment of gastrointestinal tract that includes the esophagus, stomach and the duodenum.&lt;br /&gt;
(Source: [http://www.ncbi.nlm.nih.gov/mesh/68041981 MeSH Database])&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Procedures===&lt;br /&gt;
Currently, the most commonly used imaging methods for detection of gastrointestinal disorders, including disorders of the small intestine, are&lt;br /&gt;
endoscopy and radiological imaging.&amp;lt;br&amp;gt;&lt;br /&gt;
A traditional endoscope is a device consisting of a flexible tube and an optical system. There are several types of endoscopic procedures used to&lt;br /&gt;
identify disorders in the gastrointestinal tract. The basic endoscopic procedures available include:&lt;br /&gt;
[[Image:upper endoscopy.jpg|thumb|right|300px|[http://www.thaimedicalnews.com/what-is-endoscopy-gastrointestinal-digestion-disorder-exam/2008/04/22/ Upper Endoscopy]]]&lt;br /&gt;
* '''Upper Endoscopy''': In upper endoscopy, the physician inserts an endoscope, which is an approximately 3.5 foot long tube, through the patient’s mouth. In esophagogastroduodenoscopy, or EGD, the gastroscope passes down the esophagus and into the stomach and duodenum for visual examination. In esophagoscopy, only the esophagus is viewed.&lt;br /&gt;
* '''Colonoscopy''': In colonoscopy, the physician inserts a colonoscope, which is an approximately 5.5 foot long endoscope, into the patient’s colon through the anus. Colonoscopy is the primary method for detecting disorders of the colon and is the standard screening tool for early detection of colon cancer.&lt;br /&gt;
* '''Push Enteroscopy''': Push enteroscopy involves the insertion of an approximately six-foot long push enteroscope into the mouth. Due to the length and curvature of the small intestine, push enteroscopy enables the physician to view only the first one-third of the small intestine. The procedure is time consuming and difficult to perform for the physician and significantly more difficult to bear for the patient compared to traditional endoscopy.&lt;br /&gt;
* '''Double Balloon Endoscopy''': The technique involves the use of a balloon at the end of a special enteroscope camera and an overtube, which is a tube that fits over the endoscope, and which is also fitted with a balloon. The procedure is usually done under general anesthesia, but may be done with the use of conscious sedation.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==GI Imaging==&lt;br /&gt;
Gastrointestinal endoscopy is undergoing major improvements, which are driven by new available technologies and substantial refinements of optical features. Detection, characterization and confirmation are essential steps required for proper endoscopic diagnosis. Optical and nonoptical methods can help to improve each step; these improvements are likely to increase the detection rate of neoplasias and reduce unnecessary endoscopic treatments. Furthermore, functional and molecular imaging are emerging as new diagnostic tools that could provide an opportunity for personalized medicine, in which endoscopy will define disease outcome or predict the response to targeted therapy.&lt;br /&gt;
[[Image:Key steps to endoscopic diagnosiss.png|thumb|center|1030px|[http://www.nature.com/nrgastro/journal/vaop/ncurrent/full/nrgastro.2011.152.html Key steps to endoscopic diagnosis]]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Several new technologies are now available for each step, some of them include:&lt;br /&gt;
* '''Narrow-Band Imaging(NBI)''' by Olympus America, uses filter to illuminate mucosa at specific wavelength&lt;br /&gt;
*'''Fujinon Intelligent Color Enhancement(FICE)''' by Fujinon, uses Spectral endoscopic image processing technology which has been developed to estimate spectral information from RGB image data obtained through a routine endoscopy and to better characterize mucosal tissue structures &lt;br /&gt;
*'''I-Scan''' by Pentax Medical, a next generation technology, is a dynamic, multimodal tool revealing the hidden colors, topography, vascularity, and structure of disease. i-SCAN explores the possibility of the first electronic version of chromoendoscopy (e-Chrome™) through the use of complimentary color filters and enhancements&lt;br /&gt;
*'''Third Eye Retroscope®''' by Avantis Medical Systems, an additional small-caliber endoscope that can be passed over the working channel of standard colonoscopes with the possibility of retro view—leads to a substantially increased detection of neoplastic changes&lt;br /&gt;
*'''Endoflag''' by Endopix, is a single filter, single-pass implementation that processes standard or high-definition video sequences after acquisition&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:GI Imaging.png|thumb|center|1030px|'''Classification of GI Imaging''']]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Product Portfolio Heat Map==&lt;br /&gt;
{|align=&amp;quot;center&amp;quot;&lt;br /&gt;
|&amp;lt;gflash&amp;gt;950 750 http://dolcera.com/upload/files/product_Heat_Map.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
==Market Size==&lt;br /&gt;
[[image:GI Endoscopy Market Size.png|center|900px|thumb|Source: Kalorama Information Report]]&lt;br /&gt;
&lt;br /&gt;
===Major Players===&lt;br /&gt;
====Detailed Company Profile====&lt;br /&gt;
[[Olympus Corporation]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
====Snapshot Profiles====&lt;br /&gt;
* [[Boston Scientific Snapshot| Boston Scientific]]&lt;br /&gt;
* [[Conmed Snapshot| Conmed]]&lt;br /&gt;
* [[Covidien Snapshot| Covidien]]&lt;br /&gt;
* [[Ethicon Endo Snapshot| Ethicon Endo ]]&lt;br /&gt;
* [[Fujinon Snapshot| Fujinon]]&lt;br /&gt;
* [[Given Imaging Snapshot| Given Imaging]]&lt;br /&gt;
* [[Karl Storz Snapshot| Karl Storz]]&lt;br /&gt;
* [[Hoya Snapshot| Hoya Corporation]]&lt;br /&gt;
* [[Stryker Snapshot| Stryker]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Source: [[media:kalorama.pdf|Kalorama]], Company website, Company SEC filings &lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==M&amp;amp;A Activity==&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''S.No.'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Date'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Details'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|1&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Oct-10&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.cookmedical.com/newsDetail.do?id=6614 Cook Medical Receives Two Contract Awards with HealthTrust Purchasing Group for Enteral Feeding and GI Endoscopic Supplies]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |2&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|Apr-10&lt;br /&gt;
|[http://www.prnewswire.com/news-releases/water-street-healthcare-partners-signs-definitive-agreement-to-sell-sierra-scientific-instruments-to-given-imaging-88791282.html Given Imaging Ltd acquires Sierra Scientific Instruments from Water St Healthcare Partners]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|3&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Apr-10&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.fujifilmusa.com/press/news/display_news?newsID=880031 Fujifilm signs a comprehensive Joint R&amp;amp;D aagreement with Fox Chase cancer center]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |4&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|Mar-09&lt;br /&gt;
| [http://www.karlstorz.com/cps/rde/xchg/SID-9641E54E-84C58126/karlstorz/hs.xsl/8250.htm KARL STORZ Acquires Global Care Quest]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|5&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Jan-09&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|[http://diagnosticimaging.medicaldevices-business-review.com/news/given_imaging_announces_expansion_of_distribution_agreement_with_fujifilm_090120 Given Imaging Inks Distribution Agreement with FUJIFILM]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |6&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Dec-08&lt;br /&gt;
| [http://www.dotmed.com/news/story/7624/ Given Imaging Ltd. Acquires Medtronic Bravo(R) pH Monitoring Business]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|7&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Nov-08&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.smiths.com/press_release_details.aspx?releaseID=356 Smiths Group Acquires Zhejiang Zheda Medical Instrument]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |8&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Nov-08&lt;br /&gt;
| [http://www.viatronix.com/pdfs/PR112408.pdf Visage Imaging Inks Marketing Agreement with Viatronix]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|9&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Jul-08&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.fujifilm.com/news/n080730.html FUJIFILM Merges Fujinon&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s Endoscope Business into Medical System Business Division]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |10&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Jun-08&lt;br /&gt;
| [http://www.itnonline.com/article/icad-acr-image-metrix-team-initiate-colon-cad-clinical-study ICAD and ACR Image Form Partnership to Initiate Colon-CAD Clinical Study]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|11&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Mar-08&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_31/ai_n24963346/ Karl Storz Inks Deal with EndoGastric for Marketing EsophyX and StomaphyX]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |12&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Mar-08&lt;br /&gt;
| [http://www.investinisrael.gov.il/NR/exeres/01104877-8720-4F39-8441-BD24EC58D8B9.htm Given Imaging Bags a 5-Year FSS Contract]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|13&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Nov-07&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://business.timesonline.co.uk/tol/business/industry_sectors/technology/article2903365.ece Olympus Takes Over Gyrus Group]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |14&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Aug-07&lt;br /&gt;
|[http://en.wikipedia.org/wiki/Pentax#Merger_with_Hoya PENTAX and HOYA Merge]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|15&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Apr-07&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|[http://www.news-medical.net/news/2007/06/26/26855.aspx Boston Scientific to acquire Remon Medical Technologies]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Procedure Volumes==&lt;br /&gt;
The three main areas where GI Endoscopy has considerable applications are Colon/Rectum cancer, Obesity (gastric bypass/gastric banding) and Digestive system disorders.&lt;br /&gt;
===Colon/Rectum cancer===&lt;br /&gt;
[[Image:Colon cancer.png|thumb|right|300px|[http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001308/figure/A000262.B19222/?report=objectonly Stages of Cancer]]]&lt;br /&gt;
Tumors or cancer of the colon or the rectum or both. Colorectal cancer starts in the large intestine (colon) or the rectum (end of the colon). Risk factors for colorectal cancer include chronic ulcerative colitis; familial polyposis coli; exposure to asbestos; and irradiation of the cervix uteri. ([http://www.ncbi.nlm.nih.gov/mesh?term=colorectal%20cancer MeSH]) Colorectal cancer is the third most commonly diagnosed cancer in the world, but it is more common in developed countries.&amp;lt;br&amp;gt;&lt;br /&gt;
Stages of colon cancer are:&lt;br /&gt;
*''Stage 0'': Very early cancer on the innermost layer of the intestine&lt;br /&gt;
*''Stage I'': Cancer is in the inner layers of the colon&lt;br /&gt;
*''Stage II'': Cancer has spread through the muscle wall of the colon&lt;br /&gt;
*''Stage III'': Cancer has spread to the lymph nodes&lt;br /&gt;
*''Stage IV'': Cancer has spread to other organs&lt;br /&gt;
(For more information on colon cancer [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001308/ click here])&lt;br /&gt;
====Volumes, Prevalence and Incidence====&lt;br /&gt;
*Overall, the '''lifetime risk''' of developing colorectal cancer is about '''1 in 20''' (5.1%). This risk is slightly lower in women than in men.&lt;br /&gt;
* Cases estimated in the US in '''2011''' are:&lt;br /&gt;
**''' 101,700''' cases of colon cancer &lt;br /&gt;
**'''39,510''' cases of rectal cancer &lt;br /&gt;
* Overall, colorectal cancer is the second-leading cause of cancer death in Canada.&lt;br /&gt;
** In '''2011''', an estimated '''22,200''' Canadians (12,500 men - 9,700 women) will be diagnosed with colorectal cancer and '''8,900''' (5,000 men - 3,900 women) will die from it.&lt;br /&gt;
** '''One in 14 men''' is expected to develop colorectal cancer during his lifetime and '''one in 27''' will die from it. &lt;br /&gt;
**'''One in 15 women''' is expected to develop colorectal cancer during her lifetime and '''one in 31''' will die from it.&lt;br /&gt;
** On average, '''426''' Canadians will be diagnosed with colorectal cancer every week and '''171''' will die from the disease every week.&lt;br /&gt;
(Source: [http://www.colorectal-cancer.ca/en/just-the-facts/colorectal/ Colorectal cancer association of Canada] &amp;amp; [http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-key-statistics American cancer society])&lt;br /&gt;
====Survival Rates====&lt;br /&gt;
[[Image:survival rates.png|center|thumb|800px|[http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-survival-rates Source:SEERdatabase]]]&lt;br /&gt;
====Incidence rates====&lt;br /&gt;
The estimated incidence rate of colorectal cancer in 2007 is expressed geography wise below:&lt;br /&gt;
&lt;br /&gt;
{|align = &amp;quot;center&amp;quot; border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;45%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Area'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Incidence per 100,000 people'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|North America&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|17-33.5&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Europe&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|17-33.6&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Asia&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|17-33.7&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|South America&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|17-33.4&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Africa&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|3.2-17&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
Source: Kalorama Information Report&lt;br /&gt;
&lt;br /&gt;
===Obesity (Gastric bypass/Gastric banding)===&lt;br /&gt;
A status with '''body weight''' that is grossly above the acceptable or desirable weight, usually due to accumulation of excess fats in the body. The standards may vary with age, sex, genetic or cultural background. In the Body mass index, a '''BMI greater than 30.0 kg/m2''' is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (morbid obesity).[[Image:gastric band.png|thumb|right|300px|[http://weightlosssurgery.ae/gastric-banding-surgery.php Laparoscopic Gastric Banding]]]&lt;br /&gt;
The two most common weight-loss surgeries are:&lt;br /&gt;
*[http://www.nlm.nih.gov/medlineplus/ency/article/007388.htm Laparoscopic Gastric Banding](also referred as lap band): The surgeon places a band around the upper part of your stomach, creating a small pouch to hold food. The band helps you limit how much food you eat by making you feel full after eating small amounts.&lt;br /&gt;
*[http://www.nlm.nih.gov/medlineplus/ency/article/007199.htm Gastric Bypass]: This surgery helps you lose weight by changing how your stomach and small intestine handle the food you eat. After the surgery, you will not be able to eat as much as before, and your body will not absorb all the calories and other nutrients from the food you eat.&lt;br /&gt;
====Volumes, Prevalence and Incidence====&lt;br /&gt;
* In '''United States''' obesity is estimated to cause an excess '''111,909 to 365,000 deaths per year'''&lt;br /&gt;
* '''One million''' (7.7%) of deaths in the '''European Union''' are attributed to excess weight.&lt;br /&gt;
* On an average, obesity reduces life expectancy by '''six to seven years''':&lt;br /&gt;
** A BMI of 30–35 reduces life expectancy by two to four years&lt;br /&gt;
** While morbid obesity (BMI &amp;gt; 40) reduces life expectancy by 10 years&lt;br /&gt;
* Large-scale American and European studies have found that mortality risk is lowest at a BMI of 20–25 kg/m2, with risk increasing along with changes in either direction. ([http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2960318-4/fulltext Source: thelancet] &amp;amp; [http://jama.ama-assn.org/content/282/16/1530.full jama-ama-assn])&lt;br /&gt;
*'''Obesity prevalence rate in USA'''&lt;br /&gt;
[[Image:prevalence.png|thumb|center|900px|[http://www.cdc.gov/obesity/data/trends.html Percent of Obese (BMI &amp;gt; 30) in U.S. Adults]]]&lt;br /&gt;
&lt;br /&gt;
===Digestive system disorders===&lt;br /&gt;
Diseases in any part of the gastrointestinal tract or the accessory organs (liver; biliary tract; pancreas). The digestive system disorders are categorized as: &lt;br /&gt;
*Biliary Tract Diseases&lt;br /&gt;
*Digestive System Abnormalities&lt;br /&gt;
*Digestive System Fistula&lt;br /&gt;
*Digestive System Neoplasms&lt;br /&gt;
*Gastrointestinal Diseases&lt;br /&gt;
*Liver Diseases&lt;br /&gt;
*Pancreatic Diseases&lt;br /&gt;
*Peritoneal Diseases&lt;br /&gt;
([http://www.ncbi.nlm.nih.gov/mesh?term=Digestive%20system%20disorders Source: MeSH])&lt;br /&gt;
====Volumes, Prevalence and Incidence====&lt;br /&gt;
*Hospital visits in USA (Digestive disorders as the primary reason)&lt;br /&gt;
[[image:digpri.png|thumb|center|600px|[http://www.cdc.gov/nchs/data/ad/ad374.pdf Source:CDC health statistics report]]]&lt;br /&gt;
*Disease wise breakup (Digestive disorders as the primary reason)&lt;br /&gt;
[[image:digbreakup.png|center|700px|thumb|[http://www.cdc.gov/nchs/data/series/sr_13/sr13_169.pdf Source: CDCsurvey]]]&lt;br /&gt;
*USA and Europe Procedure Volumes&lt;br /&gt;
[[Image:provol.png|center|700px|thumb|Source: Kalorama Information; WHO; US Census Bureau; Centers for Disease Control and Prevention]]&lt;br /&gt;
NOTE: All values for USA and Europe are in 000's. Data includes both in-patient and out-patient surgical procedures in all populations&lt;br /&gt;
==Reimbursements==&lt;br /&gt;
===Upper GI/ Colonoscopy===&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;90%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''CPT Code'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Procedure'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''2008 National Average Medicare Payment Facility'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43250&lt;br /&gt;
|Upper GI endoscopy including esophagus, stomach and either duodenum and/or jejunum as appropriate; with removal of tumors, polyps, or other lesions by hot biopsy forceps or bipolar cautery&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$172.91&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43251&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Upper GI endoscopy including esophagus, stomach and either duodenum and/or jejunum as appropriate; with removal of tumors, polyps, or other lesions by snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$199.58&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43255&lt;br /&gt;
|Upper GI endoscopy including esophagus, stomach and either the duodenum and/or jejunum as appropriate; diagnostic, with control of bleeding any method&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$258.99&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43256&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Upper GI endoscopy including esophagus, stomach and either the duodenum and/or jejunum as appropriate; with transendoscopic stent placement (includes predilation)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$233.09&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43258&lt;br /&gt;
|Upper GI endoscopy including esophagus, stomach and either the duodenum and/or jejunum as appropriate; with ablation of tumors, polyps, or other lesions not amendable by hot biopsy forceps, bipolar cautery or snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$244.14&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|45383&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$307.36&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|45384&lt;br /&gt;
|Colonoscopy, flexible, proximal to splenic flexure; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps or bipolar cautery&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$248.33&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|45385&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Colonoscopy, flexible, proximal to splenic flexure; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$281.84&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|91110&lt;br /&gt;
|Gastrointestinal tract imaging, intraluminal (e.g., capsule endoscopy), esophagus through ileum, with physician interpretation and report (Visualization of the colon is not reported separately)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$944.18&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
===Bariatric Surgery===&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;90%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''APC'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''APC Description (Hospital Outpatient Dept)'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Medicare Payment'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|130&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Level I Laparoscopy (CPT 43659)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$2,190.81&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|135&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Level III Skin Repair (CPT 43887)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$288.30&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|137&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Level V Skin Repair (CPT 43886, 43888)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,287.06&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|141&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Level I Upper GI Procedure (CPT 43999)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$541.59&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;90%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''CPT Code'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Procedure'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''2008 National Average Medicare Payment Facility'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43886&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric reconstructive procedure, open; revision of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$836.59&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43888&lt;br /&gt;
|Removal and replacement of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$836.59&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43644&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux-en-Y gastroenterostomy (Roux limb 150 cm or less)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,507.10&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43645&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,615.27&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43659&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Unlisted laparoscopy procedure, stomach (Removal and replacement of both adjustable gastric band and subcutaneous port component)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Carrier Priced&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43770&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric band (gastric band and subcutaneous port components)(use modifier - 52 for individual component placement)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$970.08&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43771&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Laparoscopy, surgical, gastric restrictive procedure; Revision of adjustable gastric band component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,107.95&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43772&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure; Removal of adjustable gastric band component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$833.72&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43773&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Laparoscopy, surgical, gastric restrictive procedure; Removal and placement of adjustable gastric band component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,107.95&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43774&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure: Removal of adjustable gastric band and subcutaneous port components&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$838.29&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43842&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical banded gastroplasty&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,071.01&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43843&lt;br /&gt;
|Gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical banded gastroplasty&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,097.67&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43845&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy (50 to 100 cm common channel) to limit absorption (billopancreatic diversion with duodenal switch)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,716.20&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43846&lt;br /&gt;
|Gastric restrictive procedure, with gastric bypass, for morbid obesity; with short limb (150 cm or less) Roux-en-Y gastroenterostomy&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,416.07&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43847&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric restrictive procedure, with small intestine reconstruction to limit absorption&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,553.19&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43848&lt;br /&gt;
|Revision of gastric restrictive procedure for morbid obesity (separate procedure), other than adjustable gastric band&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,680.40&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43886&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric reconstructive procedure, open; revision of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$287.18&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43887&lt;br /&gt;
|Removal of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$272.32&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43888&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Removal and replacement of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$387.34&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43999&lt;br /&gt;
|Unlisted procedure, stomach&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Carrier Priced&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|S2083&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Carrier Priced&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Technology Advancements==&lt;br /&gt;
{|align = &amp;quot;center&amp;quot; border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;60%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Areas'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Companies Involved'''&lt;br /&gt;
|-&lt;br /&gt;
|rowspan = &amp;quot;6&amp;quot;|'''Enhanced Imaging Modalities'''&lt;br /&gt;
|Olympus Medical System Corp.&lt;br /&gt;
|-&lt;br /&gt;
|Pentax Crop. (Hoya Corporation)&lt;br /&gt;
|-&lt;br /&gt;
|Fujinon&lt;br /&gt;
|-&lt;br /&gt;
|Mauna Kea Technologies&lt;br /&gt;
|-&lt;br /&gt;
|KARL STORZ&lt;br /&gt;
|-&lt;br /&gt;
|SpectraScience Inc.&lt;br /&gt;
|-&lt;br /&gt;
|'''Robotic-Assisted Endomicroscope'''&lt;br /&gt;
|EndoControl Inc.&lt;br /&gt;
|-&lt;br /&gt;
|'''Wireless Biosensors and Polymers for GI bleeding (Hemostasis)'''&lt;br /&gt;
|Pluromed Inc.&lt;br /&gt;
|-&lt;br /&gt;
|'''Electronic Nose &amp;quot;Smells&amp;quot; Disease'''&lt;br /&gt;
|Cyrano Science Inc.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:chromoendoscopy.png|thumb|center|800px|'''Enhanced Imaging Modalities''': High-definition and virtual chromoendoscopy; (a) White-light imaging during endoscopy; a lesion beside a diverticular is hardly visible (arrow). (b) Closer inspection and image enhancement reveals tubular surface structures (arrows); (c) Virtual chromoendoscopy leads to pseudocolorization and improved visualization of the flat adenoma (arrows); (d) Chromoendoscopy using methylene blue unmasks the full extent of the lesion (arrows).]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Gastrointestinal_Endoscopy_-_Market_and_Volume_analysis&amp;diff=9788</id>
		<title>Gastrointestinal Endoscopy - Market and Volume analysis</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Gastrointestinal_Endoscopy_-_Market_and_Volume_analysis&amp;diff=9788"/>
				<updated>2011-09-29T11:27:29Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: Gastrointestinal Endoscopy - Market and Volume analysis moved to Gastrointestinal Endoscopy - Landscape Report: Minor internal decision&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#REDIRECT [[Gastrointestinal Endoscopy - Landscape Report]]&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Kalorama.pdf&amp;diff=9786</id>
		<title>File:Kalorama.pdf</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Kalorama.pdf&amp;diff=9786"/>
				<updated>2011-09-29T09:38:16Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Colon_cancer.png&amp;diff=9785</id>
		<title>File:Colon cancer.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Colon_cancer.png&amp;diff=9785"/>
				<updated>2011-09-29T09:37:04Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Stryker_Snapshot&amp;diff=9784</id>
		<title>Stryker Snapshot</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Stryker_Snapshot&amp;diff=9784"/>
				<updated>2011-09-29T09:32:26Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;0&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Stryker Corporation'''&amp;lt;/font&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Brief Description'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Stryker's surgical products include such instruments as drills, saws, and even cement mixers. The company's Reconstructive division markets artificial hip and knee joints, trauma implants, bone cement, and other orthopedic supplies. The MedSurg Equipment segment houses microsurgery instruments, endoscopy equipment, and communications and patient handling tools. Stryker's Neurotechnology and Spine unit provides rods, screws, and artificial discs for spinal surgeries, as well as coils and stents for cerebral vascular procedures. The firm's products are marketed globally to hospitals, doctors, and other health care facilities via direct sales personnel and distributors.&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''Revenues'''&lt;br /&gt;
|2008: 6.72 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 6.72 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 7.32 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Net profit (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;| 1.27 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''R&amp;amp;D expenses'''&lt;br /&gt;
|2008: 367.8 million USD (5.5% of revenues)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 336.2  million USD (5.0% of revenues)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 393.9 million USD (5.4% of revenues)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Number of employees'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|20,036&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Year Established'''&lt;br /&gt;
|1938&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Headquarters'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|2825 Airview Blvd. Kalamazoo, MI 49002-1802, United States&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Key People'''&lt;br /&gt;
|Stephen MacMillan  (Chairman &amp;amp; CEO)&amp;lt;br&amp;gt;Curt Hartman   (CFO)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Segmental revenue breakdown (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Orthopedic implants: 59%&amp;lt;br&amp;gt;MedSurg equipment: 41%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Geographical revenue breakdown (2010)'''&lt;br /&gt;
|US: 65%%&amp;lt;br&amp;gt;Rest of world: 35%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Hoya_Snapshot&amp;diff=9783</id>
		<title>Hoya Snapshot</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Hoya_Snapshot&amp;diff=9783"/>
				<updated>2011-09-29T09:31:41Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;0&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Hoya Corporation'''&amp;lt;/font&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Brief Description'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|The company makes electro-optical components used in high-tech and medical products. It straddles four fields: Eye Care sells vision care products, lenses and eyeglasses, and health care supplies, including intraocular lenses for cataract surgery. Life Care (Pentax) focuses on medical endoscopic tools, and Imaging Systems produces optical components and SLR/compact digital cameras. Within its Information Technology segment, Electro-Optics makes mask blanks and photomasks for semiconductor devices and LCD panels, digital camera optical lenses, and glass substrate used in HDDs, as well as photonics (laser equipment, light sources for electronics, and optical glass). &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''Revenues'''&lt;br /&gt;
|2008: 482 billion YEN&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 454 billion YEN&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 414 billion YEN&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Net profit (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;| 64 billion YEN&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''R&amp;amp;D expenses'''&lt;br /&gt;
|2008:  17.41 billion YEN &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009:  17.63 billion YEN &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 16.56 billion YEN&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Number of employees'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|37,498&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Year Established'''&lt;br /&gt;
|1944&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Headquarters'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|2-7-5 Naka-Ochiai Shinjuku-Ku Tokyo, 161-8525, Japan&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Key People'''&lt;br /&gt;
|Hiroshi Suzuki (CEO &amp;amp; President)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Segmental revenue breakdown (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|IT : 38%&amp;lt;br&amp;gt;Eye Care: 35%&amp;lt;br&amp;gt;Pentax: 27%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Geographical revenue breakdown (2010)'''&lt;br /&gt;
|Asia/Pacific: 66%&amp;lt;br&amp;gt;Europe: 22%&amp;lt;br&amp;gt;North America: 12%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Karl_Storz_Snapshot&amp;diff=9782</id>
		<title>Karl Storz Snapshot</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Karl_Storz_Snapshot&amp;diff=9782"/>
				<updated>2011-09-29T09:30:58Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;0&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Karl Storz'''&amp;lt;/font&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Brief Description'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;| Since its beginnings in 1945, KARL STORZ has established itself worldwide as an international and highly regarded company in the production and sale of medical instruments and devices. Not a giant on an international scale, but leaders in matters that count: creativity, versatility and competence. &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Revenues'''&lt;br /&gt;
|2010:  1.24 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Net profit (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|  36.43 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Number of employees'''&lt;br /&gt;
|4,400&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Year Established'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|1959&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Headquarters'''&lt;br /&gt;
|Mittelstr. 8 Tuttlingen, Baden-Württemberg 78532, Germany&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Key People'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Charles H. Wilhelm (CEO &amp;amp; President)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Given_Imaging_Snapshot&amp;diff=9781</id>
		<title>Given Imaging Snapshot</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Given_Imaging_Snapshot&amp;diff=9781"/>
				<updated>2011-09-29T09:30:16Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;0&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Given Imaging'''&amp;lt;/font&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Brief Description'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|The company makes the Given System, one component of which is the PillCam, an ingestible capsule with an enclosed miniature video camera that takes photos of a patient's intestines or esophagus. As the PillCam moves through a patient's system, it transmits images to a wireless data recorder. The FDA-approved system, which also includes a computer workstation and imaging software, is a noninvasive alternative to traditional endoscopy. Given Imaging markets the system to gastroenterologists and hospitals worldwide. Discount Investment Corporation and its minority-owned subsidiary Elron Electronic own about 40% of the firm&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''Revenues'''&lt;br /&gt;
|2008: 125.11 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 141.76 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 157.81 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Net profit (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;| 8.48 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''R&amp;amp;D expenses'''&lt;br /&gt;
|2008: 18.29 million USD &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 16.7 million USD &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 20.2 million USD &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Number of employees'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|742&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Year Established'''&lt;br /&gt;
|1998&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Headquarters'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|2 Hacarmel St.New Industrial Park Yokneam, 20692,Israel&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Key People'''&lt;br /&gt;
|Nachum Shamir  (CEO)&amp;lt;br&amp;gt;Israel Makov   (Chairman)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Segmental revenue breakdown (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Workstations, recorders and software: 5%&amp;lt;br&amp;gt;PillCam SB capsule: 70%&amp;lt;br&amp;gt;Bravo pH monitoring products: 11.46%&amp;lt;br&amp;gt;Sierra manometry and catheters: 10.82%&amp;lt;br&amp;gt;Others: 2.72%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Geographical revenue breakdown (2010)'''&lt;br /&gt;
|US: 63.69%&amp;lt;br&amp;gt;EMEA: 25.47%&amp;lt;br&amp;gt;Rest of the World: 10.82%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Fujinon_Snapshot&amp;diff=9780</id>
		<title>Fujinon Snapshot</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Fujinon_Snapshot&amp;diff=9780"/>
				<updated>2011-09-29T09:29:38Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;0&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Fujinon'''&amp;lt;/font&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Brief Description'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Fujinon is a division of Fujifilm that specialises in the production of optical lenses for photographic, medical, video, and television use. Not only does Fujinon provide quality endoscopic and imaging equipment they also provide personalized service, support and solutions that allow healthcare professionals to be more productive. The total solution G-5 endoscope represents this comprehensive approach to their customers. Fujinon not only has the G-5 endoscope but other upper and lower GI equipment, video systems, fiberscopes, and peripherals, as well as customer service and service support. With these solutions Fujinon contributes to the betterment of global health by significantly improving diagnosis and treatment of disease by healthcare professionals.&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''Revenues'''&lt;br /&gt;
|2009: 26.98 million YEN&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 25.00 million YEN&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2011: 27.00 million YEN&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Number of employees'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|131&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Year Established'''&lt;br /&gt;
|1968&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Headquarters'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|10 Highpoint Dr Wayne, NJ 07470-7434, United States&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Key People'''&lt;br /&gt;
|Hisao Saiki  (President)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Ethicon_Endo_Snapshot&amp;diff=9779</id>
		<title>Ethicon Endo Snapshot</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Ethicon_Endo_Snapshot&amp;diff=9779"/>
				<updated>2011-09-29T09:29:05Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;0&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Ethicon Endo Surgery'''&amp;lt;/font&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Brief Description'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Ethicon Endo-Surgery is a key part of J&amp;amp;J's Medical Devices and Diagnostics segment and contributes about 19% of its parent's yearly revenue. The unit has achieved successful sales growth for its parent in recent years, especially in its advanced sterilization product lines and its energy devices, which include the Harmonic ultrasonic surgery tools and its EnSeal bipolar tissue sealing systems.Ethicon Endo-Surgery markets advanced medical devices for minimally invasive and open surgical procedures that transform patient care by drastically reducing surgery time, mortality rates and complications arising from surgery.&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''Revenues'''&lt;br /&gt;
|2008: 4.286 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 4.492 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 4.758 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Number of employees'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|1494&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Year Established'''&lt;br /&gt;
|1992&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Headquarters'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|4545 Creek Rd. Cincinnati, OH 45242, United States &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Key People'''&lt;br /&gt;
|Chuck Austin  (President)&amp;lt;br&amp;gt;Karen Licitra   (Chairman)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Geographical revenue breakdown (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|US: 41.5%&amp;lt;br&amp;gt;Rest of world: 58.5%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Covidien_Snapshot&amp;diff=9778</id>
		<title>Covidien Snapshot</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Covidien_Snapshot&amp;diff=9778"/>
				<updated>2011-09-29T09:28:32Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;0&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Covidien'''&amp;lt;/font&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Brief Description'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|With more than $10 billion in annual sales and offerings that include thousands of different products and brands, Covidien is one of the top players in the medical device industry. The company supplies health care providers with everything from generic pharmaceuticals and disposable medical products to diagnostic imaging contrast agents and surgical devices. Covidien has more than a dozen global manufacturing operations and markets its products in 140 countries. More than half of Covidien's sales are made in the US.&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''Revenues'''&lt;br /&gt;
|2008: 9.91 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 10.68 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 10.43 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Net profit (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;| 1.63 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''R&amp;amp;D expenses''' &lt;br /&gt;
|2008: 341 million USD &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 427 million USD &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 447 million USD &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Number of employees'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|41,500&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Year Established'''&lt;br /&gt;
|2009&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Headquarters'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|20 On Hatch Lower Hatch Street Dublin 2, Ireland&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Key People'''&lt;br /&gt;
|Jose Almeida  (CEO)&amp;lt;br&amp;gt;Richard Meelia   (Chairman)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Segmental revenue breakdown (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Medical Devices: 64%&amp;lt;br&amp;gt;Pharmaceutical Products: 19%&amp;lt;br&amp;gt;Medical Supplies: 17%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Geographical revenue breakdown (2010)'''&lt;br /&gt;
|US: 55%&amp;lt;br&amp;gt;EMEA: 25%&amp;lt;br&amp;gt;Rest of world: 20%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Conmed_Snapshot&amp;diff=9777</id>
		<title>Conmed Snapshot</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Conmed_Snapshot&amp;diff=9777"/>
				<updated>2011-09-29T09:27:34Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;0&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Conmed'''&amp;lt;/font&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Brief Description'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|The medical technology company develops and manufactures a wide range of electronic instruments such as electrosurgical systems, powered surgical instruments, and endoscopic devices. Arthroscopic (joint surgery) products represent the company's largest segment and include reconstruction tools, scopes, implants, and fluid management systems. CONMED also manufactures patient monitoring products and handheld medical accessories such as scissors, sutures, and staplers. Brands include Linvatec and Hall Surgical. The company sells its products in more than 100 countries through its direct sales force and independent distributors. &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''Revenues'''&lt;br /&gt;
|2008: 742.18 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 694.74 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 713.72 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Net profit (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;| 30.35 million USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''R&amp;amp;D expenses'''&lt;br /&gt;
|2008:  33.1 million USD &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009:  31.8 million USD &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010:  29.6 million USD &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Number of employees'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|3,300&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Year Established'''&lt;br /&gt;
|1970&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Headquarters'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|525 French Rd. Utica, NY 13502,United States&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Key People'''&lt;br /&gt;
|Joseph Corasanti  (CEO)&amp;lt;br&amp;gt;Eugene Corasanti   (Chairman)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Segmental revenue breakdown (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Linvatec: 60%&amp;lt;br&amp;gt;Electrosurgery: 14%&amp;lt;br&amp;gt;Endosurgery: 10%&amp;lt;br&amp;gt;Patient Care: 9%&amp;lt;br&amp;gt;Endoscopic Technologies: 7%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Geographical revenue breakdown (2010)'''&lt;br /&gt;
|US: 52%&amp;lt;br&amp;gt;Canada: 9%&amp;lt;br&amp;gt;Rest of world: 39%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Boston_Scientific_Snapshot&amp;diff=9776</id>
		<title>Boston Scientific Snapshot</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Boston_Scientific_Snapshot&amp;diff=9776"/>
				<updated>2011-09-29T09:26:54Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Click [[Gastrointestinal Endoscopy - Market and Volume analysis| here]] to go back to main page.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;0&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Boston Scientific'''&amp;lt;/font&amp;gt;&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Brief Description'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|They make medical supplies and devices used to diagnose and treat conditions in a variety of medical fields, with an emphasis on cardiovascular products and cardiac rhythm management. It also makes devices used for gynecology and urology, endoscopy, and pain management (neuromodulation). Its 13,000-plus products, made in a dozen factories worldwide, include defibrillators, catheters, coronary and urethral stents, pacemakers, biopsy forceps and needles, and urethral slings. Boston Scientific markets its wares in more than 100 countries, primarily through its own direct sales staff. &lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''Revenues'''&lt;br /&gt;
|2008: 8.05 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 8.19 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 7.81 billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Net profit (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;| (1.07) billion USD&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''R&amp;amp;D expenses'''&lt;br /&gt;
|2008: 1.006 billion USD (12.6% of revenues)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2009: 1.035 billion USD (12.5% of revenues)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|2010: 0.939 billion USD (12.0% of revenues)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Number of employees'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|25,000&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Year Established'''&lt;br /&gt;
|1979&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Headquarters'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|1 Boston Scientific Place Natick, MA 01760-1537, United States&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Key People'''&lt;br /&gt;
|J. Raymond Elliott (CEO)&amp;lt;br&amp;gt;Peter Nicholas  (Chairman)&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Segmental revenue breakdown (2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Cardiovascular group: 42%&amp;lt;br&amp;gt;Cardiac rhythm management: 28%&amp;lt;br&amp;gt;Endoscopy: 14%&amp;lt;br&amp;gt;Urology/Women's Health: 6%&amp;lt;br&amp;gt;Others: 10%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
| &lt;br /&gt;
|'''Geographical revenue breakdown (2010)'''&lt;br /&gt;
|US: 56%%&amp;lt;br&amp;gt;EMEA: 23%&amp;lt;br&amp;gt;Rest of world: 21%&lt;br /&gt;
| &lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Olympus_Corporation&amp;diff=9775</id>
		<title>Olympus Corporation</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Olympus_Corporation&amp;diff=9775"/>
				<updated>2011-09-29T09:25:49Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Company overview==&lt;br /&gt;
&lt;br /&gt;
OLYMPUS CORPORATION, a Japan-based manufacturer, mainly manufactures and sells medical products, life and industrial products, imaging products, information communication products and other products. The Company operates in five business segments. &lt;br /&gt;
* '''Medical Systems:''' Manufacture and sale of medical endoscopes, surgical endoscopes, endoscope disposal equipment and ultrasonic endoscopes&lt;br /&gt;
* '''Life and Industrial:''' Provides biological microscopes, industrial microscopes, endoscopes for industrial use and non-destructive testing equipment&lt;br /&gt;
* '''Imaging:''' Manufacture and sale of digital cameras and voice recorders&lt;br /&gt;
* '''Information Communication:''' Sale of mobile terminals, such as cellular phones &lt;br /&gt;
* '''Others:''' Development of biomaterials and systems, industrial endoscopes, nondestructive inspection equipment, printers, mobile solutions and mobile contents services, the development and sale of package software, the sale of semiconductor-related equipment and electronic machines, as well as the development of systems&lt;br /&gt;
&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
In August 2009, the Company disposed its analytical equipment business to its wholly owned subsidiary, which has been engaged in the manufacturing and sale of clinical laboratory examination equipment. In addition, the Company has sold the subsidiary to Beckman Coulter, Inc. on August 1, 2009. As a result, the Company holds no stake in the subsidiary.&amp;lt;br&amp;gt;&lt;br /&gt;
As of March 31, 2011, the Company has 188 subsidiaries and 11 associated companies.&lt;br /&gt;
&lt;br /&gt;
===Key Facts===&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;54%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Established'''&lt;br /&gt;
|1919&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Headquarters'''&lt;br /&gt;
|Tokyo, Japan&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Type'''&lt;br /&gt;
|Public Company&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Website'''&lt;br /&gt;
|[http://www.olympus-global.com/en/ www.olympus-global.com]&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Regional involvement'''&lt;br /&gt;
|Worldwide&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Business lines'''&lt;br /&gt;
|Manufacture and Sales of precision machinery and instruments &lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Employees'''&lt;br /&gt;
|34,391&amp;lt;br&amp;gt; Medical System Business: 15,000 Approx.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Group Companies'''&lt;br /&gt;
|Approx. 180 Subsidiaries&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Chairman &amp;amp; CEO'''&lt;br /&gt;
|Tsuyoshi Kikukawa&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''President &amp;amp; COO'''&lt;br /&gt;
|Michael C. Woodford&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Consolidated Net Sales (2011)'''&lt;br /&gt;
|847.1 Billion YEN&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Key Financials===&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;71%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Olympus Corporation'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Financial Year End'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|March, 31st&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Revenue'''&lt;br /&gt;
|2011: ¥ 847.10 B / $ 10.58 B&lt;br /&gt;
|-&lt;br /&gt;
|2010: ¥ 883.08 B / $ 11.03 B&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Revenue Change&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|&amp;lt;nowiki&amp;gt;-&amp;lt;/nowiki&amp;gt;4.07%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Operating Income'''&lt;br /&gt;
|2011: ¥ 35.4 B / $ 442 M&lt;br /&gt;
|-&lt;br /&gt;
|2010: ¥ 60.1 B / $ 751 M&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Operating Income Change&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|&amp;lt;nowiki&amp;gt;-&amp;lt;/nowiki&amp;gt;41.10%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Net Profit'''&lt;br /&gt;
|2011: ¥ 7.38 B / $ 92.25 M&lt;br /&gt;
|-&lt;br /&gt;
|2010: ¥ 47.76 B / $ 597 M&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Net Profit Change&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|&amp;lt;nowiki&amp;gt;-&amp;lt;/nowiki&amp;gt;84.45%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''R&amp;amp;D Expenses'''&lt;br /&gt;
|2011: ¥ 67.28 B / $ 841 M&lt;br /&gt;
|-&lt;br /&gt;
|2010: ¥ 61.85 B / $ 773 M&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Revenue Distribution===&lt;br /&gt;
{|align=&amp;quot;center&amp;quot; &lt;br /&gt;
|&amp;lt;gflash&amp;gt;1100 825 http://dolcera.com/upload/files/Revenue_Metrics.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Source: SEC fillings&lt;br /&gt;
&lt;br /&gt;
===Patents Held by Business group===&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Business Segment'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Medical Systems'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Life science &amp;amp; Industrial Systems'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Imaging Systems'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''R&amp;amp;D/Innovation'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Total'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Japan patents'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|2941&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|1067&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|2021&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|1131&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''7160'''&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''US patents'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|1059&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|680&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|1534&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|974&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''4247'''&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''China patents'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|405&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|86&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|444&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|90&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''1025'''&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Other patents'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|948&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|249&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|102&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|165&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''1464'''&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Total'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''5353'''&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''2082'''&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''4101'''&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''2360'''&lt;br /&gt;
|align = &amp;quot; center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''13896'''&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In Medical systems business, the company owns 39% of the total number of patents held by the company, with Japanese patents being the highest contributor to that.&lt;br /&gt;
&lt;br /&gt;
==Business Overview==&lt;br /&gt;
&lt;br /&gt;
===Business lines===&lt;br /&gt;
The company operates under the following business lines:&lt;br /&gt;
&lt;br /&gt;
[[Image:Business_lines.PNG|centre]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Organisation Structure===&lt;br /&gt;
&lt;br /&gt;
[[Image:OrgChart_Oympus.png|centre]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In April 2011, the company launched their regional headquarters for Asia and Oceania to coordinate regional strategy and facilitate business infrastructure development.&amp;lt;br&amp;gt;&lt;br /&gt;
Source: Company website, Linkedin&lt;br /&gt;
&lt;br /&gt;
==Medical Systems Business==&lt;br /&gt;
&lt;br /&gt;
The Medical Systems Business covers gastrointestinal endoscopes, surgical endoscopes, endotherapy devices, endoscopic ultrasound systems and medical information systems.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
With an approximately 70% share, the Olympus group has secured a leading position in the global Gastrointestinal endoscopy market. Working to expand diagnostic coverage beyond the digestive system, the group is developing new equipment and new techniques ranging from diagnosis through treatment. &lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
It's current research focus is on both minimally invasive treatment technology that reduces the burden on patients and product usability, for example, enhanced performance and functions to benefit doctors and technicians. The group's flagship products are equipped with a high-resolution endoscopic system and Narrow Band Imaging technology so that they can also support cancer diagnosis and treatment.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Medical systems business has the following business lines:&lt;br /&gt;
* '''Endoscopes''' &amp;lt;br&amp;gt;Endoscopic video imaging systems, medical information systems, fiberscope systems, broncho endoscope systems, endoscopic ultrasound systems; ultrasound fiberscopes; ultrasound probes; ultrasound centers; ultrasound-guided needle puncture systems; cleaning, disinfecting and sterilization systems; medical treatment peripherals; ancillary products&lt;br /&gt;
* '''MIP''' includes surgical endoscopes and treatment equipments&lt;br /&gt;
** '''Endosurgery''' &amp;lt;br&amp;gt;Endoscopy products for gastroenterological surgery, thoracic surgery, urology, gynecology, orthopedic surgery, neurosurgery, cardiovascular surgery, anesthesiology and otolaryngology; treatment and surgical equipment; peripherals&lt;br /&gt;
** '''Endotherapy''' &amp;lt;br&amp;gt;Endotherapy products&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Revenue===&lt;br /&gt;
Medical systems business is the biggest business segment of Olympus corporation:&lt;br /&gt;
* Net sales ratio : 40% approx.&lt;br /&gt;
* Contribution to total corporate operating income :109% approx. &lt;br /&gt;
:(before corporate allocation of expenses)&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;81%&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Metrics ( in Billion Yen)'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;''' '''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''2009'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''2010'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''2011'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;left&amp;quot; bgcolor = &amp;quot;#95B3D7&amp;quot; rowspan = &amp;quot;3&amp;quot;|'''Medical Systems'''&lt;br /&gt;
|'''Domestic'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|76.2&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|75.1&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|79.4&lt;br /&gt;
|-&lt;br /&gt;
|'''Overseas'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|307.6&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|275.7&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|275.9&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#95B3D7&amp;quot;|'''Total'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#95B3D7&amp;quot;|'''383.89'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#95B3D7&amp;quot;|'''350.75'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#95B3D7&amp;quot;|'''355.46'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;3&amp;quot;|Endoscopes&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Domestic&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|44.6&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|40.9&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|43.8&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Overseas&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|168.3&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|151&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|151.6&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Total'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''212.9'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''191.9'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''195.5'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;3&amp;quot;|MIP&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Domestic&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|31.6&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|34.2&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|35.6&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Overseas&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|139.3&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|124.6&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|124.3&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Total'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''170.9'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''158.8'''&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''159.9'''&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Projections for FY 2012===&lt;br /&gt;
Quarter 3&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
* In endoscopes, new shipments of some products (Lucera) have ground to a halt, but the company expects to see a rebound in 2nd Half. For the year as a whole it projects endoscope sales will be down 5% YoY.&lt;br /&gt;
* The company estimates 1st Half sales in the medical systems division at JPY165bn (-6% YoY), and OP at JPY27bn; it projects 2nd Half sales at JPY195bn (+8%) and OP at JPY43bn.&lt;br /&gt;
* In the medical systems division, new product launches are planned for both surgical endoscopes and energy devices (treatment tools).&lt;br /&gt;
* It projects sales of MIPs (surgical endoscopes, treatment equipment) at JPY180.5bn (+10% YoY). Sales in FY3/11 were flat YoY due mainly to the strength of the yen, but positive growth is expected this year.&lt;br /&gt;
* The company projects sales of gastrointestinal endoscopes at JPY164bn, -5% YoY, reflecting production setbacks in 1st Half.&lt;br /&gt;
* The earthquake’s impact has caused bottlenecks in purchasing of parts and materials for gastrointestinal endoscopes,leading to delays in product launches. In the latest telephone conference, the company offered no new information about timing. We believe there has been no real change from the company’s comments at the results briefing in May,and it remains to be seen whether the company will be able to launch its new products this fiscal year. The company’s FY3/12 earnings forecasts do not reflect any contribution from new products. Sales in the medical systems division got off to a slow start, falling short of projections in April-May.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Geographic Presence===&lt;br /&gt;
[[Image:Geo_olympus.PNG|center|1000px|thumb| Source: [http://www.olympus-global.com/ Olympus]]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Corporate Strategic Plan===&lt;br /&gt;
* Expand the endoscopic business base ( Gastrointestinal )&lt;br /&gt;
** Gain a dominant market share and ensure profitability in the imaging field&lt;br /&gt;
*** Early introduction and diffusion of next generation endoscope systems&lt;br /&gt;
*** Establishment of a significant presence in emerging markets&lt;br /&gt;
*** Diagnostic technology to promote early detection&lt;br /&gt;
*** Endoscope technology to achieve definite diagnoses&lt;br /&gt;
** Imaging technology for achieving early detection :Narrow Band Imaging (NBI)&lt;br /&gt;
*** Acquisition of approval of insurance reimbursement for medical effects from early cancer detection using NBI ( in Japan)&lt;br /&gt;
*** Initiative for standardization of NBI observation as diagnosis&lt;br /&gt;
* Growth Drivers&lt;br /&gt;
** Expansion of EndoTherapy field&lt;br /&gt;
*** Introduce Visera Elite, a new integrated endoscopy video system&lt;br /&gt;
*** Secure a 30% share of the global operating room imaging market in 2015&lt;br /&gt;
*** Expand the lineup of differentiated products focused on minimally invasive surgical techniques&lt;br /&gt;
*** Achieve the top share (30%) of the existing global endoscopy market in 2015. Also, secure top share of the Japanese market and further strengthen the sales structure&lt;br /&gt;
** Expansion of Chinese and Asian market&lt;br /&gt;
*** Introduce popularly prices models&lt;br /&gt;
*** Expand the size of the market and share in such markets. Increase the number of endoscopists and improve their training.&lt;br /&gt;
&lt;br /&gt;
==Endoscopes Business==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Market Share===&lt;br /&gt;
&lt;br /&gt;
[[Image:CoSHare1.PNG|centre|frame|Source: Espicom]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
The worldwide endoscopy market (comprising laparoscopy, gastro-intestinal, visualisation, arthroscopy and urology&lt;br /&gt;
products, rigid and flexible scopes, implants, surgical and other instruments) was worth approximately '''US$21.3 billion in 2009'''. Olympus’ share of this market was estimated to be 18%($3.834B), behind market leader Johnson &amp;amp; Johnson with an&lt;br /&gt;
approximate 21% market share. In third place was Covidien (13%), followed by Boston Scientific (7%), Stryker (4%), Smith &amp;amp;&lt;br /&gt;
Nephew (4%) and Karl Storz (4%).&lt;br /&gt;
&lt;br /&gt;
===Product Portfolio===&lt;br /&gt;
The company offers endoscopes in various specialties. The following is a comprehensive list of endoscopes ,according to specialty, that the company offers:&amp;lt;br&amp;gt;&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_ebus_bronchoscopes.asp EBUS Bronchoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_fiber_bronchoscopes.asp Fiber Optic Bronchoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_video_bronchoscopes.asp Video Bronchoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_capsulescopes.asp Capsule Endoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_choledochoscopes.asp Choledochoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_colonoscopes.asp Colonoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_duodenoscopes.asp Duodenoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_echoendoscopes.asp Echoendoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_enteroscopes.asp Enteroscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_esophagoscopes.asp Esophagoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_gastroscopes.asp Gastroscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_laryngoscopes.asp Laryngoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_maf.asp Intubation Scopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_rhinolaryngoscopes.asp Rhinolaryngoscopes]&lt;br /&gt;
* [http://www.olympusamerica.com/msg_section/msg_endoscopy_sigmoidoscopes.asp Sigmoidoscopes]&lt;br /&gt;
[[Image:prodcuts_olympus.PNG|center|frame| [http://www.olympus-global.com/en/ Olympus]]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Recent Developments===&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''S.No.'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Date'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''News/Development'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|1.&lt;br /&gt;
|July 2011&lt;br /&gt;
|[http://www.olympus-global.com/en/news/2011b/nr110704spiruse.html Olympus Corporation to Acquire Spirus Medical, Inc., an endoscope insertion device manufacturer]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|2.&lt;br /&gt;
|May 2011&lt;br /&gt;
|[http://www.olympus-global.com/en/news/2011a/nr110526awarde.html Narrow Band Imaging (NBI) endoscopic technology, useful in early cancer detection, selected for the Prime Minister Prize at the 2011 National Commendation for Invention]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|3.&lt;br /&gt;
|May 2011&lt;br /&gt;
|[http://www.olympusamerica.com/corporate/corp_presscenter_headline.asp?pressNo=851 Olympus ScopeGuide Receives FDA Clearance]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|4.&lt;br /&gt;
|April 2011&lt;br /&gt;
|[http://www.olympusamerica.com/corporate/corp_presscenter_headline.asp?pressNo=850 Olympus Names Luke Calcraft as President of Medical Systems Group in the Americas]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|5.&lt;br /&gt;
|February 2011&lt;br /&gt;
|[http://www.olympus-global.com/en/news/2011a/nr110210corpe.html Olympus Names Michael C. Woodford to Serve as President]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|6.&lt;br /&gt;
|October 2010&lt;br /&gt;
|[http://www.olympus-europa.com/corporate/1696_4717.htm Magnetically guided capsule endoscope system presented at UEGW in Barcelona]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|7.&lt;br /&gt;
|May 2010&lt;br /&gt;
|[http://www.olympusamerica.com/corporate/corp_presscenter_headline.asp?pressNo=762 Olympus Develops World’s Fastest, Most Compatible Endoscope Reprocessor]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|8.&lt;br /&gt;
|April 2010&lt;br /&gt;
|[http://www.olympus-europa.com/corporate/1696_4246.htm Olympus Medical Systems Corporation and Siemens Healthcare announce collaborative development of advanced magnetically guided capsule endoscope system for intragastric observation]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|9.&lt;br /&gt;
|April 2010&lt;br /&gt;
|[http://www.olympus-global.com/en/news/2010a/nr100412omsiple.html Olympus Medical Systems India Private Limited established, would take care of Sales, marketing and service for medical equipment (endoscopes and related products, and surgical products, etc.)]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|10.&lt;br /&gt;
|February 2010&lt;br /&gt;
|[http://www.olympusamerica.com/corporate/corp_presscenter_headline.asp?pressNo=745 Olympus Introduces HDTV Gastroscope with Auxiliary Water Channel]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|11.&lt;br /&gt;
|November 2009&lt;br /&gt;
|[http://www.olympusamerica.com/corporate/corp_presscenter_headline.asp?pressNo=719 Olympus Introduces World's Smallest GI Scope to Offer 4-Way Angulation and Narrow Band Imaging]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|12.&lt;br /&gt;
|October 2009&lt;br /&gt;
|[http://www.olympusamerica.com/corporate/corp_presscenter_headline.asp?pressNo=713 Improved Endo Capsule Software Enhances Diagnostic Experience]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|13.&lt;br /&gt;
|February 2009&lt;br /&gt;
|[http://www.olympusamerica.com/corporate/corp_presscenter_headline.asp?pressNo=662 Olympus Introduces World’s First Combined Endoscopic Ultrasound Processor for Imaging and Treatment of Digestive and Pulmonary Diseases]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|14.&lt;br /&gt;
|December 2008&lt;br /&gt;
|[http://www.olympus-europa.com/corporate/1696_3032.htm Olympus further enhances credentials by entering into exclusive sales and distribution partnership with market and technology leader Advanced Surgical Concepts]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|15.&lt;br /&gt;
|November 2008&lt;br /&gt;
|[http://www.olympus-europa.com/corporate/1696_2774.htm Olympus Medical Systems Europa and BrainLAB Sign Sales and Marketing Cooperation Agreement]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Gastrointestinal Endoscopes Business==&lt;br /&gt;
&lt;br /&gt;
With an approximately 70% global market share for gastrointestinal endoscopes and an established position at the medical vanguard, Olympus maintains its passion for advancing technologies in response to doctors' needs&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Diagnosis and Treatment using Gastrointestinal Endoscopy===&lt;br /&gt;
&lt;br /&gt;
'''Diagnosis'''&lt;br /&gt;
* Biopsy&lt;br /&gt;
* Cytodiagnosis&lt;br /&gt;
* Staining&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
'''Treatment'''&lt;br /&gt;
* Cancer (esophageal, stomach, colon, etc.)&lt;br /&gt;
* Varcies (esophageal)&lt;br /&gt;
* Foreign object retrieval ( esophagus, stomach) &lt;br /&gt;
* Hemostasis (stomach)&lt;br /&gt;
* Ployps (stomach, colon)&lt;br /&gt;
* Gallstones, bile duct stenosis (duodenum)&lt;br /&gt;
&lt;br /&gt;
===Market Share===&lt;br /&gt;
[[Image:GIshare.PNG|center|frame|Source: Espicom]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;52%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Company ( in Billion Yen)'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''2009'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''2010'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''2011'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Olympus&lt;br /&gt;
|align = &amp;quot;right&amp;quot;| 212.89&lt;br /&gt;
|align = &amp;quot;right&amp;quot;| 191.94 &lt;br /&gt;
|align = &amp;quot;right&amp;quot;| 195.45 &lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|FujiFilm HD&lt;br /&gt;
|align = &amp;quot;right&amp;quot;| 26.98&lt;br /&gt;
|align = &amp;quot;right&amp;quot;| 25.00 &lt;br /&gt;
|align = &amp;quot;right&amp;quot;| 27.00&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Hoya&lt;br /&gt;
|align = &amp;quot;right&amp;quot;| 48.87 &lt;br /&gt;
|align = &amp;quot;right&amp;quot;| 47.00 &lt;br /&gt;
|align = &amp;quot;right&amp;quot;| 45.00 &lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Products Offered===&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Speciality'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Details'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Picture'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Products'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;1&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|'''Gastroscopy'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| Endoscopic examination, therapy or surgery of the interior of the stomach.&lt;br /&gt;
|[[Image:Gastroscope2.PNG|120px]] [[Image:Gastroscope.PNG|120px]] [[Image:Gastroscope1.PNG|120px]]&lt;br /&gt;
|&lt;br /&gt;
* GIF-H180J: Enables one to perform upper gastrointestinal endoscopy utilising the latest auxiliary water function and the sharpest possible image quality provided by High-resolution HDTV images featuring Narrow Band Imaging™ (NBI) and Close Focus&lt;br /&gt;
* GIF-H180: Delivers the best possible image quality for upper GI. High-resolution HDTV images in combination with Narrow Band Imaging (NBI) and Close Focus functionality&lt;br /&gt;
* GIF-XP180N: Ultra-slim upper gastrointestinal endoscopy with four-way angulation, NBI compatibility and a 5.5mm diameter distal end and insertion tube&lt;br /&gt;
* GIF-Q180: Features a short bending section as well as a reduced bending radius. Manoeuvrability and observation especially in the cardia region are enhanced.  &lt;br /&gt;
* GIF-N180: The entire insertion tube measures just 4.9mm in diameter, resulting in improved insertability and the option for transnasal insertion in nearly 100 % of cases.&lt;br /&gt;
* GIF-Q165: Clear, sharp high-quality images in a large-size display and slim, 9.2 mm diameter distal end insertion tuber with wide 140° feild of view&lt;br /&gt;
* GIF-2T160: Two-channel endoscope for a variety of therapeutic applications&lt;br /&gt;
* GIF-XTQ160: Endoscope with powerful suction capabilities&lt;br /&gt;
* GIF-1TQ160: Endoscope with extended instrumentation capabilities&lt;br /&gt;
* GIF-Q160Z: Powerful 115 times magnification for detailed examination of the mucous surface&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;1&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|'''Duodenoscopy''' &lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| Endoscopic examination, therapy or surgery of the luminal surface of the duodenum&lt;br /&gt;
|[[Image:TJF-Q180V.PNG|100px]] [[Image:TJF-160VR.PNG|100px]]&lt;br /&gt;
|&lt;br /&gt;
* TJFQ180V: Provides critical visual feedback to enhance clinical decision making. In addition, a completely redesigned forceps elevator offers doctors the control needed when locking various sizes of guidewire. The unique dual locking function  sets a new standard for ease-of-use and security during instrument exchange.&lt;br /&gt;
* TJF-160VR: Innovative V Groove forcep elevator offers reliable duodenoscopic treatment capability in combination with dedicated V-System ERCP devices&lt;br /&gt;
* TJF-145: Excellent treatment capability with extra-large 4.2mm channel - perfect for a wide range of endo-therapy accessories including stents.&lt;br /&gt;
* JF-140R: Facilitates introduction and manipulation of EndoTherapy accessories (for example papillotomes and ERCP catheters). The removable distal cap makes it possible to have access to all sides of the forceps elevator which can consequently be easily and quickly cleaned.&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;1&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|'''Colonoscopy'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| Endoscopic examination, therapy or surgery of the luminal surface of the colon.&lt;br /&gt;
|[[Image:CF-180AI.PNG|100px]] [[Image:CQ-180AI.PNG|100px]] [[Image:CF-Q160DI.PNG|100px]]&lt;br /&gt;
|&lt;br /&gt;
* CF-H180AI/L: High-resolution HDTV images combined with the widest field of view ever available in a colonoscope: 170° lets you look even behind the folds potentially decreasing the miss-rate and improving orientation inside the colon.&lt;br /&gt;
* CF-Q180AI/L: The widest field of view ever available in a colonoscope: 170° lets you look even behind the folds potentially decreasing the miss-rate and improving orientation inside the colon.&lt;br /&gt;
* CF-Q160DI/L: ScopeGuide is a new Olympus product, which displays the shape and position of a colonoscope in real time throughout the examination without the use of x-rays. It based on magnetic fields generated by small coils build inside this endoscope and picked up by the antenna of ScopeGuide's main unit. From this data, the computer reconstructs a schematic picture of endoscope on the display.&lt;br /&gt;
* PCF-H180AI/L: Extra-slim colonoscope featuring outstanding high-resolution HDTV imaging and adjustable insertion characteristics&lt;br /&gt;
* CF-Q165I/L: Versatile colonoscope combining high image quality, large-size display and powerful treatment capability.&lt;br /&gt;
* CF-1T140I/L: For use in both therapeutic procedures and routine examinations, offers “graduated flexibility” for ease of insertion, and greater operational control and torque transmission to the distal end.&lt;br /&gt;
* CF-2T160I/L: Two-channel therapeutic capabilities&lt;br /&gt;
* CF-Q160ZI/L: Precision design that enables lens movement fully controlled via a connected magnification controller, which also provides foot switch operation.  Powerful 150 times zoom magnification delivers detailed close-ups&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;1&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|'''Proctoscopy'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| Endoscopic examination, therapy or surgery of the luminal surface of the rectum.&lt;br /&gt;
|[[Image:Procto.PNG|100px]]&lt;br /&gt;
|&lt;br /&gt;
* Rectal Diagnostic System: a complete line-up of instruments for rectoscopy, which have been especially designed for the diagnosis of possible disorders in the rectal region. Highest functionality combined with long-term durability distinguishes these instruments at reasonable investment costs.&lt;br /&gt;
* Transanal Endoscopic Microsurgery System: a versatile line up of transparent tubes enable clear inspection of the affected area. Access to a lesion is made easier by a &amp;quot;side window sheath&amp;quot;. Fully compatible with standard  VISERA equipment.&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;1&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|'''Enteroscopy'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Endoscopy of the small intestines accomplished while advancing the endoscope into the intestines from the stomach&lt;br /&gt;
|[[Image:Enteroscope1.png|100px]] [[Image:Enteroscope2.png|100px]]&lt;br /&gt;
|&lt;br /&gt;
* QuickClip2 Hemostatic Clip: Rotatable function provides better targeting capability . It's 9 mm clip opening is ideal for targeting lesions in the tight confines of the small bowel&lt;br /&gt;
* Injector Force Max Injection Needle: Kink-resistant sheath improves procedure efficiency and limits the occurrence of kinking in the depths of the small bowel. &lt;br /&gt;
* BiCOAG: Bipolar spiral tip allows effective coagulation at virtually any angle and centrally located flushing port allows for easy irrigation&lt;br /&gt;
* PolyLoop Ligating Loop: Proprietary ligating loop for prophylactic hemostasis&lt;br /&gt;
* Biopsy Forceps: Specially designed to minimize damage to the enteroscope with it's stainless steel construction.&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; rowspan = &amp;quot;1&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|'''Sigmoidoscopy'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Endoscopic examination, therapy or surgery of the sigmoid flexure&lt;br /&gt;
|[[Image:Sig.PNG|100px]]&lt;br /&gt;
|&lt;br /&gt;
* PCF-S: Easy-reach L/R adapter (MAJ-1072) improves control and comfort for smaller hands and has a soft insertion tube for easier insertion and improved patient comfort. It is compatible with CV-180, CV-160 and CV-140 video processors.&lt;br /&gt;
* OSF-V60: 730mm working length gives access to the entire sigmoid colon. It has a  Slim, 11.3mm insertion tube provides excellent handling while reducing patient discomfort.&lt;br /&gt;
* CF-Q160S: Superior image quality with large display size provides enhanced details throughout the image plane. When used in combination with the company's dedicated flushing pump and CV-160 video system center, a continuously clear view is ensured by a forward water jet that removes obstacles inside the colon at the touch of a switch on the scope.&lt;br /&gt;
* OSF-4: 700mm working length facilitates complete insertion. Generous 3.2mm instrument channel accommodates a wide variety of accessories.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Source: Company website&lt;br /&gt;
&lt;br /&gt;
===New Products===&lt;br /&gt;
*'''Scope Guide:'''&amp;lt;br&amp;gt;[[Image:Scope.PNG|right|140px]] is an exclusive Olympus technology designed to provide a real-time 3D image of the shape and configuration of the colonoscope inside the body. ScopeGuide assists with finding the optimal location to apply abdominal pressure, easier, more confident scope insertion, and early loop identification. The use of ScopeGuide during colonoscopies may lead to less patient discomfort.&amp;lt;br&amp;gt; By seeing the shape of the entire scope as it moves through the body, ScopeGuide provides additional visual information that is particularly helpful during difficult colonoscopies. The endoscopist can evaluate the extent of looping and get a better sense of which rotational maneuvers will be required to straighten out various loop formations that can occur during colonoscopy.&lt;br /&gt;
* '''Evis Lucera Colono-Videoscope:''' It helps in reducing the burden on patients and improving performance for both the inspection and treatment of colorectal cancer through the incorporation of two new functions, namely, high flexibility and highly responsive control at the insertion site, while adopting a thinner scope.&lt;br /&gt;
* '''Evis Lucera Gastrointestinal Videoscope:''' This slim gastrointestinal videoscope can be inserted through the nasal tract or the mouth to realise high quality images and is suited for the examination of lesions in the upper digestive tract, for example, in the stomach.&lt;br /&gt;
* '''Capsule Endoscopes:'''&amp;lt;br&amp;gt; [[Image:Capsule.png|right|120px]] They are non-invasive, endoscopic imaging by use of VIDEO CAPSULE ENDOSCOPES to perform examination of the gastrointestinal tract, especially the small bowel. After being introduced in 2007, they have become a revolution. High-resolution imaging, real-time viewing, ease of use and proprietary hard and software make EndoCapsule a comprehensive and powerful system - redefining capsule endoscopy.&amp;lt;br&amp;gt; One has to simply swallow the Endo capsule, a pill sized (11mm in external diameter and 26mm in length) capsule equipped with a tiny camera and lights, allows pictures to be taken of the entire small bowel. Endo capsule delivers high resolution images equivalent to those provided by endoscopes. EndoCapsule displays a clear and bright field of view for the fine observation of a variety of small bowel abnormalities.&amp;lt;br&amp;gt;The Real Time Viewer enables the physician to test the proper functionality before the procedure and to confirm the location of the capsule in the GI tract during the process. In addition it is now possible to check whether and when the capsule has left the stomach.&amp;lt;br&amp;gt;Product Details:[[Image:Capsule1.png|right|140px]]&lt;br /&gt;
** Supersensitive CCD &lt;br /&gt;
** Ultra compact lens &lt;br /&gt;
** Automatic Brightness Control adjusts illumination to maintain optimal imaging &lt;br /&gt;
** A wide depth of field provides superior observation &lt;br /&gt;
** 6 white LED lights always ensure a clear field of view &lt;br /&gt;
** Compact battery with energy efficient technology&lt;br /&gt;
:The company is developing technologies to expand the application of capsule endoscopes to the stomach and large bowel.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Source: Company website, SEC fillings&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Digbreakup.png&amp;diff=9774</id>
		<title>File:Digbreakup.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Digbreakup.png&amp;diff=9774"/>
				<updated>2011-09-29T09:24:21Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Prevalence.png&amp;diff=9773</id>
		<title>File:Prevalence.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Prevalence.png&amp;diff=9773"/>
				<updated>2011-09-29T09:23:47Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:GI_Imaging.png&amp;diff=9772</id>
		<title>File:GI Imaging.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:GI_Imaging.png&amp;diff=9772"/>
				<updated>2011-09-29T09:23:07Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Key_steps_to_endoscopic_diagnosiss.png&amp;diff=9771</id>
		<title>File:Key steps to endoscopic diagnosiss.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Key_steps_to_endoscopic_diagnosiss.png&amp;diff=9771"/>
				<updated>2011-09-29T09:22:24Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Upper_endoscopy.jpg&amp;diff=9770</id>
		<title>File:Upper endoscopy.jpg</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Upper_endoscopy.jpg&amp;diff=9770"/>
				<updated>2011-09-29T09:21:34Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Survival_rates.png&amp;diff=9769</id>
		<title>File:Survival rates.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Survival_rates.png&amp;diff=9769"/>
				<updated>2011-09-29T09:21:22Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Provol.png&amp;diff=9768</id>
		<title>File:Provol.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Provol.png&amp;diff=9768"/>
				<updated>2011-09-29T09:21:10Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:GI_Endoscopy_Market_Size.png&amp;diff=9767</id>
		<title>File:GI Endoscopy Market Size.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:GI_Endoscopy_Market_Size.png&amp;diff=9767"/>
				<updated>2011-09-29T09:20:56Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Gastrointestinal_Tract.png&amp;diff=9766</id>
		<title>File:Gastrointestinal Tract.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Gastrointestinal_Tract.png&amp;diff=9766"/>
				<updated>2011-09-29T09:20:44Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Gastric_band.png&amp;diff=9765</id>
		<title>File:Gastric band.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Gastric_band.png&amp;diff=9765"/>
				<updated>2011-09-29T09:20:29Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Digpri.png&amp;diff=9764</id>
		<title>File:Digpri.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Digpri.png&amp;diff=9764"/>
				<updated>2011-09-29T09:20:17Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Chromoendoscopy.png&amp;diff=9763</id>
		<title>File:Chromoendoscopy.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Chromoendoscopy.png&amp;diff=9763"/>
				<updated>2011-09-29T09:20:07Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:1030px-Key_steps_to_endoscopic_diagnosiss.png&amp;diff=9762</id>
		<title>File:1030px-Key steps to endoscopic diagnosiss.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:1030px-Key_steps_to_endoscopic_diagnosiss.png&amp;diff=9762"/>
				<updated>2011-09-29T09:19:51Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:1030px-GI_Imaging.png&amp;diff=9761</id>
		<title>File:1030px-GI Imaging.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:1030px-GI_Imaging.png&amp;diff=9761"/>
				<updated>2011-09-29T09:19:36Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:900px-Prevalence.png&amp;diff=9760</id>
		<title>File:900px-Prevalence.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:900px-Prevalence.png&amp;diff=9760"/>
				<updated>2011-09-29T09:19:18Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:700px-Digbreakup.png&amp;diff=9759</id>
		<title>File:700px-Digbreakup.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:700px-Digbreakup.png&amp;diff=9759"/>
				<updated>2011-09-29T09:19:07Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:300px-Colon_cancer.png&amp;diff=9758</id>
		<title>File:300px-Colon cancer.png</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:300px-Colon_cancer.png&amp;diff=9758"/>
				<updated>2011-09-29T09:18:55Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Gastrointestinal_Endoscopy_-_Landscape_Report&amp;diff=9757</id>
		<title>Gastrointestinal Endoscopy - Landscape Report</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Gastrointestinal_Endoscopy_-_Landscape_Report&amp;diff=9757"/>
				<updated>2011-09-29T09:16:00Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Overview==&lt;br /&gt;
===Introduction===&lt;br /&gt;
[[Image:Gastrointestinal Tract.png|thumb|right|500px|'''Gastrointestinal Tract''']]&lt;br /&gt;
'''Gastrointestinal Endoscopy''' deals with the endoscopic examination, therapy or surgery of the gastrointestinal tract. Gastrointestinal Tract generally refers to the digestive structures stretching from the mouth to anus, but does not include the accessory glandular organs such as liver, billary tract, panceras. The gastrointestinal tract is categorized into various sections, these include:&lt;br /&gt;
*'''Intestines''': The section of the alimentary canal from the stomach to the anal canal, includes the large intestine and small intestine.&lt;br /&gt;
*'''Lower Gastrointestinal Tract''': The segment of gastrointestinal tract that includes the small intestine below the duodenum, and the large intestine.&lt;br /&gt;
*'''Mouth''': The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper.&lt;br /&gt;
*'''Pharynx''': A funnel-shaped fibromuscular tube that conducts food to the esophagus, and air to the larynx and lungs. It is divided into the nasopharynx; oropharynx; and hypopharynx (laryngopharynx).&lt;br /&gt;
*'''Upper Gastrointestinal Tract''': The segment of gastrointestinal tract that includes the esophagus, stomach and the duodenum.&lt;br /&gt;
(Source: [http://www.ncbi.nlm.nih.gov/mesh/68041981 MeSH Database])&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===Procedures===&lt;br /&gt;
Currently, the most commonly used imaging methods for detection of gastrointestinal disorders, including disorders of the small intestine, are&lt;br /&gt;
endoscopy and radiological imaging.&amp;lt;br&amp;gt;&lt;br /&gt;
A traditional endoscope is a device consisting of a flexible tube and an optical system. There are several types of endoscopic procedures used to&lt;br /&gt;
identify disorders in the gastrointestinal tract. The basic endoscopic procedures available include:&lt;br /&gt;
[[Image:upper endoscopy.jpg|thumb|right|300px|[http://www.thaimedicalnews.com/what-is-endoscopy-gastrointestinal-digestion-disorder-exam/2008/04/22/ Upper Endoscopy]]]&lt;br /&gt;
* '''Upper Endoscopy''': In upper endoscopy, the physician inserts an endoscope, which is an approximately 3.5 foot long tube, through the patient’s mouth. In esophagogastroduodenoscopy, or EGD, the gastroscope passes down the esophagus and into the stomach and duodenum for visual examination. In esophagoscopy, only the esophagus is viewed.&lt;br /&gt;
* '''Colonoscopy''': In colonoscopy, the physician inserts a colonoscope, which is an approximately 5.5 foot long endoscope, into the patient’s colon through the anus. Colonoscopy is the primary method for detecting disorders of the colon and is the standard screening tool for early detection of colon cancer.&lt;br /&gt;
* '''Push Enteroscopy''': Push enteroscopy involves the insertion of an approximately six-foot long push enteroscope into the mouth. Due to the length and curvature of the small intestine, push enteroscopy enables the physician to view only the first one-third of the small intestine. The procedure is time consuming and difficult to perform for the physician and significantly more difficult to bear for the patient compared to traditional endoscopy.&lt;br /&gt;
* '''Double Balloon Endoscopy''': The technique involves the use of a balloon at the end of a special enteroscope camera and an overtube, which is a tube that fits over the endoscope, and which is also fitted with a balloon. The procedure is usually done under general anesthesia, but may be done with the use of conscious sedation.&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==GI Imaging==&lt;br /&gt;
Gastrointestinal endoscopy is undergoing major improvements, which are driven by new available technologies and substantial refinements of optical features. Detection, characterization and confirmation are essential steps required for proper endoscopic diagnosis. Optical and nonoptical methods can help to improve each step; these improvements are likely to increase the detection rate of neoplasias and reduce unnecessary endoscopic treatments. Furthermore, functional and molecular imaging are emerging as new diagnostic tools that could provide an opportunity for personalized medicine, in which endoscopy will define disease outcome or predict the response to targeted therapy.&lt;br /&gt;
[[Image:Key steps to endoscopic diagnosiss.png|thumb|center|1030px|[http://www.nature.com/nrgastro/journal/vaop/ncurrent/full/nrgastro.2011.152.html Key steps to endoscopic diagnosis]]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Several new technologies are now available for each step, some of them include:&lt;br /&gt;
* '''Narrow-Band Imaging(NBI)''' by Olympus America, uses filter to illuminate mucosa at specific wavelength&lt;br /&gt;
*'''Fujinon Intelligent Color Enhancement(FICE)''' by Fujinon, uses Spectral endoscopic image processing technology which has been developed to estimate spectral information from RGB image data obtained through a routine endoscopy and to better characterize mucosal tissue structures &lt;br /&gt;
*'''I-Scan''' by Pentax Medical, a next generation technology, is a dynamic, multimodal tool revealing the hidden colors, topography, vascularity, and structure of disease. i-SCAN explores the possibility of the first electronic version of chromoendoscopy (e-Chrome™) through the use of complimentary color filters and enhancements&lt;br /&gt;
*'''Third Eye Retroscope®''' by Avantis Medical Systems, an additional small-caliber endoscope that can be passed over the working channel of standard colonoscopes with the possibility of retro view—leads to a substantially increased detection of neoplastic changes&lt;br /&gt;
*'''Endoflag''' by Endopix, is a single filter, single-pass implementation that processes standard or high-definition video sequences after acquisition&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:GI Imaging.png|thumb|center|1030px|'''Classification of GI Imaging''']]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Product Portfolio Heat Map==&lt;br /&gt;
{|align=&amp;quot;center&amp;quot;&lt;br /&gt;
|&amp;lt;gflash&amp;gt;950 750 http://dolcera.com/upload/files/product_Heat_Map.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
==Market Size==&lt;br /&gt;
[[image:GI Endoscopy Market Size.png|center|900px|thumb|Source: Kalorama Information Report]]&lt;br /&gt;
&lt;br /&gt;
===Major Players===&lt;br /&gt;
====Detailed Company Profile====&lt;br /&gt;
[[Olympus Corporation]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
====Snapshot Profiles====&lt;br /&gt;
* [[Boston Scientific Snapshot| Boston Scientific]]&lt;br /&gt;
* [[Conmed Snapshot| Conmed]]&lt;br /&gt;
* [[Covidien Snapshot| Covidien]]&lt;br /&gt;
* [[Ethicon Endo Snapshot| Ethicon Endo ]]&lt;br /&gt;
* [[Fujinon Snapshot| Fujinon]]&lt;br /&gt;
* [[Given Imaging Snapshot| Given Imaging]]&lt;br /&gt;
* [[Karl Storz Snapshot| Karl Storz]]&lt;br /&gt;
* [[Hoya Snapshot| Hoya Corporation]]&lt;br /&gt;
* [[Stryker Snapshot| Stryker]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Source: [[media:kalorama.pdf|Kalorama]], Company website, Company SEC filings &lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==M&amp;amp;A Activity==&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''S.No.'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Date'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Details'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|1&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Oct-10&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.cookmedical.com/newsDetail.do?id=6614 Cook Medical Receives Two Contract Awards with HealthTrust Purchasing Group for Enteral Feeding and GI Endoscopic Supplies]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |2&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|Apr-10&lt;br /&gt;
|[http://www.prnewswire.com/news-releases/water-street-healthcare-partners-signs-definitive-agreement-to-sell-sierra-scientific-instruments-to-given-imaging-88791282.html Given Imaging Ltd acquires Sierra Scientific Instruments from Water St Healthcare Partners]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|3&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Apr-10&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.fujifilmusa.com/press/news/display_news?newsID=880031 Fujifilm signs a comprehensive Joint R&amp;amp;D aagreement with Fox Chase cancer center]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |4&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|Mar-09&lt;br /&gt;
| [http://www.karlstorz.com/cps/rde/xchg/SID-9641E54E-84C58126/karlstorz/hs.xsl/8250.htm KARL STORZ Acquires Global Care Quest]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|5&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Jan-09&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|[http://diagnosticimaging.medicaldevices-business-review.com/news/given_imaging_announces_expansion_of_distribution_agreement_with_fujifilm_090120 Given Imaging Inks Distribution Agreement with FUJIFILM]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |6&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Dec-08&lt;br /&gt;
| [http://www.dotmed.com/news/story/7624/ Given Imaging Ltd. Acquires Medtronic Bravo(R) pH Monitoring Business]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|7&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Nov-08&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.smiths.com/press_release_details.aspx?releaseID=356 Smiths Group Acquires Zhejiang Zheda Medical Instrument]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |8&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Nov-08&lt;br /&gt;
| [http://www.viatronix.com/pdfs/PR112408.pdf Visage Imaging Inks Marketing Agreement with Viatronix]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|9&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Jul-08&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://www.fujifilm.com/news/n080730.html FUJIFILM Merges Fujinon&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s Endoscope Business into Medical System Business Division]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |10&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Jun-08&lt;br /&gt;
| [http://www.itnonline.com/article/icad-acr-image-metrix-team-initiate-colon-cad-clinical-study ICAD and ACR Image Form Partnership to Initiate Colon-CAD Clinical Study]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|11&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Mar-08&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://findarticles.com/p/articles/mi_m0EIN/is_2008_March_31/ai_n24963346/ Karl Storz Inks Deal with EndoGastric for Marketing EsophyX and StomaphyX]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |12&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Mar-08&lt;br /&gt;
| [http://www.investinisrael.gov.il/NR/exeres/01104877-8720-4F39-8441-BD24EC58D8B9.htm Given Imaging Bags a 5-Year FSS Contract]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|13&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Nov-07&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;| [http://business.timesonline.co.uk/tol/business/industry_sectors/technology/article2903365.ece Olympus Takes Over Gyrus Group]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; |14&lt;br /&gt;
|align = &amp;quot;right&amp;quot; |Aug-07&lt;br /&gt;
|[http://en.wikipedia.org/wiki/Pentax#Merger_with_Hoya PENTAX and HOYA Merge]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;Center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|15&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Apr-07&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|[http://www.news-medical.net/news/2007/06/26/26855.aspx Boston Scientific to acquire Remon Medical Technologies]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Procedure Volumes==&lt;br /&gt;
The three main areas where GI Endoscopy has considerable applications are Colon/Rectum cancer, Obesity (gastric bypass/gastric banding) and Digestive system disorders.&lt;br /&gt;
===Colon/Rectum cancer===&lt;br /&gt;
[[Image:Colon cancer.png|thumb|right|300px|[http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001308/figure/A000262.B19222/?report=objectonly Stages of Cancer]]]&lt;br /&gt;
Tumors or cancer of the colon or the rectum or both. Colorectal cancer starts in the large intestine (colon) or the rectum (end of the colon). Risk factors for colorectal cancer include chronic ulcerative colitis; familial polyposis coli; exposure to asbestos; and irradiation of the cervix uteri. ([http://www.ncbi.nlm.nih.gov/mesh?term=colorectal%20cancer MeSH]) Colorectal cancer is the third most commonly diagnosed cancer in the world, but it is more common in developed countries.&amp;lt;br&amp;gt;&lt;br /&gt;
Stages of colon cancer are:&lt;br /&gt;
*''Stage 0'': Very early cancer on the innermost layer of the intestine&lt;br /&gt;
*''Stage I'': Cancer is in the inner layers of the colon&lt;br /&gt;
*''Stage II'': Cancer has spread through the muscle wall of the colon&lt;br /&gt;
*''Stage III'': Cancer has spread to the lymph nodes&lt;br /&gt;
*''Stage IV'': Cancer has spread to other organs&lt;br /&gt;
(For more information on colon cancer [http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001308/ click here])&lt;br /&gt;
====Volumes, Prevalence and Incidence====&lt;br /&gt;
*Overall, the '''lifetime risk''' of developing colorectal cancer is about '''1 in 20''' (5.1%). This risk is slightly lower in women than in men.&lt;br /&gt;
* Cases estimated in the US in '''2011''' are:&lt;br /&gt;
**''' 101,700''' cases of colon cancer &lt;br /&gt;
**'''39,510''' cases of rectal cancer &lt;br /&gt;
* Overall, colorectal cancer is the second-leading cause of cancer death in Canada.&lt;br /&gt;
** In '''2011''', an estimated '''22,200''' Canadians (12,500 men - 9,700 women) will be diagnosed with colorectal cancer and '''8,900''' (5,000 men - 3,900 women) will die from it.&lt;br /&gt;
** '''One in 14 men''' is expected to develop colorectal cancer during his lifetime and '''one in 27''' will die from it. &lt;br /&gt;
**'''One in 15 women''' is expected to develop colorectal cancer during her lifetime and '''one in 31''' will die from it.&lt;br /&gt;
** On average, '''426''' Canadians will be diagnosed with colorectal cancer every week and '''171''' will die from the disease every week.&lt;br /&gt;
(Source: [http://www.colorectal-cancer.ca/en/just-the-facts/colorectal/ Colorectal cancer association of Canada] &amp;amp; [http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-key-statistics American cancer society])&lt;br /&gt;
====Survival Rates====&lt;br /&gt;
[[Image:survival rates.png|center|thumb|800px|[http://www.cancer.org/Cancer/ColonandRectumCancer/DetailedGuide/colorectal-cancer-survival-rates Source:SEERdatabase]]]&lt;br /&gt;
====Incidence rates====&lt;br /&gt;
The estimated incidence rate of colorectal cancer in 2007 is expressed geography wise below:&lt;br /&gt;
&lt;br /&gt;
{|align = &amp;quot;center&amp;quot; border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;45%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Area'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Incidence per 100,000 people'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|North America&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|17-33.5&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Europe&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|17-33.6&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Asia&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|17-33.7&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|South America&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|17-33.4&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Africa&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|3.2-17&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
Source: Kalorama Information Report&lt;br /&gt;
&lt;br /&gt;
===Obesity (Gastric bypass/Gastric banding)===&lt;br /&gt;
A status with '''body weight''' that is grossly above the acceptable or desirable weight, usually due to accumulation of excess fats in the body. The standards may vary with age, sex, genetic or cultural background. In the Body mass index, a '''BMI greater than 30.0 kg/m2''' is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (morbid obesity).[[Image:gastric band.png|thumb|right|300px|[http://weightlosssurgery.ae/gastric-banding-surgery.php Laparoscopic Gastric Banding]]]&lt;br /&gt;
The two most common weight-loss surgeries are:&lt;br /&gt;
*[http://www.nlm.nih.gov/medlineplus/ency/article/007388.htm Laparoscopic Gastric Banding](also referred as lap band): The surgeon places a band around the upper part of your stomach, creating a small pouch to hold food. The band helps you limit how much food you eat by making you feel full after eating small amounts.&lt;br /&gt;
*[http://www.nlm.nih.gov/medlineplus/ency/article/007199.htm Gastric Bypass]: This surgery helps you lose weight by changing how your stomach and small intestine handle the food you eat. After the surgery, you will not be able to eat as much as before, and your body will not absorb all the calories and other nutrients from the food you eat.&lt;br /&gt;
====Volumes, Prevalence and Incidence====&lt;br /&gt;
* In '''United States''' obesity is estimated to cause an excess '''111,909 to 365,000 deaths per year'''&lt;br /&gt;
* '''One million''' (7.7%) of deaths in the '''European Union''' are attributed to excess weight.&lt;br /&gt;
* On an average, obesity reduces life expectancy by '''six to seven years''':&lt;br /&gt;
** A BMI of 30–35 reduces life expectancy by two to four years&lt;br /&gt;
** While morbid obesity (BMI &amp;gt; 40) reduces life expectancy by 10 years&lt;br /&gt;
* Large-scale American and European studies have found that mortality risk is lowest at a BMI of 20–25 kg/m2, with risk increasing along with changes in either direction. ([http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2960318-4/fulltext Source: thelancet] &amp;amp; [http://jama.ama-assn.org/content/282/16/1530.full jama-ama-assn])&lt;br /&gt;
*'''Obesity prevalence rate in USA'''&lt;br /&gt;
[[Image:prevalence.png|thumb|center|900px|[http://www.cdc.gov/obesity/data/trends.html Percent of Obese (BMI &amp;gt; 30) in U.S. Adults]]]&lt;br /&gt;
&lt;br /&gt;
===Digestive system disorders===&lt;br /&gt;
Diseases in any part of the gastrointestinal tract or the accessory organs (liver; biliary tract; pancreas). The digestive system disorders are categorized as: &lt;br /&gt;
*Biliary Tract Diseases&lt;br /&gt;
*Digestive System Abnormalities&lt;br /&gt;
*Digestive System Fistula&lt;br /&gt;
*Digestive System Neoplasms&lt;br /&gt;
*Gastrointestinal Diseases&lt;br /&gt;
*Liver Diseases&lt;br /&gt;
*Pancreatic Diseases&lt;br /&gt;
*Peritoneal Diseases&lt;br /&gt;
([http://www.ncbi.nlm.nih.gov/mesh?term=Digestive%20system%20disorders Source: MeSH])&lt;br /&gt;
====Volumes, Prevalence and Incidence====&lt;br /&gt;
*Hospital visits in USA (Digestive disorders as the primary reason)&lt;br /&gt;
[[image:digpri.png|thumb|center|600px|[http://www.cdc.gov/nchs/data/ad/ad374.pdf Source:CDC health statistics report]]]&lt;br /&gt;
*Disease wise breakup (Digestive disorders as the primary reason)&lt;br /&gt;
[[image:digbreakup.png|center|700px|thumb|[http://www.cdc.gov/nchs/data/series/sr_13/sr13_169.pdf Source: CDCsurvey]]]&lt;br /&gt;
*USA and Europe Procedure Volumes&lt;br /&gt;
[[Image:provol.png|center|700px|thumb|Source: Kalorama Information; WHO; US Census Bureau; Centers for Disease Control and Prevention]]&lt;br /&gt;
NOTE: All values for USA and Europe are in 000's. Data includes both in-patient and out-patient surgical procedures in all populations&lt;br /&gt;
==Reimbursements==&lt;br /&gt;
===Upper GI/ Colonoscopy===&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;90%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''CPT Code'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Procedure'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''2008 National Average Medicare Payment Facility'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43250&lt;br /&gt;
|Upper GI endoscopy including esophagus, stomach and either duodenum and/or jejunum as appropriate; with removal of tumors, polyps, or other lesions by hot biopsy forceps or bipolar cautery&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$172.91&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43251&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Upper GI endoscopy including esophagus, stomach and either duodenum and/or jejunum as appropriate; with removal of tumors, polyps, or other lesions by snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$199.58&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43255&lt;br /&gt;
|Upper GI endoscopy including esophagus, stomach and either the duodenum and/or jejunum as appropriate; diagnostic, with control of bleeding any method&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$258.99&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43256&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Upper GI endoscopy including esophagus, stomach and either the duodenum and/or jejunum as appropriate; with transendoscopic stent placement (includes predilation)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$233.09&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43258&lt;br /&gt;
|Upper GI endoscopy including esophagus, stomach and either the duodenum and/or jejunum as appropriate; with ablation of tumors, polyps, or other lesions not amendable by hot biopsy forceps, bipolar cautery or snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$244.14&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|45383&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Colonoscopy, flexible, proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$307.36&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|45384&lt;br /&gt;
|Colonoscopy, flexible, proximal to splenic flexure; with removal of tumor(s), polyp(s), or other lesion(s) by hot biopsy forceps or bipolar cautery&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$248.33&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|45385&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Colonoscopy, flexible, proximal to splenic flexure; with removal of tumor(s), polyp(s), or other lesion(s) by snare technique&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$281.84&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|91110&lt;br /&gt;
|Gastrointestinal tract imaging, intraluminal (e.g., capsule endoscopy), esophagus through ileum, with physician interpretation and report (Visualization of the colon is not reported separately)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$944.18&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
===Bariatric Surgery===&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;90%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''APC'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''APC Description (Hospital Outpatient Dept)'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Medicare Payment'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|130&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Level I Laparoscopy (CPT 43659)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$2,190.81&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|135&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Level III Skin Repair (CPT 43887)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$288.30&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|137&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Level V Skin Repair (CPT 43886, 43888)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,287.06&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|141&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Level I Upper GI Procedure (CPT 43999)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$541.59&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;90%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''CPT Code'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''Procedure'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#8DB4E3&amp;quot;|'''2008 National Average Medicare Payment Facility'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43886&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric reconstructive procedure, open; revision of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$836.59&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43888&lt;br /&gt;
|Removal and replacement of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$836.59&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43644&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and Roux-en-Y gastroenterostomy (Roux limb 150 cm or less)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,507.10&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43645&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure; with gastric bypass and small intestine reconstruction to limit absorption&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,615.27&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43659&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Unlisted laparoscopy procedure, stomach (Removal and replacement of both adjustable gastric band and subcutaneous port component)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Carrier Priced&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43770&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure; placement of adjustable gastric band (gastric band and subcutaneous port components)(use modifier - 52 for individual component placement)&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$970.08&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43771&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Laparoscopy, surgical, gastric restrictive procedure; Revision of adjustable gastric band component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,107.95&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43772&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure; Removal of adjustable gastric band component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$833.72&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43773&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Laparoscopy, surgical, gastric restrictive procedure; Removal and placement of adjustable gastric band component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,107.95&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43774&lt;br /&gt;
|Laparoscopy, surgical, gastric restrictive procedure: Removal of adjustable gastric band and subcutaneous port components&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$838.29&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43842&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric restrictive procedure, without gastric bypass, for morbid obesity; vertical banded gastroplasty&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,071.01&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43843&lt;br /&gt;
|Gastric restrictive procedure, without gastric bypass, for morbid obesity; other than vertical banded gastroplasty&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,097.67&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43845&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric restrictive procedure with partial gastrectomy, pylorus-preserving duodenoileostomy (50 to 100 cm common channel) to limit absorption (billopancreatic diversion with duodenal switch)&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,716.20&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43846&lt;br /&gt;
|Gastric restrictive procedure, with gastric bypass, for morbid obesity; with short limb (150 cm or less) Roux-en-Y gastroenterostomy&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,416.07&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43847&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric restrictive procedure, with small intestine reconstruction to limit absorption&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$1,553.19&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43848&lt;br /&gt;
|Revision of gastric restrictive procedure for morbid obesity (separate procedure), other than adjustable gastric band&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$1,680.40&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43886&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Gastric reconstructive procedure, open; revision of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$287.18&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43887&lt;br /&gt;
|Removal of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|$272.32&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43888&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Removal and replacement of subcutaneous port component only&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|$387.34&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|43999&lt;br /&gt;
|Unlisted procedure, stomach&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Carrier Priced&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|S2083&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Carrier Priced&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Technology Advancements==&lt;br /&gt;
{|align = &amp;quot;center&amp;quot; border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;60%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Areas'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Companies Involved'''&lt;br /&gt;
|-&lt;br /&gt;
|rowspan = &amp;quot;6&amp;quot;|'''Enhanced Imaging Modalities'''&lt;br /&gt;
|Olympus Medical System Corp.&lt;br /&gt;
|-&lt;br /&gt;
|Pentax Crop. (Hoya Corporation)&lt;br /&gt;
|-&lt;br /&gt;
|Fujinon&lt;br /&gt;
|-&lt;br /&gt;
|Mauna Kea Technologies&lt;br /&gt;
|-&lt;br /&gt;
|KARL STORZ&lt;br /&gt;
|-&lt;br /&gt;
|SpectraScience Inc.&lt;br /&gt;
|-&lt;br /&gt;
|'''Robotic-Assisted Endomicroscope'''&lt;br /&gt;
|EndoControl Inc.&lt;br /&gt;
|-&lt;br /&gt;
|'''Wireless Biosensors and Polymers for GI bleeding (Hemostasis)'''&lt;br /&gt;
|Pluromed Inc.&lt;br /&gt;
|-&lt;br /&gt;
|'''Electronic Nose &amp;quot;Smells&amp;quot; Disease'''&lt;br /&gt;
|Cyrano Science Inc.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:chromoendoscopy.png|thumb|center|800px|'''Enhanced Imaging Modalities''': High-definition and virtual chromoendoscopy; (a) White-light imaging during endoscopy; a lesion beside a diverticular is hardly visible (arrow). (b) Closer inspection and image enhancement reveals tubular surface structures (arrows); (c) Virtual chromoendoscopy leads to pseudocolorization and improved visualization of the flat adenoma (arrows); (d) Chromoendoscopy using methylene blue unmasks the full extent of the lesion (arrows).]]&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9756</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9756"/>
				<updated>2011-09-29T09:15:19Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: /* Business &amp;amp; Information Research Services */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Intellectual Property (IP) Services|Intellectual Property(IP) Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Business &amp;amp; Information Research Services|Business and Information Research Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Dolcera Technology Platforms|Dolcera Technology Platform]]&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Intellectual Property (IP) Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey;width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey; width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Alopecia - Hair Loss]] | ([http://www.youtube.com/watch?v=jAIoyKuKQ6o Video])&lt;br /&gt;
* [[Inflammation and cardiovascular drugs]] | ([http://www.youtube.com/watch?v=FVUFcz2dpIM Video])&lt;br /&gt;
* [[RNAi Database sample wiki]] | ([http://www.youtube.com/watch?v=nsZLUSPn3cg Video])&lt;br /&gt;
* [[Choline Bitartarate]]&lt;br /&gt;
* [[Non-wovens]]&lt;br /&gt;
* [[Pressure sensitive adhesives]] | ([http://www.youtube.com/watch?v=plP3TzjYsiQ Video])&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Smart Drug Delivery Systems]] | ([http://www.youtube.com/watch?v=vARe9eBFsq4 Video])&lt;br /&gt;
* [[Silicone Hydrogel contact lens]]&lt;br /&gt;
* [[SC Johnson]]&lt;br /&gt;
* [[Pinene: An off flavor in mango juice]] | ([http://www.youtube.com/watch?v=P4fI1rjPjSg Video])&lt;br /&gt;
* [[Bio-PET]]&lt;br /&gt;
* [[Interferon For Treatment of Melanoma]]&lt;br /&gt;
* [[Antibody against TNF]]&lt;br /&gt;
* [[Pressure sensitive adhesives in packaging]] &lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Hybrid Electric Vehicle Battery System]]&lt;br /&gt;
* [[Supply Chain RFID Applications]]&lt;br /&gt;
* [[Insurance sector]]&lt;br /&gt;
* [[CDMA Basics]]&lt;br /&gt;
* [[Quality of Service on CDMA platforms]]&lt;br /&gt;
* [[OLED - Organic Light Emitting Diode]]&lt;br /&gt;
* [[Carbon Nanotubes (CNT)]] | ([http://www.youtube.com/watch?v=HvZqBy8XvIE Video])&lt;br /&gt;
* [[Metallic and Ceramic construction materials]]&lt;br /&gt;
* [[Transactional memory]]&lt;br /&gt;
* [[Invalidation Search on a patent in the semiconductors space|Invalidation Search]]&lt;br /&gt;
* [[Golf Club Head Landscape]]&lt;br /&gt;
* [[Variable Valve Timing - Sample]]&lt;br /&gt;
* [[Wind Energy]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;STN Search Reports&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Markush Search Report]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard - live] &lt;br /&gt;
** ([[Alopecia Areata Dashboard Screenshots|Screenshots only]]) &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=587 RNAi Dashboard]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=27 Automotive dashboard - live]&lt;br /&gt;
** [[Automotive Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 WiMAX dashboard - live] &lt;br /&gt;
** [[WiMAX Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid_model.swf RFID dashboard]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;IP Valuation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*[[Holographic Image Display]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://dolcera.com/client/d8r3/hairloss_map.htm Alopecia/Hair loss IPMap]&lt;br /&gt;
* [[Markush Structure Search Sample]]&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Study: In re Bilski Impact&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[In re Bilski Impact assessed from US PAIR Information]]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Prior Art Search Process]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/satellite_antenna/ipmap.html Satellite Antenna IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid/ipmap.html RFID IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/multimodal_apps/ipmap.html Multimodal Applications IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/Invalidation_US4825448.htm Invalidation Claim Chart Sample]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Clinical Trial Database===&lt;br /&gt;
*[[Clinical Trial Database]]&lt;br /&gt;
&lt;br /&gt;
== Business &amp;amp; Information Research Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Veterinary Vaccines Market Report]]&lt;br /&gt;
* [[Olympus Corporation- Company Profile]]&lt;br /&gt;
* [[Rx to OTC Switch-Market Analysis]]&lt;br /&gt;
* [[Ureteral Stent - Market Analysis]], Company Profile:[[Boston Scientific - Company Profile |Boston Scientific ]]&lt;br /&gt;
* [[Cardiac Pacemakers]]&lt;br /&gt;
* [[Botox - from Medical Procedure to Household Word]]&lt;br /&gt;
* [[Diabetes products and services]]&lt;br /&gt;
* [[Drug Metabolism]]&lt;br /&gt;
* [[Toxicology]]&lt;br /&gt;
* [[Osteoporosis]]&lt;br /&gt;
* [[Oral Diabetes Drugs]]&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Premium Coffee Consumers Market Segmentation|Premium Coffee - Market Positioning]]&lt;br /&gt;
* [[Dolcera's Poster on Industrial Biotechnology|Industrial biotechnology]]&lt;br /&gt;
* [[OTC products for acne treatment]]&lt;br /&gt;
* [[Digestive Remedies Market in India and China]]&lt;br /&gt;
* [[OTC vs. Prescription Drugs]]&lt;br /&gt;
* [[Vaccines Market in Western Countries]], Company Profile:[http://dolcera.com/wiki/index.php?title=GlaxoSmithKline_profile GlaxoSmithKline]&lt;br /&gt;
* [[Gastrointestinal Endoscopy - Market and Volume analysis]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[4G wireless technology developments]]&lt;br /&gt;
* [[LTE]]&lt;br /&gt;
* [[Femtocells]]&lt;br /&gt;
* [[HDTV in the US]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics Innovation Explorer]&lt;br /&gt;
* [[Web video]]&lt;br /&gt;
* [[OLED Mobile Phones Market Research and Analysis Report]] | ([http://www.viddler.com/explore/dolcera/videos/6/ Video])&lt;br /&gt;
* [[Samsung Company Profile]]&lt;br /&gt;
* [[Virtualization]]&lt;br /&gt;
* [[Cloud Computing]]&lt;br /&gt;
* [[Estimation of liquid carrying vehicles in USA]]&lt;br /&gt;
* [[A market study on Hybrid vehicles and the concept of V2G]]&lt;br /&gt;
* [[Patent Valuation]]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Finance===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Others and CPG===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Innovative personal finance products]]&lt;br /&gt;
* [[Life Insurance Industry in US]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
*[[Deodorants Market Analysis: Acquisition of Sanex by Colgate]]&lt;br /&gt;
*[[Partner in sales planning]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Dolcera Technology Platforms ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
==== Dashboard 1.1 ====&lt;br /&gt;
* [http://www.dolcera.com/auth/dashboarddemo/dashboard.php?workfilegroup_id=154 Demo Dashboard (Alopecia)]  &lt;br /&gt;
** [[Access details]]&lt;br /&gt;
* [[Sample list of patent numbers]]&lt;br /&gt;
* [http://www.dolcera.com/auth/index.php Dashboard login page]&lt;br /&gt;
&lt;br /&gt;
==== [[Workflow for creating a Dashboard]] ====&lt;br /&gt;
&lt;br /&gt;
==== IP and Products dashboard ====&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard] &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 4G wireless product and patent dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Patent-pathway mapping ====&lt;br /&gt;
* [[Inflammation and cardiovascular drugs#Interactive signaling pathways and patents|Patent-pathway mapping]]&lt;br /&gt;
==== Sequence dashboard ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Design analysis ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dental/main.html Dental Implant Design Analysis]&lt;br /&gt;
&lt;br /&gt;
==== Innovation explorer ====&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics innovation explorer]&lt;br /&gt;
==== KPort ====&lt;br /&gt;
* [http://dolcera.com/website/demos/kport/main.html Collaboration Portal]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Buy Dolcera Reports ==&lt;br /&gt;
* [[Landscape report for HEMT]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dolcera Offerings summary &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Dolcera Offerings|Dolcera offerings summary]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;[[Technology Support]] &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like any of these sample reports?&amp;lt;/span&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;p align=&amp;quot;center&amp;quot;&amp;gt; '''These are sample reports with brief analysis''' &amp;lt;br&amp;gt;&lt;br /&gt;
'''Dolcera can provide a comprehensive report customized to your needs'''&amp;lt;/p&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; align=&amp;quot;center&amp;quot; &amp;quot;&lt;br /&gt;
|style=&amp;quot;background:lightgrey&amp;quot; align = &amp;quot;center&amp;quot;  colspan = &amp;quot;3&amp;quot;|'''[mailto:info@dolcera.com &amp;lt;span style=&amp;quot;color:#0047AB&amp;quot;&amp;gt;Buy the customized report from Dolcera&amp;lt;/span&amp;gt;]''' &lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services Patent Analytics Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/business-research-services Market Research Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools/patent-dashboard Purchase Patent Dashboard]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Landscape Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/research-processes Dolcera Processes]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/industries Industry Focus]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Search Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/alerts-and-updates Patent Alerting Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools Dolcera Tools]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Contact Dolcera&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Samir Raiyani&lt;br /&gt;
|-&lt;br /&gt;
| '''Email''': [mailto:info@dolcera.com info@dolcera.com]&lt;br /&gt;
|-&lt;br /&gt;
| '''Phone''': +1-650-269-7952, +91-40-2355-3493&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=OLED_Mobile_Phones_Market_Research_and_Analysis_Report&amp;diff=9648</id>
		<title>OLED Mobile Phones Market Research and Analysis Report</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=OLED_Mobile_Phones_Market_Research_and_Analysis_Report&amp;diff=9648"/>
				<updated>2011-09-15T12:49:19Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: /* &amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like this report?&amp;lt;/span&amp;gt; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Executive Summary==&lt;br /&gt;
&lt;br /&gt;
* The '''OLED''' (Organic Light-Emitting Diode) technology is rapidly evolving, and these improvements are changing the dynamics display screens in mobile phones, TVs, camera, etc. The report provides a technological overview of OLEDS and includes comparisons with the rival technology of LCDs. &lt;br /&gt;
* This report analyses the '''Market for OLED display mobile phones''' in terms of products, applications, market size and structure, competitive environment and technology, and determines its future prospects.&lt;br /&gt;
* The statistical tools of '''Cluster Analysis''' and '''Regression''' are used to determine the segments of smart-phones likely to adopt OLED displays&lt;br /&gt;
* '''Bass Diffusion Model''' for adoption of new technologies is applied to forecast sales of OLED display based mobile phones. This forecast is arrived at by modeling the sales on the historical sales data of certain proxy products and is graphically presented in the report.&lt;br /&gt;
* The study reveals that by 2012 cumulative sale of OLED based mobile phone is expected to reach '''183 million units''' and details the trend of these sales over the years&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Research Objective==&lt;br /&gt;
&lt;br /&gt;
* To provide a '''Technology Overview''' for OLED Mobile Phones&lt;br /&gt;
* To provide a '''Market Overview''' for OLED Mobile Phones&lt;br /&gt;
* To provide a '''Market Estimate''' for OLED Mobile Phones&lt;br /&gt;
* To forecast the '''Adoption Rate''' of OLED Mobile Phones&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Research Methodology==&lt;br /&gt;
&lt;br /&gt;
A '''four stage analysis''' was conducted:&lt;br /&gt;
&lt;br /&gt;
[[Image:4stageanalysis.jpg|center|500px]]&lt;br /&gt;
&lt;br /&gt;
===Technology Overview===&lt;br /&gt;
&lt;br /&gt;
A brief understanding of the Technology behind the OLED displays forms the introduction to this report.&lt;br /&gt;
&lt;br /&gt;
===Market Overview===&lt;br /&gt;
&lt;br /&gt;
A detailed overview of the OLED Technology forms the basis of the Analysis performed using Base Diffusion Model.&lt;br /&gt;
 &lt;br /&gt;
===Cluster Analysis===&lt;br /&gt;
&lt;br /&gt;
Cluster Analysis was used to determine a class of mobile handsets that is most likely to use OLED displays. Cluster analysis is a technique used to assign objects to groups (called clusters), such that objects from the same cluster are ''more similar'' to each other than objects from different clusters. To determine the cluster, certain attributes of a handset like input mode, display size, camera resolution, etc. were considered.&lt;br /&gt;
&lt;br /&gt;
===Bass Diffusion Model===&lt;br /&gt;
&lt;br /&gt;
The Bass Diffusion Model was used to forecast the adoption of the OLED display mobile phones by consumers. The Bass Diffusion model is a quantitative tool that describes the process of how new products get adopted as an interaction between users and potential users. In this analysis, the model was employed to forecast the sales of a new product by utilizing historical sales data of analogous products from the same product category as well as from a diverse product category. The market penetration for mobiles with OLED displays is arrived at with result for both the proxies.&lt;br /&gt;
&lt;br /&gt;
== Mobile Phone Display: Technology Overview ==&lt;br /&gt;
&lt;br /&gt;
'''OLED (Organic Light Emitting Diodes)''' is a flat display technology, made by placing a series of organic thin films between two conductors. On applying an electric current, a bright light is emitted. OLEDs use organic semiconductor material instead of inorganic semiconductor material used in conventional Light Emitting Diodes (LEDs). Through a process called electrophosphorescence, OLEDs emit light in the presence of an electric current. Like any other diode, OLEDs permit electric current to pass only in one direction. Unlike diodes made from inorganic semiconductors, OLEDs are very flexible because they are only '''100 to 500 nanometers''' thick - the human hair is 200 times thicker than it. As a result, OLED screens are very flexible and can be made in very large sheets. OLEDs use lesser energy than LEDs as well.&lt;br /&gt;
&lt;br /&gt;
The easiest way to understand OLEDs is to compare them to LCDs. LCDs are made by placing a color filter over a white backlight source – filtering out the colors that are not wanted for each pixel. If you want to display blue, you'll have to filter out green and red. OLEDs, on the other hand, are emissive, which means that you simply need to display the colors you need for each pixel, which is made from three color (RGB) OLED “pixels.”&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== Mobile Phone Display Types ===&lt;br /&gt;
There are two types of display technologies which are used in mobile phones:&lt;br /&gt;
# Liquid Crystal Display (LCD)&lt;br /&gt;
# Organic Light-Emitting Diode (OLED)&lt;br /&gt;
&lt;br /&gt;
Recent developments in LCD are Super LCD (S-LCD) and IPS (In-Plane Switching technology) Panel. IPS technology is used in Apple’s Retina display and LG’s NOVA display. OLED technology includes developments such as Super AMOLED, Super AMOLED Plus and ClearBlack.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== Difference between LCD and OLED ===&lt;br /&gt;
The LCD uses light modulating properties of liquid crystals (LCs). The liquid crystals do not emit light directly. So, a light source is needed for proper viewing. The OLED uses organic compounds that illuminate when exposed to electric currents. Hence, a backlight is not required for OLEDs. This makes OLED displays thinner than LCD displays.&lt;br /&gt;
&lt;br /&gt;
==== Difference between AMOLED and AMLCD ====&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;2&amp;quot; width=&amp;quot;90%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Properties'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''AM OLED'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''AM LCD'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|'''Thickness/Weight'''&lt;br /&gt;
|Thinner, best is 0.05 mm; lighter&lt;br /&gt;
|Thicker, best is 0.8 mm; heavier&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Diagonal Size'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Limited to small and medium sizes; largest demo is around 40&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Can be manufactured larger; largest demo is &amp;lt;nowiki&amp;gt;~&amp;lt;/nowiki&amp;gt;100&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|'''Viewing Angle'''&lt;br /&gt;
|Up to 180 degrees&lt;br /&gt;
|Narrower, depends on liquid crystal type&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Color Gamut'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|&amp;lt;nowiki&amp;gt;&amp;gt;&amp;lt;/nowiki&amp;gt;100% NTSC (top emission), around 70% NTSC (bottom); high at all gray levels&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Around 70%, up to 100% NTSC (LED backlight and new color filter); falls at low gray levels&lt;br /&gt;
|-&lt;br /&gt;
|'''Color Reproduction'''&lt;br /&gt;
|Better; gamut independent of view angle&lt;br /&gt;
|Good; gamut changes with viewing angle&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Resolution'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Lower; 308 dpi (SM), 202 dpi (polymer)&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Higher; best is 498 dpi&lt;br /&gt;
|-&lt;br /&gt;
|'''Response Time'''&lt;br /&gt;
|Faster, nanoseconds. No motion blur, good for 3D&lt;br /&gt;
|Slower, milliseconds&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Contrast Ratio'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Higher&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Lower&lt;br /&gt;
|-&lt;br /&gt;
|'''Sunlight Readability'''&lt;br /&gt;
|Better than transmissive LCD, worse than transflective LCD&lt;br /&gt;
|Ok if transflective&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Operating Temperature'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Range is larger, can operate at low temps like -40°C&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Range is smaller, lowest temp is -10°C&lt;br /&gt;
|-&lt;br /&gt;
|'''Power Consumption'''&lt;br /&gt;
|Lower at typical video content, when around 30% of pixels are on&lt;br /&gt;
|Higher at typical video content&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Lifetime'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Shorter, 5K to 30K hour, but improving&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Much longer, above 50K hour&lt;br /&gt;
|-&lt;br /&gt;
|'''Manufacturing Investment'''&lt;br /&gt;
|Lower, but lack of standards keeps the investment only slightly lower&lt;br /&gt;
|Higher&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Production Cost'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Expensive; low yield and complex structure, potential to be low cost&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Cheaper than AMOLED&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; colspan = &amp;quot;3&amp;quot;|'''[http://www.displaysearch.com/ Source: DisplaySearch]'''&lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==== OLED Construction ====&lt;br /&gt;
An OLED can be made of a single layer of organic material but multiple layers increase efficiency and effectiveness. A typical OLED is comprised of five layers of material:&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Layer'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Description'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Substrate layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|This layer supports the OLED and is made of clear plastic, glass, foil or other materials.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Anode layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|The anode layer is transparent and is positively charged. When an electric current is applied, this layer attracts electrons as they flow through the OLED. As with a LED, the anode forms &amp;quot;holes&amp;quot; onto which electrons fall.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Conducting layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|This layer is made of organic plastic material and transports the &amp;quot;holes&amp;quot; from the anode layer.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Emissive layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|This layer transports electrons from the cathode. It is also made of organic plastic molecules but there are different from those in the conducting layer. This is the layer that determines the color of the light emitted.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Cathode layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|This layer injects electrons into the OLED when an electric current is applied. Depending on the OLED and the color effect desired, this layer may or may not be transparent.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[image:oledstructure.jpg|center|406*365px|thumb|Source: [http://electronics.howstuffworks.com/oled1.htm How Stuff Works]]]&lt;br /&gt;
&lt;br /&gt;
==== Types of OLED Construction ====&lt;br /&gt;
OLEDs can be constructed in a variety of ways to serve a variety of functions. While each type of construction uses the layers described previously, the manner in which each layer is built alters the way the OLED functions. The six most common types of OLEDs are as follows:&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Type'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Description'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Passive-Matrix OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Anode and cathode laid perpendicular to each other&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|PM OLEDs are easy to make and display text and icons very effectively, particularly in small 2-inch to 3-inch screens&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Active-Matrix OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|AM OLEDs are constructed with continuous film materials&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|AM OLEDs use less energy than PM OLEDs and have faster refresh rates&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Transparent OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Constructed with transparent materials for all five layers, a transparent OLED can be made as either a PM OLED or an AM OLED&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Useful for heads-up display applications&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Top-Emitting OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|These types of OLEDs use an opaque or reflective substrate that is useful for smart card applications&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|Best suited for an active-matrix design&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Foldable OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|The substrate of this type of OLED is very flexible, allowing the OLED to be folded or rolled up&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Because of their flexibility, foldable OLEDs could be attached to fabrics with a variety of applications&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''White OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|These OLEDs emit white light that is brighter, more uniform and more energy efficient than that emitted by fluorescent lights&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|Potential to replace incandescent and fluorescent lighting in commercial industrial, and residential applications&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==== Advantages and Disadvantages ====&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;3&amp;quot;|'''Advantages of OLED over LCD'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|As there is no backlighting, OLED displays offer deeper black levels than LCD displays&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|OLED displays have better contrast ratios&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Viewing angles offered by OLEDs is more than that offered by LCDs&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot; rowspan = &amp;quot;3&amp;quot;|'''Disadvantages of OLED over LCD'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|Brightness levels of OLED display is less than that of LCD&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|Color in OLED displays are often oversaturated&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|The red, green and blue sub-pixels deteriorate and lose efficiency at different rates, thus color consistency worsens over time&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== OLED Screen Types in Mobile Phones ===&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Type'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Description'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''AMOLED'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|AMOLED relies on a TFT backplane to switch individual pixels on and off. Active-matrix displays consume significantly less power than passive-matrix counterparts. This makes them well-suited for mobile devices. AMOLED displays are manufactured by printing electroluminescent materials onto a substrate. The relatively simplistic process suggests that OLEDs will ultimately become cheaper and easier to manufacture than LCDs. The creation of the substrate is the most difficult and expensive part of the process. Currently, AMOLED screens are limited in supply. Coupled with high demand, their availability is restricted and they are found in high-end smartphones.&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Super AMOLED'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|Super-AMOLED displays are AMOLED displays with an integrated touch function. The original AMOLED screens had reduced visibility in direct sunlight. The thickness of the touch sensor is less than 0.001mm in Super AMOLED displays. This allows the screen to provide better images and to have great visibility even in direct sunlight.&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''ClearBlack'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Nokia introduced a display similar to Samsung&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s Super AMOLED known as the ClearBlack display. The ClearBlack display makes the screen more visible in direct sunlight. A polarized filter is added to the display. This allows the viewer to see through the screen&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s reflection and view the images as they would appear under more ideal conditions.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Super AMOLED Plus'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|The Super AMOLED Plus features a traditional three sub-pixels of equal proportion within one pixel. It has an increased sub-pixel count and density. As a result, the display is much crisper, especially when it comes to text. The tighter spacing between pixels also results in better visibility under direct sunlight. The displays are also thinner, brighter and more efficient (by 18%) than the old Super AMOLED displays.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== Future OLED Mobile Screen Variations ===&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Type'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Description'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Transparent Displays'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Transparent OLEDs have only transparent components (substrate, cathode and anode) and, when turned off, are up to 85 percent as transparent as their substrate. When a transparent OLED display is turned on, it allows light to pass in both directions. A transparent OLED display can be either active- or passive-matrix. TDK began production of a see-through OLED earlier this year.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Flexible Displays'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|Flexible OLEDs have substrates made of very flexible metallic foils or plastics. Flexible OLEDs are very lightweight and durable. Their use in devices such as cell phones and PDAs can reduce breakage, a major cause for return or repair. Samsung is readying flexible AMOLED displays for production next year.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==OLED Market Overview==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market: Revenue Overview===&lt;br /&gt;
* The Global OLED Display Market was estimated at '''$964 million''' for the year 2010.&lt;br /&gt;
* The market stood at '''$884 million''' in the year 2009, and showed a growth of '''11%''' for 2010.&lt;br /&gt;
* The market is estimated to reach '''$1,428 million''' by the year 2013 &lt;br /&gt;
&lt;br /&gt;
[[Image:Global_OLED.JPG|center|760*401px|thumb|Global OLED Display Market: Revenue Forecasts 2003-2013 (in $million), Source: [http://www.marketresearch.com/Frost-Sullivan-v383/LCD-OLED-Manufacturing-Equipment-6172629/ LCD and OLED Manufacturing Equipment Market, Frost &amp;amp; Sullivan ]]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market: Volume Overview===&lt;br /&gt;
&lt;br /&gt;
* The shipments of Organic Light-Emitting Diode (OLED) screens was estimated at '''100 million''' units in 2010&lt;br /&gt;
* The shipments of Organic Light-Emitting Diode (OLED) screens are set to rise to '''326.8 million''' units in 2015&lt;br /&gt;
* The market is going to be driven by booming demand for Active-Matrix (AM) displays for mobile handsets&lt;br /&gt;
* AM-OLED segment, which will boom to '''261.5 million''' units in 2015, up more than twelve fold from '''21.1 million''' in 2009&lt;br /&gt;
&lt;br /&gt;
[[Image:Global_OLED_Volume.JPG|center|659*383px|thumb|Global OLED Display Shipment 2007-2015 &lt;br /&gt;
(Millions of Unit), Source: [http://www.isuppli.com/Display-Materials-and-Systems/News/Pages/iSuppli-Issues-Fast-Facts-on-the-Display-Industry-for-SID-2010.aspx iSuppli ]]]&lt;br /&gt;
&lt;br /&gt;
===Market Potential by Geography===&lt;br /&gt;
&lt;br /&gt;
====OLED Market Potential by Geography====&lt;br /&gt;
The following chart illustrates the OLED Market Potential by Geography over the period 2004-2014:&lt;br /&gt;
{|align = &amp;quot;center&amp;quot;&lt;br /&gt;
|&amp;lt;gflash&amp;gt;1050 625 http://dolcera.com/upload/files/OLED_Geography.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Source: [http://www.icongrouponline.com/ ICON Group International]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====AMOLED Market Potential by Geography====&lt;br /&gt;
The following chart illustrates the AMOLED Market Potential by Geography over the period 2004-2014:&lt;br /&gt;
{|align = &amp;quot;center&amp;quot;&lt;br /&gt;
|&amp;lt;gflash&amp;gt;1050 625 http://dolcera.com/upload/files/AMOLED_Geography_01.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Source: [http://www.icongrouponline.com/ ICON Group International]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market Share===&lt;br /&gt;
* '''Samsung Mobile''' leads the OLED Display Market with a market share of 43.2% as reported in 2010&lt;br /&gt;
* '''TDK''' is a distant 2nd with a market share of 17.5% and is closely followed by '''RiT Display''' with a share of 16.0%&lt;br /&gt;
&lt;br /&gt;
The following chart illustrates the Global OLED Display Unit Shipment: Market Share, for the year 2010:&lt;br /&gt;
[[Image:Global_OLED_Market_Share.JPG|center|760*401px|thumb|Global OLED Display Unit Shipment: Market Share 2010&lt;br /&gt;
, Source: [http://www.displaysearch.com/cps/rde/xchg/displaysearch/hs.xsl/quarterly_oled_shipment_and_forecast_report.asp Quarterly OLED Shipment and Forecast Report, DisplaySearch ]]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==OLED Eco-System==&lt;br /&gt;
The following dashboard illustrates all the Companies in the OLED Eco-System:&lt;br /&gt;
{|align = &amp;quot;center&amp;quot;&lt;br /&gt;
|&amp;lt;gflash&amp;gt;900 425 http://dolcera.com/upload/files/OLED_Ecosystem.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
Source: [http://www.oled-info.com/ OLED-info.com]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==OLED Market Drivers &amp;amp; Restraints==&lt;br /&gt;
&lt;br /&gt;
The following figure illustrates a '''Forcefield Analysis of Market Drivers and Restraint'''s for OLED Market (2011-2017):&lt;br /&gt;
[[Image:OLED_Drivers_Restraints.JPG|center|900*533px|thumb|Forcefield Analysis of Market Drivers and Restraints for OLED Market (2011-2017)&lt;br /&gt;
, Source: [http://www.frost.com Frost &amp;amp; Sullivan]]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market Drivers===&lt;br /&gt;
The following table illustrates the '''Impact Analysis of OLED Market Drivers''' over a period of time:&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;2&amp;quot; width=&amp;quot;60%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Rank'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Driver'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''1-2 years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''3-4 Years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''5-7 years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|1&lt;br /&gt;
|Inherent Advantages of OLED Technology&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Very High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|2&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Increasing Demand for Green Products&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|3&lt;br /&gt;
|Increasing demand for OLED Display in Mobile Phones and Signage&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|4&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Rising Potential of OLED TV&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Low&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Medium&lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Inherent Advantages of OLED Technology'''&lt;br /&gt;
&lt;br /&gt;
* OLED display offer sharper images and better contrast ratios, crisp colors and faster refresh rates compared to any existing display technology.&lt;br /&gt;
* OLED Technology also offers consumers better energy management as the whole system functions at optimal power and is of organic substrate.&lt;br /&gt;
* OLED displays are created by inserting thin organic films between two conductors and require no backlight; therefore, the displays are more compact and thinner.&lt;br /&gt;
* OLED displays, especially or television, are capable of offering viewers a viewing angle of 180 degrees&lt;br /&gt;
* As the benefits of OLED displays become more prominent, the demand for OLED manufacturing equipment is expected to increase in the next three to seven years.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Increasing Demand for Green Products'''&lt;br /&gt;
&lt;br /&gt;
* The demand for lower power consumption , reduced material usage, and simplicity is expected to propel the OLED demand in the coming years&lt;br /&gt;
* The OLED manufacturing equipment market, however, is facing challenges due to its premium and manufacturing challenges. As Manufacturers realize the economies of scale, average selling price is expected to decline, further spurring demand.&lt;br /&gt;
* OLED TV market continues to evolve technologically and benefit from increasing demands for energy efficiency from consumers.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Increasing demand for OLED Displays in Mobile Phones and Signage'''&lt;br /&gt;
&lt;br /&gt;
* Technology innovations, better functionalities and falling prices are expected to keep up the demand for OLED displays in mobile phones&lt;br /&gt;
* Mobile Phones accounted for over 82.0% of the Total OLED display market. With the success of mobile phones, such as the Galaxy, the demand for OLED displays for mobile applications is expected to increase&lt;br /&gt;
* The market is also expected to benefit from increasing demand for OLED displays used for signage&lt;br /&gt;
* These factors are expected to propel the sales of OLED during the medium and later part of the forecast period.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Rising Potential of OLED TVs'''&lt;br /&gt;
&lt;br /&gt;
* The OLED market is yet to observe strong demand for TVs. High premium price and smaller display sizes are key restraints for customers. However, with increasing collaboration within the entire supply chain of the OLED market, the market is expected to experience gradual increase in attractive solutions. According to DisplaySearch, the OLED TV market is expected to generate revenue of $28 billion by 2017.&lt;br /&gt;
* The increasing momentum is expected to help commercialize the technology in the next five to seven years. Many display manufacturers have already set up dedicated manufacturing lines from Gen 3.5 to Gen 5.5.&lt;br /&gt;
* This is expected to propel OLED manufacturing equipment sales during the latter part of the forecasted period.&lt;br /&gt;
&lt;br /&gt;
Source: [http://www.frost.com Frost &amp;amp; Sullivan]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market Restraints===&lt;br /&gt;
The following table illustrates the '''Impact Analysis of OLED Market Restraints''' over a period of time:&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;2&amp;quot; width=&amp;quot;60%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Rank'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Restraint'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''1-2 years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''3-4 Years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''5-7 years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|1&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Slow Adoption Rate of New Technology&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|2&lt;br /&gt;
|Declining Prices of competing technologies&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|3&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|High cost of products&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Medium&lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Slow Adoption Rate of New Technology'''&lt;br /&gt;
&lt;br /&gt;
* The adoption rate of OLED Technology is comparatively slower than the initial launch of LCD technology. Consumers are complacent with the current technologies it offers then a myriad o advantages and benefits.&lt;br /&gt;
* The largest issues foreseen are consumer perception, cost effectiveness of the product, ease of implementation and the ability of the service to provide true blended services&lt;br /&gt;
* As a result, there is a significant and vital gap between new product design to volume manufacturing in the OLED  market&lt;br /&gt;
* Increasing costs and manufacturing complexity has hindered the adoption rate of OLED manufacturing equipment, especially for larger substrate sizes&lt;br /&gt;
* The growth of the OLED display market and, in turn equipment sales, will rely on increasing collaboration between material suppliers, technology enablers and equipment providers. Decreased time to market and focus on R&amp;amp;D will be the key to attaining the desired growth trajectory.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''High Cost of Products'''&lt;br /&gt;
&lt;br /&gt;
* The high cost of OLED display has hindered adoption rates. For Example, customers, while willing to pay a premium price for quality products, hedge until the product has reached mass adoption level. A manufacturing facility typically requires an investment of $ 1 Billion to 3 Billion.&lt;br /&gt;
* This has restrained the demand for OLED equipment. Equipment providers are still caught in a dilemma of balancing the high cost of technology development with affordable pricing for consumers.&lt;br /&gt;
* Careful adjustment of prices can help minimize the impact of this restraint. Pricing strategy is crucial for success for the overall OLED market.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Declining Prices of Competing Technologies'''&lt;br /&gt;
&lt;br /&gt;
* The LCD market is continuing to witness strong demand despite the emergence of new products in the market.&lt;br /&gt;
* LCD Technology is transitioning t meet increasing demands for higher switching speeds, becoming more environmentally friendly by using LED backlighting, becoming sleeker and more compact, and having better resolution.&lt;br /&gt;
* The LCD and other existing technologies also offer consumers the ability to buy large screen displays. This had created major barriers for increasing the adoption rate for OLED manufacturing equipment.&lt;br /&gt;
&lt;br /&gt;
Source: [http://www.frost.com Frost &amp;amp; Sullivan]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cluster Analysis for TFT Display Mobile Phones==&lt;br /&gt;
The table here summarizes the objective, methodology, procedure and result of the cluster analysis &lt;br /&gt;
[[Image:Cluster Analysis.jpg|thumb|center|1000px|[http://faculty.chass.ncsu.edu/garson/PA765/cluster.htm Source: Statnotes, North Carolina State University]]]&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Selection of model===&lt;br /&gt;
Using the analysis, one cluster of smart-phones likely to move to OLED technology was identified for each of the two categories. For the next stage of the research - that of forecasting sales - would need the historical sales data of one particular model. For this purpose, '''Apple iPhone''' from the 2nd cluster of candy-bar phones was selected because of constraint of availability of sales data for other models like Blackberry, Nokia N96, HTC Dreamers etc.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==='''A Comparison of LCD and OLED technologies'''===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The ''radar graph'' here shows the comparison between OLED and TFT LCD.&lt;br /&gt;
&lt;br /&gt;
[[Image:Comparison.jpg|500px|thumb|center|Comparison[http://digidelve.com/oled/problems Source]]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The graph depicts the following things:&lt;br /&gt;
&lt;br /&gt;
# OLEDs are ''thinner'' than LCDs.&lt;br /&gt;
# OLEDs are ''lighter'' in weight.&lt;br /&gt;
# OLEDs consume ''more power'' than LCDs but OLEDs have an inherent advantage in that they only consume power when they emit light while an LCD backlight consumes constant power regardless of the image being displayed.&lt;br /&gt;
# OLEDs ''cost more'': The Cost of an AM-LCD is currently about half that of a comparable AM-OLED display. This is  due to the maturity of LCD manufacturing processes and facilities. OLED manufacturing facilities suffer from low yields, currently at 60%-70%.&lt;br /&gt;
# OLEDs have a ''shorter lifespan'' as compared to LCDs.&lt;br /&gt;
# OLEDs have a ''faster response time'' of .01ms while LCDs have a response time about 8-12ms.&lt;br /&gt;
# OLEDs have a ''superior viewing angle'' of 180 degree while LCDs have a lower viewing angle.&lt;br /&gt;
&lt;br /&gt;
==='''Cluster Analysis'''===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Methodology====&lt;br /&gt;
&lt;br /&gt;
'''Sample Definition:''' The sample space consists of moblie phones by leading players in the smart-phone mobile category. These models were identified from Gartner reports. The models of smart-phones launched in the last three years in North America were considered. &lt;br /&gt;
&lt;br /&gt;
'''Sample Space:'''After defining the sample, the various key attributes of smart-phones like camera, display, etc. were defined. The data for these attributes for all the models was collected from the company websites as well as the following websites:&lt;br /&gt;
&lt;br /&gt;
* www.phonearena.com&lt;br /&gt;
* www.phonegg.com&lt;br /&gt;
* www.mobile.am&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The pricing information was obtained from&lt;br /&gt;
* www.fonearena.com&lt;br /&gt;
* www.india-cellular.com&lt;br /&gt;
* www.naaptaol.com&lt;br /&gt;
* www.mobilestore.com&lt;br /&gt;
* www.indiatimes.com.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
After aggregating the data we used the '''k-clustering''' method to identify the different clusters for the samples. This technique aims to partition ''n'' observations into ''k'' clusters in which each observation belongs to the cluster with the nearest mean. Hence clusters of phones with similar attributes is achieved.&lt;br /&gt;
&lt;br /&gt;
Samples were segregated into two broad categories - candy-bar phones and clamshell or sliding phones - with thickness being the differentiating parameter. This was done in order to mitigate any error due to the design of the phone(i.e. candybar,clamshell,slider), since the thicknes of the mobile could be a cause for erroneous results.&lt;br /&gt;
&lt;br /&gt;
====Cluster analysis results====&lt;br /&gt;
&lt;br /&gt;
The sheet below shows the clusters formed for the candy-bar phones.&lt;br /&gt;
&lt;br /&gt;
[[Image:Candy_bar_excels.jpg|Candy bar|1500px|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
The sheet below shows the cluster formed for the clamshell/sliding phones.&lt;br /&gt;
&lt;br /&gt;
[[Image:clamshellexcel.jpg|Clamshell_slider|650px|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
'''Definition of Attributes:'''&lt;br /&gt;
*'''Camera''' : resolution in Megapixels&lt;br /&gt;
*'''Input method''': two types of input methods - touchscreen and keyboard&lt;br /&gt;
*'''Display size''': diagonal length of the displeay screen&lt;br /&gt;
*'''Resolution''': display resolutions&lt;br /&gt;
*'''Color''': display color&lt;br /&gt;
*'''Thickness''': total thickness of the phone&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The cluster analysis results and subsequent profiling of those clusters are summarized below:&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
''' Candy - Bar Phones'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|&amp;lt;font color=&amp;quot;#262626&amp;quot;&amp;gt;'''Clusters'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|&amp;lt;font color=&amp;quot;#262626&amp;quot;&amp;gt;'''Cell phones'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|&amp;lt;font color=&amp;quot;#262626&amp;quot;&amp;gt;'''Profile'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''1'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|Apple iPhone, Samsung i910&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|* Cluster 1 consists of high end cell phones&amp;lt;br&amp;gt;* Cell phones falling in this cluster are touch screen phones with large display size&amp;lt;br&amp;gt;* This is mainly targeting the premium market which is not price sensitive as the mobile phones in this cluster are priced high&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''2'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|HTC P3470, HTC touch cruise, HTC touch diamond, HTC touch viva, HTC X7510, i780&lt;br /&gt;
|align = &amp;quot;justify&amp;quot;|* This cluster includes cell phones with moderate display size and having touch screen facility&amp;lt;br&amp;gt;* Cell phones in this cluster are in the price range of medium to high, so it is targeting the upper middle to high class.&amp;lt;br&amp;gt;* Almost all the mobile phones falling in this cluster are having WLAN facility indicating that this cluster target trendy class people and people who prefer online games and downloads on mobile phones&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''3'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|Nokia 5320 express music, Nokia 5800 express music, Nokia 6124 classic, Nokia 6220 classic, Nokia E63, i200, i450, N6120, N78, N79, Pearl 8100&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|* Mobile phones in this cluster are targeted at the middle class as these phones are of moderate price and normal input&amp;lt;br&amp;gt;* They have small display size and moderate camera resolution, which is in sync with their target market&amp;lt;br&amp;gt;* Average thickness&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''4'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|E71, i550W, N5700, N73, N82, Blackberry 7130c/7130g&lt;br /&gt;
|align = &amp;quot;justify&amp;quot;|* This cluster consists of mobile phones having high camera resolution and normal input indicating that this cluster is for people who give high preference to clicking photographs on mobile phones&amp;lt;br&amp;gt;* They have small display size with most of them not having the WLAN facility, so this is for people who low on using the browsing facilities&amp;lt;br&amp;gt;* The target segment for this cluster is the middle class segment as the mobile phones are also moderately priced&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''5'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|Curve 8310, Blackberry 8820, Curve 8300, Blackberry 8800, Blackberry bold 9000, Blackberry curve 8330&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|* It includes mobile phones having input through qwerty and with average display size&amp;lt;br&amp;gt;* Target market is Business class people who prefer using email facility on mobiles&amp;lt;br&amp;gt;* The mobile phones are low on camera resolution&amp;lt;br&amp;gt;* All the mobiles in this cluster are high priced indicating that the targeted segment for this cluster is not price sensitive&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Clamshell Phones'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''Clusters'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''Cell phones'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''Profile'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''1'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|N6650, N95 8GB, E66, 6210 navi, N85&lt;br /&gt;
|bgcolor = &amp;quot;#D3DFEE&amp;quot;|* This cluster consists of medium to high priced mobile phones and is targeted at upper middle class&amp;lt;br&amp;gt;* These mobile phones have high camera resolution and normal keypad input&amp;lt;br&amp;gt;* All the mobiles in this cluster have average display size having 16M colors&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''2'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|N96, N97&lt;br /&gt;
|* It includes mobile phones which are high priced and targeted at affluent people who are not price sensitive&amp;lt;br&amp;gt;* The mobile phones in this cluster are characterized by high camera resolution, big display size and moderate thickness&amp;lt;br&amp;gt;* WLAN facility and high graphic resolution in these mobile phones will attract people who prefer downloading and playing online games&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''3'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|HTC dream&lt;br /&gt;
|bgcolor = &amp;quot;#D3DFEE&amp;quot;|* Mobile phones in this cluster are moderately priced and, targeted at the middle class and the upper middle class segment&amp;lt;br&amp;gt;* These phones have high thickness and high camera resolution&amp;lt;br&amp;gt;* These phones are WLAN enabled and have both qwerty keypad and touch screen input&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''4'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|N76, N6290, N75, HTC shadow, E65, i620, N6110&lt;br /&gt;
|* This cluster consists of mobile phones with low camera resolution and mainly has normal keypad for input&amp;lt;br&amp;gt;* These phones have medium display size and medium to high thickness&amp;lt;br&amp;gt;* These are low to moderately priced phones targeted at the middle class segment&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Prices for AMOLED screens===&lt;br /&gt;
&lt;br /&gt;
Market data was collected for the prices of OLED screens by various manufacturers&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Company Name&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Model Number&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Size&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Resolution&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Colors&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#FFFF00&amp;quot; colspan = &amp;quot;3&amp;quot;|Price/unit(in USD)&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|0-99&lt;br /&gt;
|100-999&lt;br /&gt;
|1000 &amp;lt;nowiki&amp;gt;++&amp;lt;/nowiki&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|Chung Yuan Technology Co., Ltd&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|2.2&amp;quot;&lt;br /&gt;
|220x176&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|20.00&lt;br /&gt;
|16.5&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|Digiprotek Markcom India P Ltd.(Densitron)&lt;br /&gt;
|C0201QILK-C&lt;br /&gt;
|2&lt;br /&gt;
|176xRGBx220&lt;br /&gt;
|262K&lt;br /&gt;
|25.69&lt;br /&gt;
|24.92&lt;br /&gt;
|20.67&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|C0240QGLA-T&amp;amp;nbsp;&lt;br /&gt;
|2.4&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|35.97&lt;br /&gt;
|34.9&lt;br /&gt;
|27.83&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|P0340WQLC-T&amp;amp;nbsp;&lt;br /&gt;
|3.45&lt;br /&gt;
|480xRGBx272&lt;br /&gt;
|16M&lt;br /&gt;
|85.65&lt;br /&gt;
|83.1&lt;br /&gt;
|47.72&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|P0430WQLC-T&amp;amp;nbsp;&lt;br /&gt;
|4.3&lt;br /&gt;
|480xRGBx272&lt;br /&gt;
|16M&lt;br /&gt;
|119.90&lt;br /&gt;
|116.32&lt;br /&gt;
|85.84&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|GLYN GmbH &amp;amp; Co. KG(CMEL)&lt;br /&gt;
|C0201QILKC&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &lt;br /&gt;
|2&lt;br /&gt;
|176x220&lt;br /&gt;
|262K&lt;br /&gt;
|25.00&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|15&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|C0240QGLAT&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &lt;br /&gt;
|2.4&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|30.00&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|20&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|C0283QGLDT&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &lt;br /&gt;
|2.83&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|38&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|26&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|P0340WQLCT&amp;amp;nbsp;&amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|3.4&lt;br /&gt;
|480xRGBx272&amp;amp;nbsp;&lt;br /&gt;
|16M&lt;br /&gt;
|60.00&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|35&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|P0430WQLCT&amp;amp;nbsp;&amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|4.3&lt;br /&gt;
|480xRGBx272&lt;br /&gt;
|16M&lt;br /&gt;
|90&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|63&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|A4G Technologies(OSD)&lt;br /&gt;
|OSD020AMQCIF&lt;br /&gt;
|2&lt;br /&gt;
|176x220&lt;br /&gt;
|262K&lt;br /&gt;
|22.50&lt;br /&gt;
|20.98 &lt;br /&gt;
|19.10 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|OSD024AMQV &lt;br /&gt;
|2.4&lt;br /&gt;
|240x320&lt;br /&gt;
|262K&lt;br /&gt;
|30.20&lt;br /&gt;
|28.57 &lt;br /&gt;
|25.40 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|OSD0283AMQV&lt;br /&gt;
|2.83&lt;br /&gt;
|240x320&lt;br /&gt;
|262K&lt;br /&gt;
|38.30&lt;br /&gt;
|36.16 &lt;br /&gt;
|33.63 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|OSD0340WQLC &lt;br /&gt;
|3.4&lt;br /&gt;
|480x272&lt;br /&gt;
|16M&lt;br /&gt;
|69.50&lt;br /&gt;
|67.25 &lt;br /&gt;
|42.48 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|OSD0430WQLC-T &lt;br /&gt;
|4.3&lt;br /&gt;
|480x272&lt;br /&gt;
|16M&lt;br /&gt;
|109.00&lt;br /&gt;
|87.00 &lt;br /&gt;
|72.00 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|Blaze Technology&lt;br /&gt;
|BDO-0240QGLA-T&lt;br /&gt;
|2.4&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|20.8&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|BDO-0283QGLD-T&lt;br /&gt;
|2.83&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|26.85&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|BDO-0340WQLA-T&lt;br /&gt;
|3.4&lt;br /&gt;
|480x272&lt;br /&gt;
|16M&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|39.5&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|BDO-0430WQLA-T&lt;br /&gt;
|4.3&lt;br /&gt;
|480x272&lt;br /&gt;
|16M&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|90.6&lt;br /&gt;
&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Bass Diffusion Analysis==&lt;br /&gt;
&lt;br /&gt;
One of the most important functions during the launch of a new product is to forecast the demand for that product, as it guides many other critical decisions faced by the company. Companies can schedule their production activities once they have an idea about the demand in the coming months or years. At a high level, Bass Diffusion Model is used to determine the shape of the curve representing the cumulative adoption of the new product. Bass describes the individuals who decide to adopt an innovation independently of the actions of others as ''innovators''. Those who respond to the influences of the social system and obtain information about a new product from those who have already adopted the product are termed as ''imitators''.&lt;br /&gt;
&lt;br /&gt;
===Proxies for analysis===&lt;br /&gt;
&lt;br /&gt;
The use of the model has been made by using the historical sales data of ''proxy'' products to forecast sales for OLED display mobile phones with an assumption that OLED display mobile phones would mimic the diffusion patterns of the proxies. Hence it was important to select the proxies carefully. We used the following for this forecast:&lt;br /&gt;
* iPhone - since this was the latest revolution in mobile phone devices and consumers would show a similar adoption behavior for a new mobile phone technology even though it comes at a price premium&lt;br /&gt;
* LCD/Plasma TVs &amp;amp; Monitors - consumers spent more money to purchase screens with superior quality by significantly increasing their budget&lt;br /&gt;
** LCD and Plasma TVs and LCD monitors were treated as a single analogous product(by ascribing different weights to these) for the forecast&lt;br /&gt;
&lt;br /&gt;
===Forecasting OLED display phone sales using Analogous Products===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''The following products from different product categories were considered:'''&amp;lt;br&amp;gt;&lt;br /&gt;
:# LCD TV &lt;br /&gt;
:# Plasma Display TV&lt;br /&gt;
:# LCD Monitor&lt;br /&gt;
&lt;br /&gt;
They were considered to be befitting analogies because of the following similarities:&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:Similarities.jpg|center|600px]]&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Weighted average for the analogous products:'''&lt;br /&gt;
Weights for modeling co-efficients for the analogous products such as LCD TV, Plasma Display TV and LCD monitor had been assigned.&amp;lt;br&amp;gt;&lt;br /&gt;
To judge the similarity of analogous products to OLED, we examined two criteria.&amp;lt;br&amp;gt;&lt;br /&gt;
::a.	Market Structure&amp;lt;br&amp;gt;&lt;br /&gt;
::b.	Product Characteristics&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:Criterion.jpg|center|600px]]&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The '''S-Graph''' for the cumulative projected sale of OLED display mobiles modeled on analogous products&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart1.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
:* In 2009 and 2010 OLED Mobile Phone market would grow slowly driven by ''innovators''&lt;br /&gt;
:* From 2011 to 2015, market will grow rapidly due to the ''early adopters''&lt;br /&gt;
:* In 2016 and 2017, market will growth will dwindle as ''late adopters'' take to the phones&lt;br /&gt;
:* 2018 onwards growth will peter, as the laggards pick up the last few models and the market will saturate&lt;br /&gt;
:* From 2016 the technology will near obsolescence and a new technology would replace it&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Comparison of Adoption rate of Innovators with those of Imitators'''&amp;lt;br&amp;gt;&lt;br /&gt;
The model helps to determine sales to innovators and imitators for each year:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart2.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
This graph shows that a small number of innovators will kick-start the sales. OLED display mobile Phones will get off to a slow start in first 2 years. Once a '''''critical mass''''' is reached by the end of the second year, strong imitative effects will take over as the innovators decrease.&lt;br /&gt;
&lt;br /&gt;
===Detailed Analysis===&lt;br /&gt;
&lt;br /&gt;
The detailed modeling with a description of parameters and mathematical equations can be viewed here:&amp;lt;br&amp;gt;&lt;br /&gt;
[[Bass Diffusion Analysis for OLED display phones]]&lt;br /&gt;
&lt;br /&gt;
==OLED Mobile Phone Projections Based on I-Phone==&lt;br /&gt;
&lt;br /&gt;
The '''S-Graph''' for the cumulative projected sale of OLED display mobiles modeled on analogous products&lt;br /&gt;
&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart3.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
:* From Q1,'09 to Q3,'09, the OLED display mobile phone market would grow slowly, driven by ''innovators''&lt;br /&gt;
:* From Q4,'09 to Q4,'10 market will grow rapidly due to the ''early adopters''&lt;br /&gt;
:* From Q1,'11 and Q3,'11 market growth will dwindle as ''late adopters'' take to the phones&lt;br /&gt;
:* Q4,'11 onwards growth will peter, as the laggards pick up the last few models and the market will saturate&lt;br /&gt;
:* From Q4, the technology will near obsolescence and a new technology would substitute it&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Comparison of Adoption rate of Innovators with those of Imitators'''&amp;lt;br&amp;gt;&lt;br /&gt;
The model helps to determine sales to innovators and imitators for each year:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart4.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
This graph shows that a small number of innovators will kick-start the sales. OLED display mobile Phones will get off to a slow start in first three quarters. Once a '''''critical mass''''' is reached by the end of the Q3, strong imitative effects will take over as the innovators decrease.&lt;br /&gt;
&lt;br /&gt;
===Detailed Analysis===&lt;br /&gt;
&lt;br /&gt;
The detailed modeling with a description of parameters and mathematical equations can be viewed here:&amp;lt;br&amp;gt;&lt;br /&gt;
[[Bass Diffusion Analysis for OLED display phones]]&lt;br /&gt;
&lt;br /&gt;
==Comparing projections==&lt;br /&gt;
Since disparate product categories had been used for the two forecasts, the two were compared to cross validate the results [[media:Bass-Model_OLED_comparison.xls|''&amp;lt;&amp;lt;excel sheet with calculations&amp;gt;&amp;gt;'']]&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart5.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
:* Looking at the forecast for OLED display mobile phones based on analogous products and on iPhone, both are seen to be ''convergent''&lt;br /&gt;
:* This validates the forecast&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Sneak Preview of some models using OLED technology==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;font-size:100%&amp;quot; border=&amp;quot;1&amp;quot; cellpadding=&amp;quot;5&amp;quot; cellspacing=&amp;quot;0&amp;quot;  width=80%&lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:Apple.jpg|thumb|center|200px|[http://www.appleiphoneapps.com/2009/03/next-iphone-to-have-oled-display-why-should-you-care/ Source: appleiphoneapps.com]]]&lt;br /&gt;
| width=60% valign=top | '''1. Apple iPhone''' - It’s nothing official at the moment, but word on the street is that Apple might have chosen a series of OLED displays for its next round of handsets. Such a move would certainly be in the best interests of battery life, as the iPhone isn’t noted for its battery capabilities. Considering the amount of new features that were announced in the iPhone 3.0 firmware update, it would be fairly practical to have a capacitive OLED display in the future.&lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:Nokia.jpg|thumb|center|200px|[http://www.mobilephonereviews.org/category/nokia/ Source: Mobile Phone Reviews]]]&lt;br /&gt;
&lt;br /&gt;
| width=60% valign=top | '''2. Nokia''' - '''Nokia 6600''' Slide Mobile Phone is a 3G device with large OLED display and 3.2 megapixel camera. It has curved edges and with a weight of 110g is a bit heavy to hold. The 2.2” screen supports 16 million colors and comes with QVGA resolution. The dimensions of the phone are 90 x 45 x 14mm.&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:Samsung.jpg|thumb|center|200px|[http://www.att-phones.org/att-samsung-a877-phone-will-be-available.html Source: ATT Phones]]]&lt;br /&gt;
&lt;br /&gt;
| width=60% valign=top | '''3. Samsung''' - '''Samsung A877''' features include a 3.2-inch WQVGA AMOLED touchscreen, a 3 megapixel camera, GPS, HSDPA and Bluetooth. And as well at it supports AT&amp;amp;T’s 3G service.&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
| width=40% valign=top | [[Image:Sony.jpg|thumb|center|200px|[http://www.itechnews.net/2008/01/08/sony-ericsson-z555-stylish-phone/ Source: Itechnews]]]&lt;br /&gt;
| width=60% valign=top | '''4. Sony''' - '''Sony Ericsson Z555''' features a 1.9-inch LCD display, an OLED 128×36 external display, a 1.3 Megapixel camera with 4x digital zoom.&lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:LG Mobile.jpg|thumb|center|200px|[http://www.unwiredview.com/2008/02/20/lg-sh150a-gets-am-oled-display-with-26-million-colors-and-hd-support/ Source: Unwiredview]]]&lt;br /&gt;
| width=60% valign=top | '''5. LG''' - One of the first handsets to get the new AM OLED, is already advanced '''LG SH150''' DMB TV phone. &lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:Motorola.jpg|thumb|center|200px|[http://www.itechnews.net/2007/10/12/motorola-u9-mobile-phone/ Source: Itechnews]]]&lt;br /&gt;
| width=60% valign=top | '''6. Motorola''' - The '''MOTO U9''' is a Quad-band phone with a 2-inch QVGA LCD display, a 1.45-inch secondary OLED display, integrated music player, Bluetooth, 25MB internal memory and a microSD card slot.&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==&amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like this report?&amp;lt;/span&amp;gt;==&lt;br /&gt;
&amp;lt;p align=&amp;quot;center&amp;quot;&amp;gt; '''This is only a sample report with brief analysis''' &amp;lt;br&amp;gt;&lt;br /&gt;
'''Dolcera can provide a comprehensive report customized to your needs'''&amp;lt;/p&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; align=&amp;quot;center&amp;quot; &amp;quot;&lt;br /&gt;
|style=&amp;quot;background:lightgrey&amp;quot; align = &amp;quot;center&amp;quot;  colspan = &amp;quot;3&amp;quot;|'''[mailto:info@dolcera.com &amp;lt;span style=&amp;quot;color:#0047AB&amp;quot;&amp;gt;Buy the customized report from Dolcera&amp;lt;/span&amp;gt;]''' &lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services Patent Analytics Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/business-research-services Market Research Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools/patent-dashboard Purchase Patent Dashboard]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Landscape Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/research-processes Dolcera Processes]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/industries Industry Focus]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Search Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/alerts-and-updates Patent Alerting Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools Dolcera Tools]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Contact Dolcera==&lt;br /&gt;
&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Samir Raiyani&lt;br /&gt;
|-&lt;br /&gt;
| '''Email''': [mailto:info@dolcera.com info@dolcera.com]&lt;br /&gt;
|-&lt;br /&gt;
| '''Phone''': +1-650-269-7952&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=OLED_Mobile_Phones_Market_Research_and_Analysis_Report&amp;diff=9646</id>
		<title>OLED Mobile Phones Market Research and Analysis Report</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=OLED_Mobile_Phones_Market_Research_and_Analysis_Report&amp;diff=9646"/>
				<updated>2011-09-15T12:48:20Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: /* &amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like this report?&amp;lt;/span&amp;gt; */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Executive Summary==&lt;br /&gt;
&lt;br /&gt;
* The '''OLED''' (Organic Light-Emitting Diode) technology is rapidly evolving, and these improvements are changing the dynamics display screens in mobile phones, TVs, camera, etc. The report provides a technological overview of OLEDS and includes comparisons with the rival technology of LCDs. &lt;br /&gt;
* This report analyses the '''Market for OLED display mobile phones''' in terms of products, applications, market size and structure, competitive environment and technology, and determines its future prospects.&lt;br /&gt;
* The statistical tools of '''Cluster Analysis''' and '''Regression''' are used to determine the segments of smart-phones likely to adopt OLED displays&lt;br /&gt;
* '''Bass Diffusion Model''' for adoption of new technologies is applied to forecast sales of OLED display based mobile phones. This forecast is arrived at by modeling the sales on the historical sales data of certain proxy products and is graphically presented in the report.&lt;br /&gt;
* The study reveals that by 2012 cumulative sale of OLED based mobile phone is expected to reach '''183 million units''' and details the trend of these sales over the years&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Research Objective==&lt;br /&gt;
&lt;br /&gt;
* To provide a '''Technology Overview''' for OLED Mobile Phones&lt;br /&gt;
* To provide a '''Market Overview''' for OLED Mobile Phones&lt;br /&gt;
* To provide a '''Market Estimate''' for OLED Mobile Phones&lt;br /&gt;
* To forecast the '''Adoption Rate''' of OLED Mobile Phones&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Research Methodology==&lt;br /&gt;
&lt;br /&gt;
A '''four stage analysis''' was conducted:&lt;br /&gt;
&lt;br /&gt;
[[Image:4stageanalysis.jpg|center|500px]]&lt;br /&gt;
&lt;br /&gt;
===Technology Overview===&lt;br /&gt;
&lt;br /&gt;
A brief understanding of the Technology behind the OLED displays forms the introduction to this report.&lt;br /&gt;
&lt;br /&gt;
===Market Overview===&lt;br /&gt;
&lt;br /&gt;
A detailed overview of the OLED Technology forms the basis of the Analysis performed using Base Diffusion Model.&lt;br /&gt;
 &lt;br /&gt;
===Cluster Analysis===&lt;br /&gt;
&lt;br /&gt;
Cluster Analysis was used to determine a class of mobile handsets that is most likely to use OLED displays. Cluster analysis is a technique used to assign objects to groups (called clusters), such that objects from the same cluster are ''more similar'' to each other than objects from different clusters. To determine the cluster, certain attributes of a handset like input mode, display size, camera resolution, etc. were considered.&lt;br /&gt;
&lt;br /&gt;
===Bass Diffusion Model===&lt;br /&gt;
&lt;br /&gt;
The Bass Diffusion Model was used to forecast the adoption of the OLED display mobile phones by consumers. The Bass Diffusion model is a quantitative tool that describes the process of how new products get adopted as an interaction between users and potential users. In this analysis, the model was employed to forecast the sales of a new product by utilizing historical sales data of analogous products from the same product category as well as from a diverse product category. The market penetration for mobiles with OLED displays is arrived at with result for both the proxies.&lt;br /&gt;
&lt;br /&gt;
== Mobile Phone Display: Technology Overview ==&lt;br /&gt;
&lt;br /&gt;
'''OLED (Organic Light Emitting Diodes)''' is a flat display technology, made by placing a series of organic thin films between two conductors. On applying an electric current, a bright light is emitted. OLEDs use organic semiconductor material instead of inorganic semiconductor material used in conventional Light Emitting Diodes (LEDs). Through a process called electrophosphorescence, OLEDs emit light in the presence of an electric current. Like any other diode, OLEDs permit electric current to pass only in one direction. Unlike diodes made from inorganic semiconductors, OLEDs are very flexible because they are only '''100 to 500 nanometers''' thick - the human hair is 200 times thicker than it. As a result, OLED screens are very flexible and can be made in very large sheets. OLEDs use lesser energy than LEDs as well.&lt;br /&gt;
&lt;br /&gt;
The easiest way to understand OLEDs is to compare them to LCDs. LCDs are made by placing a color filter over a white backlight source – filtering out the colors that are not wanted for each pixel. If you want to display blue, you'll have to filter out green and red. OLEDs, on the other hand, are emissive, which means that you simply need to display the colors you need for each pixel, which is made from three color (RGB) OLED “pixels.”&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== Mobile Phone Display Types ===&lt;br /&gt;
There are two types of display technologies which are used in mobile phones:&lt;br /&gt;
# Liquid Crystal Display (LCD)&lt;br /&gt;
# Organic Light-Emitting Diode (OLED)&lt;br /&gt;
&lt;br /&gt;
Recent developments in LCD are Super LCD (S-LCD) and IPS (In-Plane Switching technology) Panel. IPS technology is used in Apple’s Retina display and LG’s NOVA display. OLED technology includes developments such as Super AMOLED, Super AMOLED Plus and ClearBlack.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== Difference between LCD and OLED ===&lt;br /&gt;
The LCD uses light modulating properties of liquid crystals (LCs). The liquid crystals do not emit light directly. So, a light source is needed for proper viewing. The OLED uses organic compounds that illuminate when exposed to electric currents. Hence, a backlight is not required for OLEDs. This makes OLED displays thinner than LCD displays.&lt;br /&gt;
&lt;br /&gt;
==== Difference between AMOLED and AMLCD ====&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;2&amp;quot; width=&amp;quot;90%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Properties'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''AM OLED'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''AM LCD'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|'''Thickness/Weight'''&lt;br /&gt;
|Thinner, best is 0.05 mm; lighter&lt;br /&gt;
|Thicker, best is 0.8 mm; heavier&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Diagonal Size'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Limited to small and medium sizes; largest demo is around 40&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Can be manufactured larger; largest demo is &amp;lt;nowiki&amp;gt;~&amp;lt;/nowiki&amp;gt;100&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|'''Viewing Angle'''&lt;br /&gt;
|Up to 180 degrees&lt;br /&gt;
|Narrower, depends on liquid crystal type&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Color Gamut'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|&amp;lt;nowiki&amp;gt;&amp;gt;&amp;lt;/nowiki&amp;gt;100% NTSC (top emission), around 70% NTSC (bottom); high at all gray levels&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Around 70%, up to 100% NTSC (LED backlight and new color filter); falls at low gray levels&lt;br /&gt;
|-&lt;br /&gt;
|'''Color Reproduction'''&lt;br /&gt;
|Better; gamut independent of view angle&lt;br /&gt;
|Good; gamut changes with viewing angle&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Resolution'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Lower; 308 dpi (SM), 202 dpi (polymer)&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Higher; best is 498 dpi&lt;br /&gt;
|-&lt;br /&gt;
|'''Response Time'''&lt;br /&gt;
|Faster, nanoseconds. No motion blur, good for 3D&lt;br /&gt;
|Slower, milliseconds&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Contrast Ratio'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Higher&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Lower&lt;br /&gt;
|-&lt;br /&gt;
|'''Sunlight Readability'''&lt;br /&gt;
|Better than transmissive LCD, worse than transflective LCD&lt;br /&gt;
|Ok if transflective&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Operating Temperature'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Range is larger, can operate at low temps like -40°C&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Range is smaller, lowest temp is -10°C&lt;br /&gt;
|-&lt;br /&gt;
|'''Power Consumption'''&lt;br /&gt;
|Lower at typical video content, when around 30% of pixels are on&lt;br /&gt;
|Higher at typical video content&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Lifetime'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Shorter, 5K to 30K hour, but improving&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Much longer, above 50K hour&lt;br /&gt;
|-&lt;br /&gt;
|'''Manufacturing Investment'''&lt;br /&gt;
|Lower, but lack of standards keeps the investment only slightly lower&lt;br /&gt;
|Higher&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Production Cost'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Expensive; low yield and complex structure, potential to be low cost&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Cheaper than AMOLED&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; colspan = &amp;quot;3&amp;quot;|'''[http://www.displaysearch.com/ Source: DisplaySearch]'''&lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==== OLED Construction ====&lt;br /&gt;
An OLED can be made of a single layer of organic material but multiple layers increase efficiency and effectiveness. A typical OLED is comprised of five layers of material:&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Layer'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Description'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Substrate layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|This layer supports the OLED and is made of clear plastic, glass, foil or other materials.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Anode layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|The anode layer is transparent and is positively charged. When an electric current is applied, this layer attracts electrons as they flow through the OLED. As with a LED, the anode forms &amp;quot;holes&amp;quot; onto which electrons fall.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Conducting layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|This layer is made of organic plastic material and transports the &amp;quot;holes&amp;quot; from the anode layer.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Emissive layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|This layer transports electrons from the cathode. It is also made of organic plastic molecules but there are different from those in the conducting layer. This is the layer that determines the color of the light emitted.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Cathode layer'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|This layer injects electrons into the OLED when an electric current is applied. Depending on the OLED and the color effect desired, this layer may or may not be transparent.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[image:oledstructure.jpg|center|406*365px|thumb|Source: [http://electronics.howstuffworks.com/oled1.htm How Stuff Works]]]&lt;br /&gt;
&lt;br /&gt;
==== Types of OLED Construction ====&lt;br /&gt;
OLEDs can be constructed in a variety of ways to serve a variety of functions. While each type of construction uses the layers described previously, the manner in which each layer is built alters the way the OLED functions. The six most common types of OLEDs are as follows:&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Type'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Description'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Passive-Matrix OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Anode and cathode laid perpendicular to each other&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|PM OLEDs are easy to make and display text and icons very effectively, particularly in small 2-inch to 3-inch screens&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Active-Matrix OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|AM OLEDs are constructed with continuous film materials&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|AM OLEDs use less energy than PM OLEDs and have faster refresh rates&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Transparent OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Constructed with transparent materials for all five layers, a transparent OLED can be made as either a PM OLED or an AM OLED&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Useful for heads-up display applications&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Top-Emitting OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|These types of OLEDs use an opaque or reflective substrate that is useful for smart card applications&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|Best suited for an active-matrix design&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Foldable OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|The substrate of this type of OLED is very flexible, allowing the OLED to be folded or rolled up&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Because of their flexibility, foldable OLEDs could be attached to fabrics with a variety of applications&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''White OLED'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|These OLEDs emit white light that is brighter, more uniform and more energy efficient than that emitted by fluorescent lights&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|Potential to replace incandescent and fluorescent lighting in commercial industrial, and residential applications&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==== Advantages and Disadvantages ====&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot; rowspan = &amp;quot;3&amp;quot;|'''Advantages of OLED over LCD'''&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|As there is no backlighting, OLED displays offer deeper black levels than LCD displays&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|OLED displays have better contrast ratios&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Viewing angles offered by OLEDs is more than that offered by LCDs&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot; rowspan = &amp;quot;3&amp;quot;|'''Disadvantages of OLED over LCD'''&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|Brightness levels of OLED display is less than that of LCD&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|Color in OLED displays are often oversaturated&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|The red, green and blue sub-pixels deteriorate and lose efficiency at different rates, thus color consistency worsens over time&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== OLED Screen Types in Mobile Phones ===&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Type'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Description'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''AMOLED'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|AMOLED relies on a TFT backplane to switch individual pixels on and off. Active-matrix displays consume significantly less power than passive-matrix counterparts. This makes them well-suited for mobile devices. AMOLED displays are manufactured by printing electroluminescent materials onto a substrate. The relatively simplistic process suggests that OLEDs will ultimately become cheaper and easier to manufacture than LCDs. The creation of the substrate is the most difficult and expensive part of the process. Currently, AMOLED screens are limited in supply. Coupled with high demand, their availability is restricted and they are found in high-end smartphones.&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Super AMOLED'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|Super-AMOLED displays are AMOLED displays with an integrated touch function. The original AMOLED screens had reduced visibility in direct sunlight. The thickness of the touch sensor is less than 0.001mm in Super AMOLED displays. This allows the screen to provide better images and to have great visibility even in direct sunlight.&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''ClearBlack'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Nokia introduced a display similar to Samsung&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s Super AMOLED known as the ClearBlack display. The ClearBlack display makes the screen more visible in direct sunlight. A polarized filter is added to the display. This allows the viewer to see through the screen&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s reflection and view the images as they would appear under more ideal conditions.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Super AMOLED Plus'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|The Super AMOLED Plus features a traditional three sub-pixels of equal proportion within one pixel. It has an increased sub-pixel count and density. As a result, the display is much crisper, especially when it comes to text. The tighter spacing between pixels also results in better visibility under direct sunlight. The displays are also thinner, brighter and more efficient (by 18%) than the old Super AMOLED displays.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
=== Future OLED Mobile Screen Variations ===&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;75%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Type'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Description'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|'''Transparent Displays'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|Transparent OLEDs have only transparent components (substrate, cathode and anode) and, when turned off, are up to 85 percent as transparent as their substrate. When a transparent OLED display is turned on, it allows light to pass in both directions. A transparent OLED display can be either active- or passive-matrix. TDK began production of a see-through OLED earlier this year.&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#B8CCE4&amp;quot;|'''Flexible Displays'''&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#B8CCE4&amp;quot;|Flexible OLEDs have substrates made of very flexible metallic foils or plastics. Flexible OLEDs are very lightweight and durable. Their use in devices such as cell phones and PDAs can reduce breakage, a major cause for return or repair. Samsung is readying flexible AMOLED displays for production next year.&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==OLED Market Overview==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market: Revenue Overview===&lt;br /&gt;
* The Global OLED Display Market was estimated at '''$964 million''' for the year 2010.&lt;br /&gt;
* The market stood at '''$884 million''' in the year 2009, and showed a growth of '''11%''' for 2010.&lt;br /&gt;
* The market is estimated to reach '''$1,428 million''' by the year 2013 &lt;br /&gt;
&lt;br /&gt;
[[Image:Global_OLED.JPG|center|760*401px|thumb|Global OLED Display Market: Revenue Forecasts 2003-2013 (in $million), Source: [http://www.marketresearch.com/Frost-Sullivan-v383/LCD-OLED-Manufacturing-Equipment-6172629/ LCD and OLED Manufacturing Equipment Market, Frost &amp;amp; Sullivan ]]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market: Volume Overview===&lt;br /&gt;
&lt;br /&gt;
* The shipments of Organic Light-Emitting Diode (OLED) screens was estimated at '''100 million''' units in 2010&lt;br /&gt;
* The shipments of Organic Light-Emitting Diode (OLED) screens are set to rise to '''326.8 million''' units in 2015&lt;br /&gt;
* The market is going to be driven by booming demand for Active-Matrix (AM) displays for mobile handsets&lt;br /&gt;
* AM-OLED segment, which will boom to '''261.5 million''' units in 2015, up more than twelve fold from '''21.1 million''' in 2009&lt;br /&gt;
&lt;br /&gt;
[[Image:Global_OLED_Volume.JPG|center|659*383px|thumb|Global OLED Display Shipment 2007-2015 &lt;br /&gt;
(Millions of Unit), Source: [http://www.isuppli.com/Display-Materials-and-Systems/News/Pages/iSuppli-Issues-Fast-Facts-on-the-Display-Industry-for-SID-2010.aspx iSuppli ]]]&lt;br /&gt;
&lt;br /&gt;
===Market Potential by Geography===&lt;br /&gt;
&lt;br /&gt;
====OLED Market Potential by Geography====&lt;br /&gt;
The following chart illustrates the OLED Market Potential by Geography over the period 2004-2014:&lt;br /&gt;
{|align = &amp;quot;center&amp;quot;&lt;br /&gt;
|&amp;lt;gflash&amp;gt;1050 625 http://dolcera.com/upload/files/OLED_Geography.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Source: [http://www.icongrouponline.com/ ICON Group International]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====AMOLED Market Potential by Geography====&lt;br /&gt;
The following chart illustrates the AMOLED Market Potential by Geography over the period 2004-2014:&lt;br /&gt;
{|align = &amp;quot;center&amp;quot;&lt;br /&gt;
|&amp;lt;gflash&amp;gt;1050 625 http://dolcera.com/upload/files/AMOLED_Geography_01.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
Source: [http://www.icongrouponline.com/ ICON Group International]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market Share===&lt;br /&gt;
* '''Samsung Mobile''' leads the OLED Display Market with a market share of 43.2% as reported in 2010&lt;br /&gt;
* '''TDK''' is a distant 2nd with a market share of 17.5% and is closely followed by '''RiT Display''' with a share of 16.0%&lt;br /&gt;
&lt;br /&gt;
The following chart illustrates the Global OLED Display Unit Shipment: Market Share, for the year 2010:&lt;br /&gt;
[[Image:Global_OLED_Market_Share.JPG|center|760*401px|thumb|Global OLED Display Unit Shipment: Market Share 2010&lt;br /&gt;
, Source: [http://www.displaysearch.com/cps/rde/xchg/displaysearch/hs.xsl/quarterly_oled_shipment_and_forecast_report.asp Quarterly OLED Shipment and Forecast Report, DisplaySearch ]]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==OLED Eco-System==&lt;br /&gt;
The following dashboard illustrates all the Companies in the OLED Eco-System:&lt;br /&gt;
{|align = &amp;quot;center&amp;quot;&lt;br /&gt;
|&amp;lt;gflash&amp;gt;900 425 http://dolcera.com/upload/files/OLED_Ecosystem.swf&amp;lt;/gflash&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
Source: [http://www.oled-info.com/ OLED-info.com]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==OLED Market Drivers &amp;amp; Restraints==&lt;br /&gt;
&lt;br /&gt;
The following figure illustrates a '''Forcefield Analysis of Market Drivers and Restraint'''s for OLED Market (2011-2017):&lt;br /&gt;
[[Image:OLED_Drivers_Restraints.JPG|center|900*533px|thumb|Forcefield Analysis of Market Drivers and Restraints for OLED Market (2011-2017)&lt;br /&gt;
, Source: [http://www.frost.com Frost &amp;amp; Sullivan]]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market Drivers===&lt;br /&gt;
The following table illustrates the '''Impact Analysis of OLED Market Drivers''' over a period of time:&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;2&amp;quot; width=&amp;quot;60%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Rank'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Driver'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''1-2 years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''3-4 Years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''5-7 years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|1&lt;br /&gt;
|Inherent Advantages of OLED Technology&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Very High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|2&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Increasing Demand for Green Products&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|3&lt;br /&gt;
|Increasing demand for OLED Display in Mobile Phones and Signage&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|4&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Rising Potential of OLED TV&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Low&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Medium&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Medium&lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Inherent Advantages of OLED Technology'''&lt;br /&gt;
&lt;br /&gt;
* OLED display offer sharper images and better contrast ratios, crisp colors and faster refresh rates compared to any existing display technology.&lt;br /&gt;
* OLED Technology also offers consumers better energy management as the whole system functions at optimal power and is of organic substrate.&lt;br /&gt;
* OLED displays are created by inserting thin organic films between two conductors and require no backlight; therefore, the displays are more compact and thinner.&lt;br /&gt;
* OLED displays, especially or television, are capable of offering viewers a viewing angle of 180 degrees&lt;br /&gt;
* As the benefits of OLED displays become more prominent, the demand for OLED manufacturing equipment is expected to increase in the next three to seven years.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Increasing Demand for Green Products'''&lt;br /&gt;
&lt;br /&gt;
* The demand for lower power consumption , reduced material usage, and simplicity is expected to propel the OLED demand in the coming years&lt;br /&gt;
* The OLED manufacturing equipment market, however, is facing challenges due to its premium and manufacturing challenges. As Manufacturers realize the economies of scale, average selling price is expected to decline, further spurring demand.&lt;br /&gt;
* OLED TV market continues to evolve technologically and benefit from increasing demands for energy efficiency from consumers.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Increasing demand for OLED Displays in Mobile Phones and Signage'''&lt;br /&gt;
&lt;br /&gt;
* Technology innovations, better functionalities and falling prices are expected to keep up the demand for OLED displays in mobile phones&lt;br /&gt;
* Mobile Phones accounted for over 82.0% of the Total OLED display market. With the success of mobile phones, such as the Galaxy, the demand for OLED displays for mobile applications is expected to increase&lt;br /&gt;
* The market is also expected to benefit from increasing demand for OLED displays used for signage&lt;br /&gt;
* These factors are expected to propel the sales of OLED during the medium and later part of the forecast period.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Rising Potential of OLED TVs'''&lt;br /&gt;
&lt;br /&gt;
* The OLED market is yet to observe strong demand for TVs. High premium price and smaller display sizes are key restraints for customers. However, with increasing collaboration within the entire supply chain of the OLED market, the market is expected to experience gradual increase in attractive solutions. According to DisplaySearch, the OLED TV market is expected to generate revenue of $28 billion by 2017.&lt;br /&gt;
* The increasing momentum is expected to help commercialize the technology in the next five to seven years. Many display manufacturers have already set up dedicated manufacturing lines from Gen 3.5 to Gen 5.5.&lt;br /&gt;
* This is expected to propel OLED manufacturing equipment sales during the latter part of the forecasted period.&lt;br /&gt;
&lt;br /&gt;
Source: [http://www.frost.com Frost &amp;amp; Sullivan]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
===OLED Market Restraints===&lt;br /&gt;
The following table illustrates the '''Impact Analysis of OLED Market Restraints''' over a period of time:&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;2&amp;quot; width=&amp;quot;60%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Rank'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Restraint'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''1-2 years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''3-4 Years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#376091&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''5-7 years'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|1&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Slow Adoption Rate of New Technology&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|2&lt;br /&gt;
|Declining Prices of competing technologies&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|High&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|3&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|High cost of products&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|High&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#C5D9F1&amp;quot;|Medium&lt;br /&gt;
|-&lt;br /&gt;
|}&amp;lt;br clear=&amp;quot;all&amp;quot;&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Slow Adoption Rate of New Technology'''&lt;br /&gt;
&lt;br /&gt;
* The adoption rate of OLED Technology is comparatively slower than the initial launch of LCD technology. Consumers are complacent with the current technologies it offers then a myriad o advantages and benefits.&lt;br /&gt;
* The largest issues foreseen are consumer perception, cost effectiveness of the product, ease of implementation and the ability of the service to provide true blended services&lt;br /&gt;
* As a result, there is a significant and vital gap between new product design to volume manufacturing in the OLED  market&lt;br /&gt;
* Increasing costs and manufacturing complexity has hindered the adoption rate of OLED manufacturing equipment, especially for larger substrate sizes&lt;br /&gt;
* The growth of the OLED display market and, in turn equipment sales, will rely on increasing collaboration between material suppliers, technology enablers and equipment providers. Decreased time to market and focus on R&amp;amp;D will be the key to attaining the desired growth trajectory.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''High Cost of Products'''&lt;br /&gt;
&lt;br /&gt;
* The high cost of OLED display has hindered adoption rates. For Example, customers, while willing to pay a premium price for quality products, hedge until the product has reached mass adoption level. A manufacturing facility typically requires an investment of $ 1 Billion to 3 Billion.&lt;br /&gt;
* This has restrained the demand for OLED equipment. Equipment providers are still caught in a dilemma of balancing the high cost of technology development with affordable pricing for consumers.&lt;br /&gt;
* Careful adjustment of prices can help minimize the impact of this restraint. Pricing strategy is crucial for success for the overall OLED market.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Declining Prices of Competing Technologies'''&lt;br /&gt;
&lt;br /&gt;
* The LCD market is continuing to witness strong demand despite the emergence of new products in the market.&lt;br /&gt;
* LCD Technology is transitioning t meet increasing demands for higher switching speeds, becoming more environmentally friendly by using LED backlighting, becoming sleeker and more compact, and having better resolution.&lt;br /&gt;
* The LCD and other existing technologies also offer consumers the ability to buy large screen displays. This had created major barriers for increasing the adoption rate for OLED manufacturing equipment.&lt;br /&gt;
&lt;br /&gt;
Source: [http://www.frost.com Frost &amp;amp; Sullivan]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Cluster Analysis for TFT Display Mobile Phones==&lt;br /&gt;
The table here summarizes the objective, methodology, procedure and result of the cluster analysis &lt;br /&gt;
[[Image:Cluster Analysis.jpg|thumb|center|1000px|[http://faculty.chass.ncsu.edu/garson/PA765/cluster.htm Source: Statnotes, North Carolina State University]]]&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Selection of model===&lt;br /&gt;
Using the analysis, one cluster of smart-phones likely to move to OLED technology was identified for each of the two categories. For the next stage of the research - that of forecasting sales - would need the historical sales data of one particular model. For this purpose, '''Apple iPhone''' from the 2nd cluster of candy-bar phones was selected because of constraint of availability of sales data for other models like Blackberry, Nokia N96, HTC Dreamers etc.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==='''A Comparison of LCD and OLED technologies'''===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The ''radar graph'' here shows the comparison between OLED and TFT LCD.&lt;br /&gt;
&lt;br /&gt;
[[Image:Comparison.jpg|500px|thumb|center|Comparison[http://digidelve.com/oled/problems Source]]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The graph depicts the following things:&lt;br /&gt;
&lt;br /&gt;
# OLEDs are ''thinner'' than LCDs.&lt;br /&gt;
# OLEDs are ''lighter'' in weight.&lt;br /&gt;
# OLEDs consume ''more power'' than LCDs but OLEDs have an inherent advantage in that they only consume power when they emit light while an LCD backlight consumes constant power regardless of the image being displayed.&lt;br /&gt;
# OLEDs ''cost more'': The Cost of an AM-LCD is currently about half that of a comparable AM-OLED display. This is  due to the maturity of LCD manufacturing processes and facilities. OLED manufacturing facilities suffer from low yields, currently at 60%-70%.&lt;br /&gt;
# OLEDs have a ''shorter lifespan'' as compared to LCDs.&lt;br /&gt;
# OLEDs have a ''faster response time'' of .01ms while LCDs have a response time about 8-12ms.&lt;br /&gt;
# OLEDs have a ''superior viewing angle'' of 180 degree while LCDs have a lower viewing angle.&lt;br /&gt;
&lt;br /&gt;
==='''Cluster Analysis'''===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Methodology====&lt;br /&gt;
&lt;br /&gt;
'''Sample Definition:''' The sample space consists of moblie phones by leading players in the smart-phone mobile category. These models were identified from Gartner reports. The models of smart-phones launched in the last three years in North America were considered. &lt;br /&gt;
&lt;br /&gt;
'''Sample Space:'''After defining the sample, the various key attributes of smart-phones like camera, display, etc. were defined. The data for these attributes for all the models was collected from the company websites as well as the following websites:&lt;br /&gt;
&lt;br /&gt;
* www.phonearena.com&lt;br /&gt;
* www.phonegg.com&lt;br /&gt;
* www.mobile.am&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The pricing information was obtained from&lt;br /&gt;
* www.fonearena.com&lt;br /&gt;
* www.india-cellular.com&lt;br /&gt;
* www.naaptaol.com&lt;br /&gt;
* www.mobilestore.com&lt;br /&gt;
* www.indiatimes.com.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
After aggregating the data we used the '''k-clustering''' method to identify the different clusters for the samples. This technique aims to partition ''n'' observations into ''k'' clusters in which each observation belongs to the cluster with the nearest mean. Hence clusters of phones with similar attributes is achieved.&lt;br /&gt;
&lt;br /&gt;
Samples were segregated into two broad categories - candy-bar phones and clamshell or sliding phones - with thickness being the differentiating parameter. This was done in order to mitigate any error due to the design of the phone(i.e. candybar,clamshell,slider), since the thicknes of the mobile could be a cause for erroneous results.&lt;br /&gt;
&lt;br /&gt;
====Cluster analysis results====&lt;br /&gt;
&lt;br /&gt;
The sheet below shows the clusters formed for the candy-bar phones.&lt;br /&gt;
&lt;br /&gt;
[[Image:Candy_bar_excels.jpg|Candy bar|1500px|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
The sheet below shows the cluster formed for the clamshell/sliding phones.&lt;br /&gt;
&lt;br /&gt;
[[Image:clamshellexcel.jpg|Clamshell_slider|650px|center|thumb]]&lt;br /&gt;
&lt;br /&gt;
'''Definition of Attributes:'''&lt;br /&gt;
*'''Camera''' : resolution in Megapixels&lt;br /&gt;
*'''Input method''': two types of input methods - touchscreen and keyboard&lt;br /&gt;
*'''Display size''': diagonal length of the displeay screen&lt;br /&gt;
*'''Resolution''': display resolutions&lt;br /&gt;
*'''Color''': display color&lt;br /&gt;
*'''Thickness''': total thickness of the phone&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The cluster analysis results and subsequent profiling of those clusters are summarized below:&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
''' Candy - Bar Phones'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|&amp;lt;font color=&amp;quot;#262626&amp;quot;&amp;gt;'''Clusters'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|&amp;lt;font color=&amp;quot;#262626&amp;quot;&amp;gt;'''Cell phones'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|&amp;lt;font color=&amp;quot;#262626&amp;quot;&amp;gt;'''Profile'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''1'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|Apple iPhone, Samsung i910&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|* Cluster 1 consists of high end cell phones&amp;lt;br&amp;gt;* Cell phones falling in this cluster are touch screen phones with large display size&amp;lt;br&amp;gt;* This is mainly targeting the premium market which is not price sensitive as the mobile phones in this cluster are priced high&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''2'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|HTC P3470, HTC touch cruise, HTC touch diamond, HTC touch viva, HTC X7510, i780&lt;br /&gt;
|align = &amp;quot;justify&amp;quot;|* This cluster includes cell phones with moderate display size and having touch screen facility&amp;lt;br&amp;gt;* Cell phones in this cluster are in the price range of medium to high, so it is targeting the upper middle to high class.&amp;lt;br&amp;gt;* Almost all the mobile phones falling in this cluster are having WLAN facility indicating that this cluster target trendy class people and people who prefer online games and downloads on mobile phones&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''3'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|Nokia 5320 express music, Nokia 5800 express music, Nokia 6124 classic, Nokia 6220 classic, Nokia E63, i200, i450, N6120, N78, N79, Pearl 8100&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|* Mobile phones in this cluster are targeted at the middle class as these phones are of moderate price and normal input&amp;lt;br&amp;gt;* They have small display size and moderate camera resolution, which is in sync with their target market&amp;lt;br&amp;gt;* Average thickness&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''4'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|E71, i550W, N5700, N73, N82, Blackberry 7130c/7130g&lt;br /&gt;
|align = &amp;quot;justify&amp;quot;|* This cluster consists of mobile phones having high camera resolution and normal input indicating that this cluster is for people who give high preference to clicking photographs on mobile phones&amp;lt;br&amp;gt;* They have small display size with most of them not having the WLAN facility, so this is for people who low on using the browsing facilities&amp;lt;br&amp;gt;* The target segment for this cluster is the middle class segment as the mobile phones are also moderately priced&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''5'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|Curve 8310, Blackberry 8820, Curve 8300, Blackberry 8800, Blackberry bold 9000, Blackberry curve 8330&lt;br /&gt;
|align = &amp;quot;justify&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|* It includes mobile phones having input through qwerty and with average display size&amp;lt;br&amp;gt;* Target market is Business class people who prefer using email facility on mobiles&amp;lt;br&amp;gt;* The mobile phones are low on camera resolution&amp;lt;br&amp;gt;* All the mobiles in this cluster are high priced indicating that the targeted segment for this cluster is not price sensitive&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Clamshell Phones'''&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''Clusters'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''Cell phones'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''Profile'''&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''1'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|N6650, N95 8GB, E66, 6210 navi, N85&lt;br /&gt;
|bgcolor = &amp;quot;#D3DFEE&amp;quot;|* This cluster consists of medium to high priced mobile phones and is targeted at upper middle class&amp;lt;br&amp;gt;* These mobile phones have high camera resolution and normal keypad input&amp;lt;br&amp;gt;* All the mobiles in this cluster have average display size having 16M colors&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''2'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|N96, N97&lt;br /&gt;
|* It includes mobile phones which are high priced and targeted at affluent people who are not price sensitive&amp;lt;br&amp;gt;* The mobile phones in this cluster are characterized by high camera resolution, big display size and moderate thickness&amp;lt;br&amp;gt;* WLAN facility and high graphic resolution in these mobile phones will attract people who prefer downloading and playing online games&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|'''3'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#D3DFEE&amp;quot;|HTC dream&lt;br /&gt;
|bgcolor = &amp;quot;#D3DFEE&amp;quot;|* Mobile phones in this cluster are moderately priced and, targeted at the middle class and the upper middle class segment&amp;lt;br&amp;gt;* These phones have high thickness and high camera resolution&amp;lt;br&amp;gt;* These phones are WLAN enabled and have both qwerty keypad and touch screen input&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|'''4'''&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|N76, N6290, N75, HTC shadow, E65, i620, N6110&lt;br /&gt;
|* This cluster consists of mobile phones with low camera resolution and mainly has normal keypad for input&amp;lt;br&amp;gt;* These phones have medium display size and medium to high thickness&amp;lt;br&amp;gt;* These are low to moderately priced phones targeted at the middle class segment&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
=== Prices for AMOLED screens===&lt;br /&gt;
&lt;br /&gt;
Market data was collected for the prices of OLED screens by various manufacturers&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Company Name&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Model Number&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Size&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Resolution&lt;br /&gt;
|bgcolor = &amp;quot;#FFFF00&amp;quot;|Colors&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#FFFF00&amp;quot; colspan = &amp;quot;3&amp;quot;|Price/unit(in USD)&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|0-99&lt;br /&gt;
|100-999&lt;br /&gt;
|1000 &amp;lt;nowiki&amp;gt;++&amp;lt;/nowiki&amp;gt;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|Chung Yuan Technology Co., Ltd&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|2.2&amp;quot;&lt;br /&gt;
|220x176&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|20.00&lt;br /&gt;
|16.5&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|Digiprotek Markcom India P Ltd.(Densitron)&lt;br /&gt;
|C0201QILK-C&lt;br /&gt;
|2&lt;br /&gt;
|176xRGBx220&lt;br /&gt;
|262K&lt;br /&gt;
|25.69&lt;br /&gt;
|24.92&lt;br /&gt;
|20.67&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|C0240QGLA-T&amp;amp;nbsp;&lt;br /&gt;
|2.4&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|35.97&lt;br /&gt;
|34.9&lt;br /&gt;
|27.83&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|P0340WQLC-T&amp;amp;nbsp;&lt;br /&gt;
|3.45&lt;br /&gt;
|480xRGBx272&lt;br /&gt;
|16M&lt;br /&gt;
|85.65&lt;br /&gt;
|83.1&lt;br /&gt;
|47.72&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|P0430WQLC-T&amp;amp;nbsp;&lt;br /&gt;
|4.3&lt;br /&gt;
|480xRGBx272&lt;br /&gt;
|16M&lt;br /&gt;
|119.90&lt;br /&gt;
|116.32&lt;br /&gt;
|85.84&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|GLYN GmbH &amp;amp; Co. KG(CMEL)&lt;br /&gt;
|C0201QILKC&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &lt;br /&gt;
|2&lt;br /&gt;
|176x220&lt;br /&gt;
|262K&lt;br /&gt;
|25.00&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|15&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|C0240QGLAT&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &lt;br /&gt;
|2.4&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|30.00&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|20&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|C0283QGLDT&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp; &lt;br /&gt;
|2.83&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|38&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|26&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|P0340WQLCT&amp;amp;nbsp;&amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|3.4&lt;br /&gt;
|480xRGBx272&amp;amp;nbsp;&lt;br /&gt;
|16M&lt;br /&gt;
|60.00&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|35&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|P0430WQLCT&amp;amp;nbsp;&amp;amp;nbsp; &amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|4.3&lt;br /&gt;
|480xRGBx272&lt;br /&gt;
|16M&lt;br /&gt;
|90&amp;amp;nbsp;&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|63&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|A4G Technologies(OSD)&lt;br /&gt;
|OSD020AMQCIF&lt;br /&gt;
|2&lt;br /&gt;
|176x220&lt;br /&gt;
|262K&lt;br /&gt;
|22.50&lt;br /&gt;
|20.98 &lt;br /&gt;
|19.10 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|OSD024AMQV &lt;br /&gt;
|2.4&lt;br /&gt;
|240x320&lt;br /&gt;
|262K&lt;br /&gt;
|30.20&lt;br /&gt;
|28.57 &lt;br /&gt;
|25.40 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|OSD0283AMQV&lt;br /&gt;
|2.83&lt;br /&gt;
|240x320&lt;br /&gt;
|262K&lt;br /&gt;
|38.30&lt;br /&gt;
|36.16 &lt;br /&gt;
|33.63 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|OSD0340WQLC &lt;br /&gt;
|3.4&lt;br /&gt;
|480x272&lt;br /&gt;
|16M&lt;br /&gt;
|69.50&lt;br /&gt;
|67.25 &lt;br /&gt;
|42.48 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|OSD0430WQLC-T &lt;br /&gt;
|4.3&lt;br /&gt;
|480x272&lt;br /&gt;
|16M&lt;br /&gt;
|109.00&lt;br /&gt;
|87.00 &lt;br /&gt;
|72.00 &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|Blaze Technology&lt;br /&gt;
|BDO-0240QGLA-T&lt;br /&gt;
|2.4&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|20.8&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|BDO-0283QGLD-T&lt;br /&gt;
|2.83&lt;br /&gt;
|240xRGBx320&lt;br /&gt;
|262K&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|26.85&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|BDO-0340WQLA-T&lt;br /&gt;
|3.4&lt;br /&gt;
|480x272&lt;br /&gt;
|16M&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|39.5&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|&amp;amp;nbsp;&lt;br /&gt;
|BDO-0430WQLA-T&lt;br /&gt;
|4.3&lt;br /&gt;
|480x272&lt;br /&gt;
|16M&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|&amp;amp;nbsp;&lt;br /&gt;
|90.6&lt;br /&gt;
&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==&amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like this report?&amp;lt;/span&amp;gt;==&lt;br /&gt;
&amp;lt;p align=&amp;quot;center&amp;quot;&amp;gt; '''This is only a sample report with brief analysis''' &amp;lt;br&amp;gt;&lt;br /&gt;
'''Dolcera can provide a comprehensive report customized to your needs'''&amp;lt;/p&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; align=&amp;quot;center&amp;quot; &amp;quot;&lt;br /&gt;
|style=&amp;quot;background:lightgrey&amp;quot; align = &amp;quot;center&amp;quot;  colspan = &amp;quot;3&amp;quot;|'''[mailto:info@dolcera.com &amp;lt;span style=&amp;quot;color:#0047AB&amp;quot;&amp;gt;Buy the customized report from Dolcera&amp;lt;/span&amp;gt;]''' &lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services Patent Analytics Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/business-research-services Market Research Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools/patent-dashboard Purchase Patent Dashboard]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Landscape Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/research-processes Dolcera Processes]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/industries Industry Focus]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Search Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/alerts-and-updates Patent Alerting Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools Dolcera Tools]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Bass Diffusion Analysis==&lt;br /&gt;
&lt;br /&gt;
One of the most important functions during the launch of a new product is to forecast the demand for that product, as it guides many other critical decisions faced by the company. Companies can schedule their production activities once they have an idea about the demand in the coming months or years. At a high level, Bass Diffusion Model is used to determine the shape of the curve representing the cumulative adoption of the new product. Bass describes the individuals who decide to adopt an innovation independently of the actions of others as ''innovators''. Those who respond to the influences of the social system and obtain information about a new product from those who have already adopted the product are termed as ''imitators''.&lt;br /&gt;
&lt;br /&gt;
===Proxies for analysis===&lt;br /&gt;
&lt;br /&gt;
The use of the model has been made by using the historical sales data of ''proxy'' products to forecast sales for OLED display mobile phones with an assumption that OLED display mobile phones would mimic the diffusion patterns of the proxies. Hence it was important to select the proxies carefully. We used the following for this forecast:&lt;br /&gt;
* iPhone - since this was the latest revolution in mobile phone devices and consumers would show a similar adoption behavior for a new mobile phone technology even though it comes at a price premium&lt;br /&gt;
* LCD/Plasma TVs &amp;amp; Monitors - consumers spent more money to purchase screens with superior quality by significantly increasing their budget&lt;br /&gt;
** LCD and Plasma TVs and LCD monitors were treated as a single analogous product(by ascribing different weights to these) for the forecast&lt;br /&gt;
&lt;br /&gt;
===Forecasting OLED display phone sales using Analogous Products===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''The following products from different product categories were considered:'''&amp;lt;br&amp;gt;&lt;br /&gt;
:# LCD TV &lt;br /&gt;
:# Plasma Display TV&lt;br /&gt;
:# LCD Monitor&lt;br /&gt;
&lt;br /&gt;
They were considered to be befitting analogies because of the following similarities:&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:Similarities.jpg|center|600px]]&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Weighted average for the analogous products:'''&lt;br /&gt;
Weights for modeling co-efficients for the analogous products such as LCD TV, Plasma Display TV and LCD monitor had been assigned.&amp;lt;br&amp;gt;&lt;br /&gt;
To judge the similarity of analogous products to OLED, we examined two criteria.&amp;lt;br&amp;gt;&lt;br /&gt;
::a.	Market Structure&amp;lt;br&amp;gt;&lt;br /&gt;
::b.	Product Characteristics&amp;lt;br&amp;gt;&lt;br /&gt;
[[Image:Criterion.jpg|center|600px]]&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The '''S-Graph''' for the cumulative projected sale of OLED display mobiles modeled on analogous products&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart1.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
:* In 2009 and 2010 OLED Mobile Phone market would grow slowly driven by ''innovators''&lt;br /&gt;
:* From 2011 to 2015, market will grow rapidly due to the ''early adopters''&lt;br /&gt;
:* In 2016 and 2017, market will growth will dwindle as ''late adopters'' take to the phones&lt;br /&gt;
:* 2018 onwards growth will peter, as the laggards pick up the last few models and the market will saturate&lt;br /&gt;
:* From 2016 the technology will near obsolescence and a new technology would replace it&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''Comparison of Adoption rate of Innovators with those of Imitators'''&amp;lt;br&amp;gt;&lt;br /&gt;
The model helps to determine sales to innovators and imitators for each year:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart2.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
This graph shows that a small number of innovators will kick-start the sales. OLED display mobile Phones will get off to a slow start in first 2 years. Once a '''''critical mass''''' is reached by the end of the second year, strong imitative effects will take over as the innovators decrease.&lt;br /&gt;
&lt;br /&gt;
===Detailed Analysis===&lt;br /&gt;
&lt;br /&gt;
The detailed modeling with a description of parameters and mathematical equations can be viewed here:&amp;lt;br&amp;gt;&lt;br /&gt;
[[Bass Diffusion Analysis for OLED display phones]]&lt;br /&gt;
&lt;br /&gt;
==OLED Mobile Phone Projections Based on I-Phone==&lt;br /&gt;
&lt;br /&gt;
The '''S-Graph''' for the cumulative projected sale of OLED display mobiles modeled on analogous products&lt;br /&gt;
&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart3.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
:* From Q1,'09 to Q3,'09, the OLED display mobile phone market would grow slowly, driven by ''innovators''&lt;br /&gt;
:* From Q4,'09 to Q4,'10 market will grow rapidly due to the ''early adopters''&lt;br /&gt;
:* From Q1,'11 and Q3,'11 market growth will dwindle as ''late adopters'' take to the phones&lt;br /&gt;
:* Q4,'11 onwards growth will peter, as the laggards pick up the last few models and the market will saturate&lt;br /&gt;
:* From Q4, the technology will near obsolescence and a new technology would substitute it&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
'''Comparison of Adoption rate of Innovators with those of Imitators'''&amp;lt;br&amp;gt;&lt;br /&gt;
The model helps to determine sales to innovators and imitators for each year:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart4.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
This graph shows that a small number of innovators will kick-start the sales. OLED display mobile Phones will get off to a slow start in first three quarters. Once a '''''critical mass''''' is reached by the end of the Q3, strong imitative effects will take over as the innovators decrease.&lt;br /&gt;
&lt;br /&gt;
===Detailed Analysis===&lt;br /&gt;
&lt;br /&gt;
The detailed modeling with a description of parameters and mathematical equations can be viewed here:&amp;lt;br&amp;gt;&lt;br /&gt;
[[Bass Diffusion Analysis for OLED display phones]]&lt;br /&gt;
&lt;br /&gt;
==Comparing projections==&lt;br /&gt;
Since disparate product categories had been used for the two forecasts, the two were compared to cross validate the results [[media:Bass-Model_OLED_comparison.xls|''&amp;lt;&amp;lt;excel sheet with calculations&amp;gt;&amp;gt;'']]&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;center&amp;gt;&amp;lt;gflash&amp;gt;650 430 http://www.dolcera.com/website/assets/Chart5.swf&amp;lt;/gflash&amp;gt;&amp;lt;/center&amp;gt;&lt;br /&gt;
&lt;br /&gt;
:* Looking at the forecast for OLED display mobile phones based on analogous products and on iPhone, both are seen to be ''convergent''&lt;br /&gt;
:* This validates the forecast&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Sneak Preview of some models using OLED technology==&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; style=&amp;quot;font-size:100%&amp;quot; border=&amp;quot;1&amp;quot; cellpadding=&amp;quot;5&amp;quot; cellspacing=&amp;quot;0&amp;quot;  width=80%&lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:Apple.jpg|thumb|center|200px|[http://www.appleiphoneapps.com/2009/03/next-iphone-to-have-oled-display-why-should-you-care/ Source: appleiphoneapps.com]]]&lt;br /&gt;
| width=60% valign=top | '''1. Apple iPhone''' - It’s nothing official at the moment, but word on the street is that Apple might have chosen a series of OLED displays for its next round of handsets. Such a move would certainly be in the best interests of battery life, as the iPhone isn’t noted for its battery capabilities. Considering the amount of new features that were announced in the iPhone 3.0 firmware update, it would be fairly practical to have a capacitive OLED display in the future.&lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:Nokia.jpg|thumb|center|200px|[http://www.mobilephonereviews.org/category/nokia/ Source: Mobile Phone Reviews]]]&lt;br /&gt;
&lt;br /&gt;
| width=60% valign=top | '''2. Nokia''' - '''Nokia 6600''' Slide Mobile Phone is a 3G device with large OLED display and 3.2 megapixel camera. It has curved edges and with a weight of 110g is a bit heavy to hold. The 2.2” screen supports 16 million colors and comes with QVGA resolution. The dimensions of the phone are 90 x 45 x 14mm.&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:Samsung.jpg|thumb|center|200px|[http://www.att-phones.org/att-samsung-a877-phone-will-be-available.html Source: ATT Phones]]]&lt;br /&gt;
&lt;br /&gt;
| width=60% valign=top | '''3. Samsung''' - '''Samsung A877''' features include a 3.2-inch WQVGA AMOLED touchscreen, a 3 megapixel camera, GPS, HSDPA and Bluetooth. And as well at it supports AT&amp;amp;T’s 3G service.&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
| width=40% valign=top | [[Image:Sony.jpg|thumb|center|200px|[http://www.itechnews.net/2008/01/08/sony-ericsson-z555-stylish-phone/ Source: Itechnews]]]&lt;br /&gt;
| width=60% valign=top | '''4. Sony''' - '''Sony Ericsson Z555''' features a 1.9-inch LCD display, an OLED 128×36 external display, a 1.3 Megapixel camera with 4x digital zoom.&lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:LG Mobile.jpg|thumb|center|200px|[http://www.unwiredview.com/2008/02/20/lg-sh150a-gets-am-oled-display-with-26-million-colors-and-hd-support/ Source: Unwiredview]]]&lt;br /&gt;
| width=60% valign=top | '''5. LG''' - One of the first handsets to get the new AM OLED, is already advanced '''LG SH150''' DMB TV phone. &lt;br /&gt;
|-&lt;br /&gt;
| width=40% valign=top | [[Image:Motorola.jpg|thumb|center|200px|[http://www.itechnews.net/2007/10/12/motorola-u9-mobile-phone/ Source: Itechnews]]]&lt;br /&gt;
| width=60% valign=top | '''6. Motorola''' - The '''MOTO U9''' is a Quad-band phone with a 2-inch QVGA LCD display, a 1.45-inch secondary OLED display, integrated music player, Bluetooth, 25MB internal memory and a microSD card slot.&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==&amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like this report?&amp;lt;/span&amp;gt;==&lt;br /&gt;
&amp;lt;p align=&amp;quot;center&amp;quot;&amp;gt; '''This is only a sample report with brief analysis''' &amp;lt;br&amp;gt;&lt;br /&gt;
'''Dolcera can provide a comprehensive report customized to your needs'''&amp;lt;/p&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; align=&amp;quot;center&amp;quot; &amp;quot;&lt;br /&gt;
|style=&amp;quot;background:lightgrey&amp;quot; align = &amp;quot;center&amp;quot;  colspan = &amp;quot;3&amp;quot;|'''[mailto:info@dolcera.com &amp;lt;span style=&amp;quot;color:#0047AB&amp;quot;&amp;gt;Buy the customized report from Dolcera&amp;lt;/span&amp;gt;]''' &lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services Patent Analytics Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/business-research-services Market Research Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools/patent-dashboard Purchase Patent Dashboard]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Landscape Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/research-processes Dolcera Processes]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/industries Industry Focus]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Search Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/alerts-and-updates Patent Alerting Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools Dolcera Tools]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
==Contact Dolcera==&lt;br /&gt;
&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Samir Raiyani&lt;br /&gt;
|-&lt;br /&gt;
| '''Email''': [mailto:info@dolcera.com info@dolcera.com]&lt;br /&gt;
|-&lt;br /&gt;
| '''Phone''': +1-650-269-7952&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9643</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9643"/>
				<updated>2011-09-15T10:51:42Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: /* Others and CPG */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Intellectual Property (IP) Services|Intellectual Property(IP) Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Business &amp;amp; Information Research Services|Business and Information Research Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Dolcera Technology Platforms|Dolcera Technology Platform]]&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Intellectual Property (IP) Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey;width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey; width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Alopecia - Hair Loss]] | ([http://www.youtube.com/watch?v=jAIoyKuKQ6o Video])&lt;br /&gt;
* [[Inflammation and cardiovascular drugs]] | ([http://www.youtube.com/watch?v=FVUFcz2dpIM Video])&lt;br /&gt;
* [[RNAi Database sample wiki]] | ([http://www.youtube.com/watch?v=nsZLUSPn3cg Video])&lt;br /&gt;
* [[Choline Bitartarate]]&lt;br /&gt;
* [[Non-wovens]]&lt;br /&gt;
* [[Pressure sensitive adhesives]] | ([http://www.youtube.com/watch?v=plP3TzjYsiQ Video])&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Smart Drug Delivery Systems]] | ([http://www.youtube.com/watch?v=vARe9eBFsq4 Video])&lt;br /&gt;
* [[Silicone Hydrogel contact lens]]&lt;br /&gt;
* [[SC Johnson]]&lt;br /&gt;
* [[Pinene: An off flavor in mango juice]] | ([http://www.youtube.com/watch?v=P4fI1rjPjSg Video])&lt;br /&gt;
* [[Bio-PET]]&lt;br /&gt;
* [[Interferon For Treatment of Melanoma]]&lt;br /&gt;
* [[Antibody against TNF]]&lt;br /&gt;
* [[Pressure sensitive adhesives in packaging]] &lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Hybrid Electric Vehicle Battery System]]&lt;br /&gt;
* [[Supply Chain RFID Applications]]&lt;br /&gt;
* [[Insurance sector]]&lt;br /&gt;
* [[CDMA Basics]]&lt;br /&gt;
* [[Quality of Service on CDMA platforms]]&lt;br /&gt;
* [[OLED - Organic Light Emitting Diode]]&lt;br /&gt;
* [[Carbon Nanotubes (CNT)]] | ([http://www.youtube.com/watch?v=HvZqBy8XvIE Video])&lt;br /&gt;
* [[Metallic and Ceramic construction materials]]&lt;br /&gt;
* [[Transactional memory]]&lt;br /&gt;
* [[Invalidation Search on a patent in the semiconductors space|Invalidation Search]]&lt;br /&gt;
* [[Golf Club Head Landscape]]&lt;br /&gt;
* [[Variable Valve Timing - Sample]]&lt;br /&gt;
* [[Wind Energy]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;STN Search Reports&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Markush Search Report]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard - live] &lt;br /&gt;
** ([[Alopecia Areata Dashboard Screenshots|Screenshots only]]) &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=587 RNAi Dashboard]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=27 Automotive dashboard - live]&lt;br /&gt;
** [[Automotive Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 WiMAX dashboard - live] &lt;br /&gt;
** [[WiMAX Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid_model.swf RFID dashboard]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;IP Valuation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*[[Holographic Image Display]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://dolcera.com/client/d8r3/hairloss_map.htm Alopecia/Hair loss IPMap]&lt;br /&gt;
* [[Markush Structure Search Sample]]&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Study: In re Bilski Impact&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[In re Bilski Impact assessed from US PAIR Information]]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Prior Art Search Process]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/satellite_antenna/ipmap.html Satellite Antenna IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid/ipmap.html RFID IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/multimodal_apps/ipmap.html Multimodal Applications IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/Invalidation_US4825448.htm Invalidation Claim Chart Sample]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Clinical Trial Database===&lt;br /&gt;
*[[Clinical Trial Database]]&lt;br /&gt;
&lt;br /&gt;
== Business &amp;amp; Information Research Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Diabetes products and services]]&lt;br /&gt;
* [[Drug Metabolism]]&lt;br /&gt;
* [[Toxicology]]&lt;br /&gt;
* [[Osteoporosis]]&lt;br /&gt;
* [[Oral Diabetes Drugs]]&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Premium Coffee Consumers Market Segmentation|Premium Coffee - Market Positioning]]&lt;br /&gt;
* [[Dolcera's Poster on Industrial Biotechnology|Industrial biotechnology]]&lt;br /&gt;
* [[OTC products for acne treatment]]&lt;br /&gt;
* [[Botox - from Medical Procedure to Household Word]]&lt;br /&gt;
* [[Digestive Remedies Market in India and China]]&lt;br /&gt;
* [[OTC vs. Prescription Drugs]]&lt;br /&gt;
* [[Rx to OTC Switch-Market Analysis]]&lt;br /&gt;
* [[Vaccines Market in Western Countries]], Company Profile:[http://dolcera.com/wiki/index.php?title=GlaxoSmithKline_profile GlaxoSmithKline]&lt;br /&gt;
* [[Ureteral Stent - Market Analysis]], Company Profile:[[Boston Scientific - Company Profile |Boston Scientific ]]&lt;br /&gt;
* [[Cardiac Pacemakers]]&lt;br /&gt;
* [[Olympus Corporation- Company Profile]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[4G wireless technology developments]]&lt;br /&gt;
* [[LTE]]&lt;br /&gt;
* [[Femtocells]]&lt;br /&gt;
* [[HDTV in the US]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics Innovation Explorer]&lt;br /&gt;
* [[Web video]]&lt;br /&gt;
* [[OLED Mobile Phones Market Research and Analysis Report]] | ([http://www.viddler.com/explore/dolcera/videos/6/ Video])&lt;br /&gt;
* [[Virtualization]]&lt;br /&gt;
* [[Cloud Computing]]&lt;br /&gt;
* [[Estimation of liquid carrying vehicles in USA]]&lt;br /&gt;
* [[A market study on Hybrid vehicles and the concept of V2G]]&lt;br /&gt;
* [[Patent Valuation]]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Finance===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Others and CPG===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Innovative personal finance products]]&lt;br /&gt;
* [[Life Insurance Industry in US]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
*[[Deodorants Market Analysis: Acquisition of Sanex by Colgate]]&lt;br /&gt;
*[[Partner in sales planning]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Dolcera Technology Platforms ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
==== Dashboard 1.1 ====&lt;br /&gt;
* [http://www.dolcera.com/auth/dashboarddemo/dashboard.php?workfilegroup_id=154 Demo Dashboard (Alopecia)]  &lt;br /&gt;
** [[Access details]]&lt;br /&gt;
* [[Sample list of patent numbers]]&lt;br /&gt;
* [http://www.dolcera.com/auth/index.php Dashboard login page]&lt;br /&gt;
&lt;br /&gt;
==== [[Workflow for creating a Dashboard]] ====&lt;br /&gt;
&lt;br /&gt;
==== IP and Products dashboard ====&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard] &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 4G wireless product and patent dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Patent-pathway mapping ====&lt;br /&gt;
* [[Inflammation and cardiovascular drugs#Interactive signaling pathways and patents|Patent-pathway mapping]]&lt;br /&gt;
==== Sequence dashboard ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Design analysis ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dental/main.html Dental Implant Design Analysis]&lt;br /&gt;
&lt;br /&gt;
==== Innovation explorer ====&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics innovation explorer]&lt;br /&gt;
==== KPort ====&lt;br /&gt;
* [http://dolcera.com/website/demos/kport/main.html Collaboration Portal]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dolcera Offerings summary &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Dolcera Offerings|Dolcera offerings summary]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;[[Technology Support]] &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like any of these sample reports?&amp;lt;/span&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;p align=&amp;quot;center&amp;quot;&amp;gt; '''These are sample reports with brief analysis''' &amp;lt;br&amp;gt;&lt;br /&gt;
'''Dolcera can provide a comprehensive report customized to your needs'''&amp;lt;/p&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; align=&amp;quot;center&amp;quot; &amp;quot;&lt;br /&gt;
|style=&amp;quot;background:lightgrey&amp;quot; align = &amp;quot;center&amp;quot;  colspan = &amp;quot;3&amp;quot;|'''[mailto:info@dolcera.com &amp;lt;span style=&amp;quot;color:#0047AB&amp;quot;&amp;gt;Buy the customized report from Dolcera&amp;lt;/span&amp;gt;]''' &lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services Patent Analytics Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/business-research-services Market Research Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools/patent-dashboard Purchase Patent Dashboard]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Landscape Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/research-processes Dolcera Processes]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/industries Industry Focus]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Search Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/alerts-and-updates Patent Alerting Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools Dolcera Tools]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Contact Dolcera&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Samir Raiyani&lt;br /&gt;
|-&lt;br /&gt;
| '''Email''': [mailto:info@dolcera.com info@dolcera.com]&lt;br /&gt;
|-&lt;br /&gt;
| '''Phone''': +1-650-269-7952, +91-40-2355-3493&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=List_of_all_subsidiaries_(77)&amp;diff=9642</id>
		<title>List of all subsidiaries (77)</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=List_of_all_subsidiaries_(77)&amp;diff=9642"/>
				<updated>2011-09-15T10:51:05Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;50%&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Sr. No'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;SUBSIDIARIES AND AFFILIATED COMPANIES&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;Stake&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|1&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LG Display&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|38%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|2&lt;br /&gt;
|LG INNOTEK&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|48%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|3&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Hi Plaza&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|4&lt;br /&gt;
|Hi Business Logitics&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|5&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LG Ericsson&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|50%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|6&lt;br /&gt;
|Hi M Solutek&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|7&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Hi Tele Service&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|8&lt;br /&gt;
|LG Public Small Business Cooperation Fund&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|50%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|9&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Innovation Investment Fund&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|83%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|10&lt;br /&gt;
|K-TV Tech Investment Fund&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|11&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Innopla&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|20%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|12&lt;br /&gt;
|NARA M-tech&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|20%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|13&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|MTH&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|21%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|14&lt;br /&gt;
|EIC Properties&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|38%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|15&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|HLDS&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|49%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|16&lt;br /&gt;
|LG Holdings (HK) Hungary&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|49%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|17&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|TRIVENI United States&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|87%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|18&lt;br /&gt;
|EMGS Romania&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|50%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|19&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Hi Logistics China China&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|20&lt;br /&gt;
|Global OLED Technology LLC&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|33%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|21&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEAP Australia&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|22&lt;br /&gt;
|LGEAT&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|23&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGECI Canada&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|24&lt;br /&gt;
|LGEPH Philippines&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|25&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEEC Egypt&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|26&lt;br /&gt;
|LGEGF United Arab Emirates&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|27&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEIL India&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|28&lt;br /&gt;
|LGEIN Indonesia&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|29&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEJP Japan&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|30&lt;br /&gt;
|LGEMC Morocco&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|31&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEME United Arab Emirates&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|32&lt;br /&gt;
|LGEML Malaysia&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|33&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEMS Morocco&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|34&lt;br /&gt;
|LGEPR Peru&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|35&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEPS Panama&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|36&lt;br /&gt;
|LGETH Thailand&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|37&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGETT Taiwan, Republic of China&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|38&lt;br /&gt;
|LGEUS United States&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|39&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGESI India&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|40&lt;br /&gt;
|LGEMF France&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|41&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEOT United Arab Emirates&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|42&lt;br /&gt;
|LGEWR Poland&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|43&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGELV Latvia&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|44&lt;br /&gt;
|LGEMA Poland&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|45&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGERI&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|95%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|46&lt;br /&gt;
|LGEEH Netherlands&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|47&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGESL Singapore&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|48&lt;br /&gt;
|LGESR Saudi Arabia&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|49%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|49&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEAF United Kingdom&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|50&lt;br /&gt;
|LGETK Turkey&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|51&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGELF&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|52&lt;br /&gt;
|LGEDF United Arab Emirates&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|53&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEAK Kazakhstan&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|54&lt;br /&gt;
|LGEAS Algeria&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|70%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|55&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEAG Australia&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|56&lt;br /&gt;
|LGECB Colombia&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|57&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEHZ China&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|80%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|58&lt;br /&gt;
|LGEND China&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|70%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|59&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEPN China&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|70%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|60&lt;br /&gt;
|LGEQH China&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|61&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGESH China&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|70%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|62&lt;br /&gt;
|LGESP Singapore&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|63&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEVN Vietnam&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|64&lt;br /&gt;
|LGESY China&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|79%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|65&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGETA China&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|80%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|66&lt;br /&gt;
|LGEUR Ukraine&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|67&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEYT China&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|70%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|68&lt;br /&gt;
|LGE (China) R&amp;amp;D Center China&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|69&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEHN&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|70%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|70&lt;br /&gt;
|LGECL Chile&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|71&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGEQD China&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|70%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|72&lt;br /&gt;
|LGEKS&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|73&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGERA Rwanda&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|74&lt;br /&gt;
|LGERM Russia&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|75&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGCRC&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|76&lt;br /&gt;
|Shinsung Venture Investment Fund&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|96%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|77&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LGETL China&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|67%&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:LGE.jpg&amp;diff=9641</id>
		<title>File:LGE.jpg</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:LGE.jpg&amp;diff=9641"/>
				<updated>2011-09-15T10:33:45Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:LG_revenue_segment.jpeg&amp;diff=9640</id>
		<title>File:LG revenue segment.jpeg</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:LG_revenue_segment.jpeg&amp;diff=9640"/>
				<updated>2011-09-15T10:33:27Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:LG_segments.jpeg&amp;diff=9639</id>
		<title>File:LG segments.jpeg</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:LG_segments.jpeg&amp;diff=9639"/>
				<updated>2011-09-15T10:32:55Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Lg_geography.jpeg&amp;diff=9638</id>
		<title>File:Lg geography.jpeg</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Lg_geography.jpeg&amp;diff=9638"/>
				<updated>2011-09-15T10:32:36Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Profit_trend_LG.jpeg&amp;diff=9637</id>
		<title>File:Profit trend LG.jpeg</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Profit_trend_LG.jpeg&amp;diff=9637"/>
				<updated>2011-09-15T10:32:17Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Revenue_trend11.jpeg&amp;diff=9636</id>
		<title>File:Revenue trend11.jpeg</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Revenue_trend11.jpeg&amp;diff=9636"/>
				<updated>2011-09-15T10:31:41Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=LG_Electronics-Company_Profile&amp;diff=9635</id>
		<title>LG Electronics-Company Profile</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=LG_Electronics-Company_Profile&amp;diff=9635"/>
				<updated>2011-09-15T10:27:07Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__TOC__&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
===Key Information===&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;100%&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#376091&amp;quot; colspan = &amp;quot;2&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''LG Electronics Ltd.(LGE)'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''Revenues'''&lt;br /&gt;
|2010:  $48.27B &lt;br /&gt;
|-&lt;br /&gt;
|2009:  $43.52B &lt;br /&gt;
|-&lt;br /&gt;
|2008:  $44.84B&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Revenue CAGR (2008 - 2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|3.8%&lt;br /&gt;
|-&lt;br /&gt;
|'''Net profit (2010)'''&lt;br /&gt;
|$1.14B&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Net profit CAGR (2008 - 2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|67.2%&lt;br /&gt;
|-&lt;br /&gt;
|rowspan = &amp;quot;3&amp;quot;|'''R&amp;amp;D expenses (Percentage of Revenue)'''&lt;br /&gt;
|2010:$1397.35M (2.37%)&lt;br /&gt;
|-&lt;br /&gt;
|2009:$1182.33M (2.29%)&lt;br /&gt;
|-&lt;br /&gt;
|2008: $424.07M (0.82%)&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Number of employees'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|82,772&lt;br /&gt;
|-&lt;br /&gt;
|'''Year Established'''&lt;br /&gt;
|1958&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Headquarters'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Seoul, South Korea&lt;br /&gt;
|-&lt;br /&gt;
|'''Key People'''&lt;br /&gt;
|Koo Bon-joon (CEO)&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Principal areas of business'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Consumer Products Manufacturers: Consumer Electronics, Audio Equipment, Video Equipment, Appliances, Telecommunications Equipment&lt;br /&gt;
|-&lt;br /&gt;
|'''Segmental breakdown based on turnover (2010)'''&lt;br /&gt;
|Home Entertainment 20.48%&amp;lt;br&amp;gt;Mobile Communications 12.84%&amp;lt;br&amp;gt;Home App 9.90%&amp;lt;br&amp;gt;Air Conditioning 4.47%&amp;lt;br&amp;gt;Business Solution 4.48%&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|'''Geographical breakdown based on turnover(2010)'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|Europe (17%)&amp;lt;br&amp;gt;North America (22%)&amp;lt;br&amp;gt;South America (13%)&amp;lt;br&amp;gt;Korea (15%)&amp;lt;br&amp;gt;P R China (8%)&amp;lt;br&amp;gt;Asia (20%)&amp;lt;br&amp;gt;ROW (5%)&lt;br /&gt;
|-&lt;br /&gt;
|'''Main Subsidiaries (2010)'''&lt;br /&gt;
|LG Display (37.9%)&amp;lt;br&amp;gt;LG Innotek (50.60%)&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot; rowspan = &amp;quot;2&amp;quot;|'''Recent Acquisition Summary'''&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|&amp;lt;nowiki&amp;gt;-&amp;lt;/nowiki&amp;gt; Acquired Air-conditioning Division of LS Mtron for KRW 150 billion on 10th March 2011&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#C5D9F1&amp;quot;|&amp;lt;nowiki&amp;gt;-&amp;lt;/nowiki&amp;gt; Acquired Rental Business of Healthcare Rental Co. Ltd.&lt;br /&gt;
|-&lt;br /&gt;
|'''Recent License Deals Summary'''&lt;br /&gt;
|&amp;lt;nowiki&amp;gt;-&amp;lt;/nowiki&amp;gt; Rovi and LG Electronics signed a licensing deal on 22nd June 2011 to further integrate DivX Technology in LGs consumer electronics products&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
===Vision===&lt;br /&gt;
LG Electronics continues to pursue its 21&amp;lt;sup&amp;gt;st&amp;lt;/sup&amp;gt; century vision of becoming a worldwide leader in digital—ensuring customer satisfaction through innovative products and superior service while aiming to rank among the world&amp;lt;nowiki&amp;gt;’&amp;lt;/nowiki&amp;gt;s top three electronics, information, and telecommunications firms by 2010.&lt;br /&gt;
&lt;br /&gt;
===Years in Business===&lt;br /&gt;
53 Years&lt;br /&gt;
&lt;br /&gt;
===Industry Type===&lt;br /&gt;
Consumer Products Manufacturers&lt;br /&gt;
&lt;br /&gt;
• Consumer Electronics&lt;br /&gt;
&lt;br /&gt;
• Audio Equipment&lt;br /&gt;
&lt;br /&gt;
• Video Equipment&lt;br /&gt;
&lt;br /&gt;
• Appliances&lt;br /&gt;
&lt;br /&gt;
• Telecommunications Equipment&lt;br /&gt;
&lt;br /&gt;
===Stock Exchanges listed in with their codes===&lt;br /&gt;
Primary Symbol &amp;amp; Exchange:066570 - Ordinary Shares – Korea&lt;br /&gt;
&lt;br /&gt;
Other Symbol &amp;amp; Exchange: LGLD - GDR - London&lt;br /&gt;
&lt;br /&gt;
===Contact===&lt;br /&gt;
20, Youido-dong, Yongdungpo-gu&amp;lt;br&amp;gt;Seoul 150-721&amp;lt;br&amp;gt;South Korea&lt;br /&gt;
&lt;br /&gt;
'''Phone '''&amp;lt;nowiki&amp;gt;+&amp;lt;/nowiki&amp;gt;82-2-3777-1114&lt;br /&gt;
&lt;br /&gt;
'''Fax '''&amp;lt;nowiki&amp;gt;+&amp;lt;/nowiki&amp;gt;82-2-3777-3428&lt;br /&gt;
&lt;br /&gt;
URL: [http://www.lg.co.kr/ http://www.lg.co.kr];  http://www.lge.co.kr&lt;br /&gt;
&lt;br /&gt;
===Major Subsidiaries===&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;80%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Sr. No'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;SUBSIDIARIES AND AFFILIATED COMPANIES&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;Stake&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|1&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LG Display&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|38%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|2&lt;br /&gt;
|LG INNOTEK&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|48%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|3&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Hi Plaza&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|4&lt;br /&gt;
|Hi Business Logitics&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|5&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LG Ericsson&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|50%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|6&lt;br /&gt;
|Hi M Solutek&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|7&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Hi Tele Service&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|8&lt;br /&gt;
|LG Public Small Business Cooperation Fund&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|50%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|9&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|Innovation Investment Fund&lt;br /&gt;
|align = &amp;quot;center&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|83%&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|10&lt;br /&gt;
|K-TV Tech Investment Fund&lt;br /&gt;
|align = &amp;quot;center&amp;quot;|100%&lt;br /&gt;
|-&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
'''[[ List of all subsidiaries (77)]]'''&lt;br /&gt;
&lt;br /&gt;
==Company Financials==&lt;br /&gt;
===Revenue Trends - 2006 to 2010===&lt;br /&gt;
[[image:revenue_trend11.jpeg|centre]]&lt;br /&gt;
&lt;br /&gt;
===Profit Trends - 2006 to 2010===&lt;br /&gt;
[[image:profit_trend_LG.jpeg|centre]]&lt;br /&gt;
&lt;br /&gt;
===Geographical Analysis===&lt;br /&gt;
[[image:lg_geography.jpeg|centre]]&lt;br /&gt;
&lt;br /&gt;
===Shareholding Pattern=== &lt;br /&gt;
 {|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; width=&amp;quot;50%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Major Shareholders'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|bgcolor = &amp;quot;#4F81BD&amp;quot;|&amp;lt;font color=&amp;quot;#FFFFFF&amp;quot;&amp;gt;'''Stake'''&amp;lt;/font&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
|bgcolor = &amp;quot;#DBE5F1&amp;quot;|LG Corp.&lt;br /&gt;
|align = &amp;quot;right&amp;quot; bgcolor = &amp;quot;#DBE5F1&amp;quot;|34.80%&lt;br /&gt;
|-&lt;br /&gt;
|National Pension Service&lt;br /&gt;
|align = &amp;quot;right&amp;quot;|5.04%&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
==Major Segments of LG Electronics==&lt;br /&gt;
&lt;br /&gt;
Typical Products of LG Electronics can be classified in following categories  &lt;br /&gt;
&lt;br /&gt;
[[image:LG_segments.jpeg|centre]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Revenue Breakdown among Various Categories based on 2010 Sales&lt;br /&gt;
&lt;br /&gt;
[[image:LG_revenue_segment.jpeg|centre]]&lt;br /&gt;
&lt;br /&gt;
==Stock Performance of LG Electronics in 2010==&lt;br /&gt;
===Stock Price:===&lt;br /&gt;
• Share Price (20-May-10): 101,000&lt;br /&gt;
&lt;br /&gt;
• 52-Week High (02-Sep-09): 148,500&lt;br /&gt;
&lt;br /&gt;
• 52-Week Low (20-May-10): 101,000&lt;br /&gt;
&lt;br /&gt;
• Currency: KRW&lt;br /&gt;
&lt;br /&gt;
===Dividend Information:===&lt;br /&gt;
• Dividend: 1,750 KRW&lt;br /&gt;
&lt;br /&gt;
• Pay Date: April 16, 2010&lt;br /&gt;
&lt;br /&gt;
• Ex-Dividend Date: December 29, 2009&lt;br /&gt;
&lt;br /&gt;
==SWOT Analysis of LG Electronics==&lt;br /&gt;
[[Image:LGE.jpg |centre]]&lt;br /&gt;
&lt;br /&gt;
==Porter's 5 Forces analysis- Display Industry==&lt;br /&gt;
[[Image:Porter1.png|center|frame]]&lt;br /&gt;
&lt;br /&gt;
==Analysis of display business==&lt;br /&gt;
&lt;br /&gt;
LG Display accounted for approximately 30% of LGE's revenues in 2010. Display business is capital-intensive, competitive and cyclical.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Image:diaplay mkt breakup.jpg|centre]]&lt;br /&gt;
&lt;br /&gt;
===LCD display market in 2010===&lt;br /&gt;
&lt;br /&gt;
[[image:Segmentation.png|centre|700px]]&lt;br /&gt;
&lt;br /&gt;
===Large Area TFT market===&lt;br /&gt;
{|&lt;br /&gt;
|[[image:La_tft_detail_1.png|left|550px|thumb| Sources: [http://www.displaybank.com/ Displaybank],[http://www.displaysearch.com/ Displaysearch]]]&lt;br /&gt;
|[[image:La_tft_detail_2.png|right|550px|thumb| Sources: [http://www.displaybank.com/ Displaybank],[http://www.displaysearch.com/ Displaysearch]]]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
Year on year there was an increase in shipments for all the products of large area TFT LCD. In total the revenue grew by 25% in 2010 up from 20% in 2009. After recession and a laggard growth of 11.5% in 2008, the market has picked up and the revenue is growing.&lt;br /&gt;
&lt;br /&gt;
* Market revenue overall is growing, but the most promising product and market that uses this technology is Television. With a growth of 42.9% in 2010 up from 32.4% in 2009, the market looks profitable.&lt;br /&gt;
* Notebook PC market also looks profitable, with a growth rate of 31.7%, but a decline from the previous year from 36.6%. The OLED technology is eating up the market share of the TFT LCD market share in this market.&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9634</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9634"/>
				<updated>2011-09-15T10:26:14Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: /* Others and CPG */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Intellectual Property (IP) Services|Intellectual Property(IP) Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Business &amp;amp; Information Research Services|Business and Information Research Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Dolcera Technology Platforms|Dolcera Technology Platform]]&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Intellectual Property (IP) Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey;width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey; width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Alopecia - Hair Loss]] | ([http://www.youtube.com/watch?v=jAIoyKuKQ6o Video])&lt;br /&gt;
* [[Inflammation and cardiovascular drugs]] | ([http://www.youtube.com/watch?v=FVUFcz2dpIM Video])&lt;br /&gt;
* [[RNAi Database sample wiki]] | ([http://www.youtube.com/watch?v=nsZLUSPn3cg Video])&lt;br /&gt;
* [[Choline Bitartarate]]&lt;br /&gt;
* [[Non-wovens]]&lt;br /&gt;
* [[Pressure sensitive adhesives]] | ([http://www.youtube.com/watch?v=plP3TzjYsiQ Video])&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Smart Drug Delivery Systems]] | ([http://www.youtube.com/watch?v=vARe9eBFsq4 Video])&lt;br /&gt;
* [[Silicone Hydrogel contact lens]]&lt;br /&gt;
* [[SC Johnson]]&lt;br /&gt;
* [[Pinene: An off flavor in mango juice]] | ([http://www.youtube.com/watch?v=P4fI1rjPjSg Video])&lt;br /&gt;
* [[Bio-PET]]&lt;br /&gt;
* [[Interferon For Treatment of Melanoma]]&lt;br /&gt;
* [[Antibody against TNF]]&lt;br /&gt;
* [[Pressure sensitive adhesives in packaging]] &lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Hybrid Electric Vehicle Battery System]]&lt;br /&gt;
* [[Supply Chain RFID Applications]]&lt;br /&gt;
* [[Insurance sector]]&lt;br /&gt;
* [[CDMA Basics]]&lt;br /&gt;
* [[Quality of Service on CDMA platforms]]&lt;br /&gt;
* [[OLED - Organic Light Emitting Diode]]&lt;br /&gt;
* [[Carbon Nanotubes (CNT)]] | ([http://www.youtube.com/watch?v=HvZqBy8XvIE Video])&lt;br /&gt;
* [[Metallic and Ceramic construction materials]]&lt;br /&gt;
* [[Transactional memory]]&lt;br /&gt;
* [[Invalidation Search on a patent in the semiconductors space|Invalidation Search]]&lt;br /&gt;
* [[Golf Club Head Landscape]]&lt;br /&gt;
* [[Variable Valve Timing - Sample]]&lt;br /&gt;
* [[Wind Energy]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;STN Search Reports&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Markush Search Report]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard - live] &lt;br /&gt;
** ([[Alopecia Areata Dashboard Screenshots|Screenshots only]]) &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=587 RNAi Dashboard]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=27 Automotive dashboard - live]&lt;br /&gt;
** [[Automotive Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 WiMAX dashboard - live] &lt;br /&gt;
** [[WiMAX Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid_model.swf RFID dashboard]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;IP Valuation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*[[Holographic Image Display]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://dolcera.com/client/d8r3/hairloss_map.htm Alopecia/Hair loss IPMap]&lt;br /&gt;
* [[Markush Structure Search Sample]]&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Study: In re Bilski Impact&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[In re Bilski Impact assessed from US PAIR Information]]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Prior Art Search Process]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/satellite_antenna/ipmap.html Satellite Antenna IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid/ipmap.html RFID IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/multimodal_apps/ipmap.html Multimodal Applications IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/Invalidation_US4825448.htm Invalidation Claim Chart Sample]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Clinical Trial Database===&lt;br /&gt;
*[[Clinical Trial Database]]&lt;br /&gt;
&lt;br /&gt;
== Business &amp;amp; Information Research Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Diabetes products and services]]&lt;br /&gt;
* [[Drug Metabolism]]&lt;br /&gt;
* [[Toxicology]]&lt;br /&gt;
* [[Osteoporosis]]&lt;br /&gt;
* [[Oral Diabetes Drugs]]&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Premium Coffee Consumers Market Segmentation|Premium Coffee - Market Positioning]]&lt;br /&gt;
* [[Dolcera's Poster on Industrial Biotechnology|Industrial biotechnology]]&lt;br /&gt;
* [[OTC products for acne treatment]]&lt;br /&gt;
* [[Botox - from Medical Procedure to Household Word]]&lt;br /&gt;
* [[Digestive Remedies Market in India and China]]&lt;br /&gt;
* [[OTC vs. Prescription Drugs]]&lt;br /&gt;
* [[Rx to OTC Switch-Market Analysis]]&lt;br /&gt;
* [[Vaccines Market in Western Countries]], Company Profile:[http://dolcera.com/wiki/index.php?title=GlaxoSmithKline_profile GlaxoSmithKline]&lt;br /&gt;
* [[Ureteral Stent - Market Analysis]], Company Profile:[[Boston Scientific - Company Profile |Boston Scientific ]]&lt;br /&gt;
* [[Cardiac Pacemakers]]&lt;br /&gt;
* [[Olympus Corporation- Company Profile]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[4G wireless technology developments]]&lt;br /&gt;
* [[LTE]]&lt;br /&gt;
* [[Femtocells]]&lt;br /&gt;
* [[HDTV in the US]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics Innovation Explorer]&lt;br /&gt;
* [[Web video]]&lt;br /&gt;
* [[OLED Mobile Phones Market Research and Analysis Report]] | ([http://www.viddler.com/explore/dolcera/videos/6/ Video])&lt;br /&gt;
* [[Virtualization]]&lt;br /&gt;
* [[Cloud Computing]]&lt;br /&gt;
* [[Estimation of liquid carrying vehicles in USA]]&lt;br /&gt;
* [[A market study on Hybrid vehicles and the concept of V2G]]&lt;br /&gt;
* [[Patent Valuation]]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Finance===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Others and CPG===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Innovative personal finance products]]&lt;br /&gt;
* [[Life Insurance Industry in US]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
*[[Deodorants Market Analysis: Acquisition of Sanex by Colgate]]&lt;br /&gt;
*[[Partner in sales planning]]&lt;br /&gt;
*[[LG Electronics-Company Profile]]&lt;br /&gt;
&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Dolcera Technology Platforms ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
==== Dashboard 1.1 ====&lt;br /&gt;
* [http://www.dolcera.com/auth/dashboarddemo/dashboard.php?workfilegroup_id=154 Demo Dashboard (Alopecia)]  &lt;br /&gt;
** [[Access details]]&lt;br /&gt;
* [[Sample list of patent numbers]]&lt;br /&gt;
* [http://www.dolcera.com/auth/index.php Dashboard login page]&lt;br /&gt;
&lt;br /&gt;
==== [[Workflow for creating a Dashboard]] ====&lt;br /&gt;
&lt;br /&gt;
==== IP and Products dashboard ====&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard] &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 4G wireless product and patent dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Patent-pathway mapping ====&lt;br /&gt;
* [[Inflammation and cardiovascular drugs#Interactive signaling pathways and patents|Patent-pathway mapping]]&lt;br /&gt;
==== Sequence dashboard ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Design analysis ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dental/main.html Dental Implant Design Analysis]&lt;br /&gt;
&lt;br /&gt;
==== Innovation explorer ====&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics innovation explorer]&lt;br /&gt;
==== KPort ====&lt;br /&gt;
* [http://dolcera.com/website/demos/kport/main.html Collaboration Portal]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dolcera Offerings summary &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Dolcera Offerings|Dolcera offerings summary]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;[[Technology Support]] &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like any of these sample reports?&amp;lt;/span&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;p align=&amp;quot;center&amp;quot;&amp;gt; '''These are sample reports with brief analysis''' &amp;lt;br&amp;gt;&lt;br /&gt;
'''Dolcera can provide a comprehensive report customized to your needs'''&amp;lt;/p&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; align=&amp;quot;center&amp;quot; &amp;quot;&lt;br /&gt;
|style=&amp;quot;background:lightgrey&amp;quot; align = &amp;quot;center&amp;quot;  colspan = &amp;quot;3&amp;quot;|'''[mailto:info@dolcera.com &amp;lt;span style=&amp;quot;color:#0047AB&amp;quot;&amp;gt;Buy the customized report from Dolcera&amp;lt;/span&amp;gt;]''' &lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services Patent Analytics Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/business-research-services Market Research Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools/patent-dashboard Purchase Patent Dashboard]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Landscape Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/research-processes Dolcera Processes]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/industries Industry Focus]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Search Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/alerts-and-updates Patent Alerting Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools Dolcera Tools]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Contact Dolcera&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Samir Raiyani&lt;br /&gt;
|-&lt;br /&gt;
| '''Email''': [mailto:info@dolcera.com info@dolcera.com]&lt;br /&gt;
|-&lt;br /&gt;
| '''Phone''': +1-650-269-7952, +91-40-2355-3493&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9633</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9633"/>
				<updated>2011-09-15T10:11:52Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: /* Others and CPG */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Intellectual Property (IP) Services|Intellectual Property(IP) Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Business &amp;amp; Information Research Services|Business and Information Research Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Dolcera Technology Platforms|Dolcera Technology Platform]]&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Intellectual Property (IP) Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey;width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey; width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Alopecia - Hair Loss]] | ([http://www.youtube.com/watch?v=jAIoyKuKQ6o Video])&lt;br /&gt;
* [[Inflammation and cardiovascular drugs]] | ([http://www.youtube.com/watch?v=FVUFcz2dpIM Video])&lt;br /&gt;
* [[RNAi Database sample wiki]] | ([http://www.youtube.com/watch?v=nsZLUSPn3cg Video])&lt;br /&gt;
* [[Choline Bitartarate]]&lt;br /&gt;
* [[Non-wovens]]&lt;br /&gt;
* [[Pressure sensitive adhesives]] | ([http://www.youtube.com/watch?v=plP3TzjYsiQ Video])&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Smart Drug Delivery Systems]] | ([http://www.youtube.com/watch?v=vARe9eBFsq4 Video])&lt;br /&gt;
* [[Silicone Hydrogel contact lens]]&lt;br /&gt;
* [[SC Johnson]]&lt;br /&gt;
* [[Pinene: An off flavor in mango juice]] | ([http://www.youtube.com/watch?v=P4fI1rjPjSg Video])&lt;br /&gt;
* [[Bio-PET]]&lt;br /&gt;
* [[Interferon For Treatment of Melanoma]]&lt;br /&gt;
* [[Antibody against TNF]]&lt;br /&gt;
* [[Pressure sensitive adhesives in packaging]] &lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Hybrid Electric Vehicle Battery System]]&lt;br /&gt;
* [[Supply Chain RFID Applications]]&lt;br /&gt;
* [[Insurance sector]]&lt;br /&gt;
* [[CDMA Basics]]&lt;br /&gt;
* [[Quality of Service on CDMA platforms]]&lt;br /&gt;
* [[OLED - Organic Light Emitting Diode]]&lt;br /&gt;
* [[Carbon Nanotubes (CNT)]] | ([http://www.youtube.com/watch?v=HvZqBy8XvIE Video])&lt;br /&gt;
* [[Metallic and Ceramic construction materials]]&lt;br /&gt;
* [[Transactional memory]]&lt;br /&gt;
* [[Invalidation Search on a patent in the semiconductors space|Invalidation Search]]&lt;br /&gt;
* [[Golf Club Head Landscape]]&lt;br /&gt;
* [[Variable Valve Timing - Sample]]&lt;br /&gt;
* [[Wind Energy]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;STN Search Reports&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Markush Search Report]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard - live] &lt;br /&gt;
** ([[Alopecia Areata Dashboard Screenshots|Screenshots only]]) &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=587 RNAi Dashboard]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=27 Automotive dashboard - live]&lt;br /&gt;
** [[Automotive Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 WiMAX dashboard - live] &lt;br /&gt;
** [[WiMAX Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid_model.swf RFID dashboard]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;IP Valuation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*[[Holographic Image Display]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://dolcera.com/client/d8r3/hairloss_map.htm Alopecia/Hair loss IPMap]&lt;br /&gt;
* [[Markush Structure Search Sample]]&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Study: In re Bilski Impact&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[In re Bilski Impact assessed from US PAIR Information]]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Prior Art Search Process]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/satellite_antenna/ipmap.html Satellite Antenna IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid/ipmap.html RFID IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/multimodal_apps/ipmap.html Multimodal Applications IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/Invalidation_US4825448.htm Invalidation Claim Chart Sample]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Clinical Trial Database===&lt;br /&gt;
*[[Clinical Trial Database]]&lt;br /&gt;
&lt;br /&gt;
== Business &amp;amp; Information Research Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Diabetes products and services]]&lt;br /&gt;
* [[Drug Metabolism]]&lt;br /&gt;
* [[Toxicology]]&lt;br /&gt;
* [[Osteoporosis]]&lt;br /&gt;
* [[Oral Diabetes Drugs]]&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Premium Coffee Consumers Market Segmentation|Premium Coffee - Market Positioning]]&lt;br /&gt;
* [[Dolcera's Poster on Industrial Biotechnology|Industrial biotechnology]]&lt;br /&gt;
* [[OTC products for acne treatment]]&lt;br /&gt;
* [[Botox - from Medical Procedure to Household Word]]&lt;br /&gt;
* [[Digestive Remedies Market in India and China]]&lt;br /&gt;
* [[OTC vs. Prescription Drugs]]&lt;br /&gt;
* [[Rx to OTC Switch-Market Analysis]]&lt;br /&gt;
* [[Vaccines Market in Western Countries]], Company Profile:[http://dolcera.com/wiki/index.php?title=GlaxoSmithKline_profile GlaxoSmithKline]&lt;br /&gt;
* [[Ureteral Stent - Market Analysis]], Company Profile:[[Boston Scientific - Company Profile |Boston Scientific ]]&lt;br /&gt;
* [[Cardiac Pacemakers]]&lt;br /&gt;
* [[Olympus Corporation- Company Profile]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[4G wireless technology developments]]&lt;br /&gt;
* [[LTE]]&lt;br /&gt;
* [[Femtocells]]&lt;br /&gt;
* [[HDTV in the US]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics Innovation Explorer]&lt;br /&gt;
* [[Web video]]&lt;br /&gt;
* [[OLED Mobile Phones Market Research and Analysis Report]] | ([http://www.viddler.com/explore/dolcera/videos/6/ Video])&lt;br /&gt;
* [[Virtualization]]&lt;br /&gt;
* [[Cloud Computing]]&lt;br /&gt;
* [[Estimation of liquid carrying vehicles in USA]]&lt;br /&gt;
* [[A market study on Hybrid vehicles and the concept of V2G]]&lt;br /&gt;
* [[Patent Valuation]]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Finance===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Others and CPG===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Innovative personal finance products]]&lt;br /&gt;
* [[Life Insurance Industry in US]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
*[[Deodorants Market Analysis: Acquisition of Sanex by Colgate]]&lt;br /&gt;
*[[Partner in sales planning]]&lt;br /&gt;
*[[LG Electronic's Acquisition Analysis]]&lt;br /&gt;
&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Dolcera Technology Platforms ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
==== Dashboard 1.1 ====&lt;br /&gt;
* [http://www.dolcera.com/auth/dashboarddemo/dashboard.php?workfilegroup_id=154 Demo Dashboard (Alopecia)]  &lt;br /&gt;
** [[Access details]]&lt;br /&gt;
* [[Sample list of patent numbers]]&lt;br /&gt;
* [http://www.dolcera.com/auth/index.php Dashboard login page]&lt;br /&gt;
&lt;br /&gt;
==== [[Workflow for creating a Dashboard]] ====&lt;br /&gt;
&lt;br /&gt;
==== IP and Products dashboard ====&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard] &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 4G wireless product and patent dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Patent-pathway mapping ====&lt;br /&gt;
* [[Inflammation and cardiovascular drugs#Interactive signaling pathways and patents|Patent-pathway mapping]]&lt;br /&gt;
==== Sequence dashboard ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Design analysis ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dental/main.html Dental Implant Design Analysis]&lt;br /&gt;
&lt;br /&gt;
==== Innovation explorer ====&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics innovation explorer]&lt;br /&gt;
==== KPort ====&lt;br /&gt;
* [http://dolcera.com/website/demos/kport/main.html Collaboration Portal]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dolcera Offerings summary &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Dolcera Offerings|Dolcera offerings summary]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;[[Technology Support]] &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like any of these sample reports?&amp;lt;/span&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;p align=&amp;quot;center&amp;quot;&amp;gt; '''These are sample reports with brief analysis''' &amp;lt;br&amp;gt;&lt;br /&gt;
'''Dolcera can provide a comprehensive report customized to your needs'''&amp;lt;/p&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; align=&amp;quot;center&amp;quot; &amp;quot;&lt;br /&gt;
|style=&amp;quot;background:lightgrey&amp;quot; align = &amp;quot;center&amp;quot;  colspan = &amp;quot;3&amp;quot;|'''[mailto:info@dolcera.com &amp;lt;span style=&amp;quot;color:#0047AB&amp;quot;&amp;gt;Buy the customized report from Dolcera&amp;lt;/span&amp;gt;]''' &lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services Patent Analytics Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/business-research-services Market Research Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools/patent-dashboard Purchase Patent Dashboard]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Landscape Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/research-processes Dolcera Processes]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/industries Industry Focus]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Search Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/alerts-and-updates Patent Alerting Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools Dolcera Tools]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Contact Dolcera&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Samir Raiyani&lt;br /&gt;
|-&lt;br /&gt;
| '''Email''': [mailto:info@dolcera.com info@dolcera.com]&lt;br /&gt;
|-&lt;br /&gt;
| '''Phone''': +1-650-269-7952, +91-40-2355-3493&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9632</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=Main_Page&amp;diff=9632"/>
				<updated>2011-09-15T10:09:59Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: /* Others and CPG */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Intellectual Property (IP) Services|Intellectual Property(IP) Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Business &amp;amp; Information Research Services|Business and Information Research Services]]&amp;lt;/font&amp;gt;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;lt;font color=&amp;quot;#0000FF&amp;quot;&amp;gt;&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;[[#Dolcera Technology Platforms|Dolcera Technology Platform]]&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== Intellectual Property (IP) Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey;width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey; width:50%&amp;quot; valign = &amp;quot;top&amp;quot; align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Alopecia - Hair Loss]] | ([http://www.youtube.com/watch?v=jAIoyKuKQ6o Video])&lt;br /&gt;
* [[Inflammation and cardiovascular drugs]] | ([http://www.youtube.com/watch?v=FVUFcz2dpIM Video])&lt;br /&gt;
* [[RNAi Database sample wiki]] | ([http://www.youtube.com/watch?v=nsZLUSPn3cg Video])&lt;br /&gt;
* [[Choline Bitartarate]]&lt;br /&gt;
* [[Non-wovens]]&lt;br /&gt;
* [[Pressure sensitive adhesives]] | ([http://www.youtube.com/watch?v=plP3TzjYsiQ Video])&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Smart Drug Delivery Systems]] | ([http://www.youtube.com/watch?v=vARe9eBFsq4 Video])&lt;br /&gt;
* [[Silicone Hydrogel contact lens]]&lt;br /&gt;
* [[SC Johnson]]&lt;br /&gt;
* [[Pinene: An off flavor in mango juice]] | ([http://www.youtube.com/watch?v=P4fI1rjPjSg Video])&lt;br /&gt;
* [[Bio-PET]]&lt;br /&gt;
* [[Interferon For Treatment of Melanoma]]&lt;br /&gt;
* [[Antibody against TNF]]&lt;br /&gt;
* [[Pressure sensitive adhesives in packaging]] &lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Landscape reports &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Hybrid Electric Vehicle Battery System]]&lt;br /&gt;
* [[Supply Chain RFID Applications]]&lt;br /&gt;
* [[Insurance sector]]&lt;br /&gt;
* [[CDMA Basics]]&lt;br /&gt;
* [[Quality of Service on CDMA platforms]]&lt;br /&gt;
* [[OLED - Organic Light Emitting Diode]]&lt;br /&gt;
* [[Carbon Nanotubes (CNT)]] | ([http://www.youtube.com/watch?v=HvZqBy8XvIE Video])&lt;br /&gt;
* [[Metallic and Ceramic construction materials]]&lt;br /&gt;
* [[Transactional memory]]&lt;br /&gt;
* [[Invalidation Search on a patent in the semiconductors space|Invalidation Search]]&lt;br /&gt;
* [[Golf Club Head Landscape]]&lt;br /&gt;
* [[Variable Valve Timing - Sample]]&lt;br /&gt;
* [[Wind Energy]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;STN Search Reports&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Markush Search Report]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard - live] &lt;br /&gt;
** ([[Alopecia Areata Dashboard Screenshots|Screenshots only]]) &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=587 RNAi Dashboard]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dashboard&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=27 Automotive dashboard - live]&lt;br /&gt;
** [[Automotive Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 WiMAX dashboard - live] &lt;br /&gt;
** [[WiMAX Dashboard Screenshots|Screenshots only]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid_model.swf RFID dashboard]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;IP Valuation&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
*[[Holographic Image Display]]&lt;br /&gt;
|-&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [http://dolcera.com/client/d8r3/hairloss_map.htm Alopecia/Hair loss IPMap]&lt;br /&gt;
* [[Markush Structure Search Sample]]&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt; Study: In re Bilski Impact&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[In re Bilski Impact assessed from US PAIR Information]]&lt;br /&gt;
| valign = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Prior Art / Invalidation / FTO Search&amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Prior Art Search Process]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/satellite_antenna/ipmap.html Satellite Antenna IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/rfid/ipmap.html RFID IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/multimodal_apps/ipmap.html Multimodal Applications IPMap]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/Invalidation_US4825448.htm Invalidation Claim Chart Sample]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
===Clinical Trial Database===&lt;br /&gt;
*[[Clinical Trial Database]]&lt;br /&gt;
&lt;br /&gt;
== Business &amp;amp; Information Research Services ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;| &lt;br /&gt;
===Life Sciences and Chemistry===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Technology===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Diabetes products and services]]&lt;br /&gt;
* [[Drug Metabolism]]&lt;br /&gt;
* [[Toxicology]]&lt;br /&gt;
* [[Osteoporosis]]&lt;br /&gt;
* [[Oral Diabetes Drugs]]&lt;br /&gt;
* [[Ureteral Stent]]&lt;br /&gt;
* [[Premium Coffee Consumers Market Segmentation|Premium Coffee - Market Positioning]]&lt;br /&gt;
* [[Dolcera's Poster on Industrial Biotechnology|Industrial biotechnology]]&lt;br /&gt;
* [[OTC products for acne treatment]]&lt;br /&gt;
* [[Botox - from Medical Procedure to Household Word]]&lt;br /&gt;
* [[Digestive Remedies Market in India and China]]&lt;br /&gt;
* [[OTC vs. Prescription Drugs]]&lt;br /&gt;
* [[Rx to OTC Switch-Market Analysis]]&lt;br /&gt;
* [[Vaccines Market in Western Countries]], Company Profile:[http://dolcera.com/wiki/index.php?title=GlaxoSmithKline_profile GlaxoSmithKline]&lt;br /&gt;
* [[Ureteral Stent - Market Analysis]], Company Profile:[[Boston Scientific - Company Profile |Boston Scientific ]]&lt;br /&gt;
* [[Cardiac Pacemakers]]&lt;br /&gt;
* [[Olympus Corporation- Company Profile]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[4G wireless technology developments]]&lt;br /&gt;
* [[LTE]]&lt;br /&gt;
* [[Femtocells]]&lt;br /&gt;
* [[HDTV in the US]]&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics Innovation Explorer]&lt;br /&gt;
* [[Web video]]&lt;br /&gt;
* [[OLED Mobile Phones Market Research and Analysis Report]] | ([http://www.viddler.com/explore/dolcera/videos/6/ Video])&lt;br /&gt;
* [[Virtualization]]&lt;br /&gt;
* [[Cloud Computing]]&lt;br /&gt;
* [[Estimation of liquid carrying vehicles in USA]]&lt;br /&gt;
* [[A market study on Hybrid vehicles and the concept of V2G]]&lt;br /&gt;
* [[Patent Valuation]]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
&lt;br /&gt;
===Finance===&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; valign=top width=50% align = &amp;quot;left&amp;quot;|&lt;br /&gt;
===Others and CPG===&lt;br /&gt;
|-&lt;br /&gt;
| valign=top |&lt;br /&gt;
* [[Innovative personal finance products]]&lt;br /&gt;
* [[Life Insurance Industry in US]]&lt;br /&gt;
| valign=top |&lt;br /&gt;
*[[Deodorants Market Analysis: Acquisition of Sanex by Colgate]]&lt;br /&gt;
*[[Partner in sales planning]]&lt;br /&gt;
&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
== Dolcera Technology Platforms ==&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9;width:100%&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;top&amp;quot; |&lt;br /&gt;
&lt;br /&gt;
==== Dashboard 1.1 ====&lt;br /&gt;
* [http://www.dolcera.com/auth/dashboarddemo/dashboard.php?workfilegroup_id=154 Demo Dashboard (Alopecia)]  &lt;br /&gt;
** [[Access details]]&lt;br /&gt;
* [[Sample list of patent numbers]]&lt;br /&gt;
* [http://www.dolcera.com/auth/index.php Dashboard login page]&lt;br /&gt;
&lt;br /&gt;
==== [[Workflow for creating a Dashboard]] ====&lt;br /&gt;
&lt;br /&gt;
==== IP and Products dashboard ====&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfilegroup_id=10 Alopecia areata dashboard] &lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/stent_model.swf Stent dashboard]&lt;br /&gt;
* [[Legal Updates Demo|Legal updates dashboard]]&lt;br /&gt;
* [http://client.dolcera.com/dashboard/dashboard.html?workfile_id=54 4G wireless product and patent dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Patent-pathway mapping ====&lt;br /&gt;
* [[Inflammation and cardiovascular drugs#Interactive signaling pathways and patents|Patent-pathway mapping]]&lt;br /&gt;
==== Sequence dashboard ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dna/main.html Sequence dashboard]&lt;br /&gt;
&lt;br /&gt;
==== Design analysis ====&lt;br /&gt;
* [http://www.dolcera.com/website/demos/dental/main.html Dental Implant Design Analysis]&lt;br /&gt;
&lt;br /&gt;
==== Innovation explorer ====&lt;br /&gt;
* [http://www.dolcera.com/ipmapdemo/innovation_explorer/innovation_explorer.html Household robotics innovation explorer]&lt;br /&gt;
==== KPort ====&lt;br /&gt;
* [http://dolcera.com/website/demos/kport/main.html Collaboration Portal]&lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;Dolcera Offerings summary &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
* [[Dolcera Offerings|Dolcera offerings summary]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;3&amp;quot;&amp;gt;&amp;lt;b&amp;gt;[[Technology Support]] &amp;lt;/b&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;font size = &amp;quot;4&amp;quot;&amp;gt;&amp;lt;span style=&amp;quot;color:#C41E3A&amp;quot;&amp;gt;Like any of these sample reports?&amp;lt;/span&amp;gt;&amp;lt;/font&amp;gt;&lt;br /&gt;
&amp;lt;p align=&amp;quot;center&amp;quot;&amp;gt; '''These are sample reports with brief analysis''' &amp;lt;br&amp;gt;&lt;br /&gt;
'''Dolcera can provide a comprehensive report customized to your needs'''&amp;lt;/p&amp;gt;&lt;br /&gt;
{|border=&amp;quot;2&amp;quot; cellspacing=&amp;quot;0&amp;quot; cellpadding=&amp;quot;4&amp;quot; align=&amp;quot;center&amp;quot; &amp;quot;&lt;br /&gt;
|style=&amp;quot;background:lightgrey&amp;quot; align = &amp;quot;center&amp;quot;  colspan = &amp;quot;3&amp;quot;|'''[mailto:info@dolcera.com &amp;lt;span style=&amp;quot;color:#0047AB&amp;quot;&amp;gt;Buy the customized report from Dolcera&amp;lt;/span&amp;gt;]''' &lt;br /&gt;
|-&lt;br /&gt;
| align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services Patent Analytics Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/business-research-services Market Research Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools/patent-dashboard Purchase Patent Dashboard]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Landscape Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/research-processes Dolcera Processes]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/industries Industry Focus]&lt;br /&gt;
|-&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/patent-search/patent-landscapes Patent Search Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/services/ip-patent-analytics-services/alerts-and-updates Patent Alerting Services]&lt;br /&gt;
|align = &amp;quot;center&amp;quot;| [http://www.dolcera.com/website_prod/tools Dolcera Tools]&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
{| style=&amp;quot;border:1px solid #AAA; background:#E9E9E9&amp;quot; align=&amp;quot;center&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Contact Dolcera&lt;br /&gt;
|-&lt;br /&gt;
! style=&amp;quot;background:lightgrey&amp;quot; | Samir Raiyani&lt;br /&gt;
|-&lt;br /&gt;
| '''Email''': [mailto:info@dolcera.com info@dolcera.com]&lt;br /&gt;
|-&lt;br /&gt;
| '''Phone''': +1-650-269-7952, +91-40-2355-3493&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	<entry>
		<id>https://www.dolcera.com/wiki/index.php?title=File:Lg_supply_chain.jpeg&amp;diff=9631</id>
		<title>File:Lg supply chain.jpeg</title>
		<link rel="alternate" type="text/html" href="https://www.dolcera.com/wiki/index.php?title=File:Lg_supply_chain.jpeg&amp;diff=9631"/>
				<updated>2011-09-15T10:09:09Z</updated>
		
		<summary type="html">&lt;p&gt;Amika.sethi: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>Amika.sethi</name></author>	</entry>

	</feed>